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Mosaic genetic analysis has been widely used in different model organisms such as the fruit 
fly to study gene-function in a cell-autonomous or tissue-specific fashion. More recently, and 
less easily conducted, mosaic genetic analysis in mice has also been enabled with the ambition 
to shed light on human gene function and disease. These genetic tools are of particular 
interest, but not restricted to, the study of the brain. Notably, the MADM technology offers a 
genetic approach in mice to visualize and concomitantly manipulate small subsets of 
genetically defined cells at a clonal level and single cell resolution. MADM-based analysis has 
already advanced the study of genetic mechanisms regulating brain development and is 
expected that further MADM-based analysis of genetic alterations will continue to reveal 
important insights on the fundamental principles of development and disease to potentially 
assist in the development of new therapies or treatments. 
In summary, this work completed and characterized the necessary genome-wide genetic tools 
to perform MADM-based analysis at single cell level of the vast majority of mouse genes in 
virtually any cell type and provided a protocol to perform lineage tracing using the novel 
MADM resource. Importantly, this work also explored and revealed novel aspects of 
biologically relevant events in an in vivo context, such as the chromosome-specific bias of 
chromatid sister segregation pattern, the generation of cell-type diversity in the cerebral 
cortex and in the cerebellum and finally, the relevance of the interplay between the cell-
autonomous gene function and cell-non-autonomous (community) effects in radial glial 
progenitor lineage progression.  
This work provides a foundation and opens the door to further elucidating the molecular 
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1 Chapter 1 – Introduction 
 
1.1 Thesis Outline 
This thesis consists of different projects outlined throughout 5 chapters. The main and 
unifying topic is the mosaic genetic analysis to study gene function in mice in vivo. 
The first chapter consists of a general introduction to cortical development in mice and to the 
MADM technology, a powerful genetic tool to perform genetic mosaic analysis at single cell 
level in mice. In general, mosaic genetic analysis in mammals has been enabled in different 
modalities with the ambition to shed light on human gene function and disease. This chapter 
includes the content of two preview articles that I wrote together with my supervisor for 
articles in the journals Brain and Neuron which discuss important aspects of cortical 
development and neural progenitor proliferation behavior. 
The second chapter consists of a manuscript that we have submitted for publication and 
discusses the extension of the MADM technology (Mosaic Analysis with Double Markers) to 
all mouse autosomes. Notably, the MADM technology has already advanced the study of 
genetic mechanisms regulating brain development. Consequently, it is expected that MADM-
based analysis of genetic alterations will continue to reveal important insights on the 
fundamental principles of development and disease to potentially assist in the development 
of new therapies or treatments. The extension of the MADM resource now enables the 
genetic dissection of the cell-autonomous function of the vast majority (>96%) of mouse 
genes in virtually any cell-type. 
The novel transgenic MADM mice were generated in collaboration with T. Rülicke from the 
VetMedUni Wien and with past members of the Luo lab at Stanford University. Next, I 
validated the use of all transgenic mice across a variety of organs and in clinically relevant 
stem cell niches with technical support from a number of lab members and rotation students. 
In order to get insights into chromosome biology I capitalized on the novel MADM resource 
and its property of inducing interchromosomal recombination to trace sister chromatid 
segregation upon mitosis for the first time comprehensively for all mouse autosomes and in 






The third chapter consists of two collaborative projects on clonal analysis using MADM; a 
protocol published in the jorunal JoVE and a preprint published in the repository bioRxiv. 
Clonal analysis using MADM provides a unique quantitative framework to measure the 
proliferative behavior, cellular output, and lineage relationship of individual progenitors and 
their daughter cells. In the interest of making available methods to exploit the MADM 
resource, I have contributed together with other Hippenmeyer lab members to the 
generation of a protocol to perform lineage tracing and functional genetic analysis of 
candidate genes at a single cell level using MADM. Furthermore, I have illustrated the 
applicability and power of MADM-based clonal analysis by contributing to the MADM analysis 
of sparse clones in the cerebellum to gain insights into cerebellar neuronal diversity in a 
collaborative effort led by the Hassan lab.  
The fourth chapter consists of unpublished data and discusses the functional genetic analysis 
of the Pten gene using MADM. PTEN mutations in human are responsible of neurological 
deficits and cortical abnormalities, thus, it is expected that Pten has a critical role in neural 
stem cell lineage progression. In order to investigate its role during different steps of neural 
stem cell lineage progression I established a quantitative genetic strategy with technical 
support from a lab technician and 2 interns. I then investigated the cell-autonomous function 
and cell-non-autonomous effects of Pten in neurogenesis and astrocyte production. 






1.2 The Cerebral Cortex 
 
The mammalian cerebral cortex is the seat of cognitive abilities, sensory perception and 
consciousness. It is a complex, highly organized six-layered structure composed of hundreds 
of different neuronal cell types and glia cells. Distinct neuronal populations are located in 
different cortical layers and areas and have unique morphological features and transcriptional 
signatures. Briefly, there are two main classes of cortical neurons; projection neurons and 
interneurons. Projection neurons display excitatory properties and may extend axons to 
distant areas within and beyond the cortex, whereas interneurons display inhibitory 
properties and form local connections. Projection neurons are generated from progenitors in 
the dorsal telencephalon. In contrast, interneurons are generated mainly from progenitors in 
the ventral telencephalon and migrate towards their final location within the cortex (Greig et 
al., 2013; Molyneaux et al., 2007). 
Yet, how the cortex arises from NSCs in the developing brain remains a major unsolved 
question. The programs regulating the generation of postmitotic neurons and glia by NSCs 
need to be precisely implemented in order to ensure proper development of the cerebral 
cortex. Impairments in neurogenesis lead to alterations of the cortical cytoarchitecture, which 
is generally thought to reflect the underlying cause for neurodevelopmental disorders in 
human such as lissencephaly, microcephaly, megalencephaly, autism and epilepsy (Barkovich 
et al., 2015; Hu et al., 2014; Silbereis et al., 2016) (Figure 1). 
Impairments in cortical development can lead to alterations of the cortical 
cytoarchitecture and result in neurodevelopmental disorders such as lissencephaly, 
microcephaly, megalencephaly, autism and epilepsy. In some instances, mutations in 
critical genes for cortical development have been identified and further studied. 




1.3 Neural Stem Cell Lineage Progression across Time in Mice 
 
In mice, the cerebral cortex develops from the early neuroepithelium, composed by a 
common progenitor cell type known as neuroepithelial stem cell (NESC), that gives rise to all 
subsequent neural progenitor cells and to different neuronal lineages (Figure 2). Initially, 
NESCs amplify their own pool and around embryonic day (E) 9 begin to transform into radial 
glial progenitor (RGP) cells (Howard et al., 2008). RGPs are the major neural progenitors in 
the developing cortex and their division dynamics along a precise temporal lineage 
progression determine the final number of neurons in the mature cortex (Beattie and 
Hippenmeyer, 2017; Lodato and Arlotta, 2015; Taverna et al., 2014).  
RGPs may perform symmetric or asymmetric mitotic cell division at the surface of the 
ventricular zone (VZ). RGPs initially undergo symmetric proliferative divisions where each RGP 
generates two RGPs in order to amplify the progenitor pool (Cai et al., 2002; Taverna et al., 
The cerebral cortex arises from the early neuroepithelium, lined by neuroepithelial stem cells 
(NESCs), which will give rise to all neural progenitors and different neuronal lineages. Initially, 
NESCs amplify the pool of progenitors and then proceed to transform into radial glial 
progenitor (RGP) cells. RGPs may continue to amplify the pool or progenitors or to self-renew 
while generating different progenitor and neuronal cell types. Newly generated neurons 
proceed to migrate and form the cortical plate in an inside-outside fashion. That is, early born 
neurons settle at the lower-layers of the cortical plate, whereas late-born neurons settle at 
the upper-layers. RGP cells may also generate other types of progenitors that give rise to glia 
cells, including astrocytes. Finally, shortly postnatally, the neuroepithelium transforms and 
establishes the adult stem cell niche.  
  




2014). Subsequently, at around E12, RGPs transition into a neurogenic state and divide 
asymmetrically to renew a RGP and to additionally generate a neuron (Alvarez-Buylla et al., 
1998; García-Verdugo et al., 2002) or a transient amplifying progenitor, such as an 
intermediate progenitor (IP) that can continue to divide in the subventricular zone (SVZ) and 
further produce neurons (Noctor et al., 2004). The earliest born excitatory projection neurons 
split the preplate into the superficial marginal zone and the deeper subplate (Hoerder-
Suabedissen and Molnár, 2015; Luskin and Shatz, 1985) and eventually form the layer 6 of the 
cortex. Next, nascent neurons, generated through consecutive waves of neurogenesis, 
migrate radially along the RGP cell process through previously generated neurons and settle 
at the most superficial layer of the developing cortex where they proceed to mature, 
differentiate and connect with other neurons. Consequently, the 6 different layers of the 
cortex are generated in an ‘inside-outside’ fashion where early born neurons populate the 
deep layers (layers 5-6) and later born neurons populate the superficial layers of the cortex 
(layers 2-4) (Hansen et al., 2017; Hippenmeyer, 2014; Marín et al., 2010; Rakic, 2009). Deep 
layer neurons consist of corticofugal neurons that innervate brain regions beyond the cortex 
including the thalamus, brainstem and spinal cord. In contrast, superficial layer neurons 
consist of intracortical neurons which may project locally, ipsilaterally or to the contralateral 
hemisphere (Greig et al., 2013; Lodato et al., 2015). 
Neurogenesis finishes at around E17 and is generally known to be followed by gliogenesis 
(Costa et al., 2009; Magavi et al., 2012; Schmechel and Rakic, 1979; Voigt, 1989), where RGPs 
may also produce glia intermediate progenitors that give rise to glia cells, including astrocytes 
and oligodendrocytes, which are important for the development, maintenance and overall 
function of neuronal assemblies (Chung et al., 2015; Freeman and Rowitch, 2013). 
Nonetheless, the underlying principles that regulate glia production at the individual RGP 
level are not yet clear (Bayraktar et al., 2014; Molofsky and Deneen, 2015). Finally, shortly 
after birth the neuroepithelium transforms and establishes the adult stem cell niche within 
the lateral ventricle (Doetsch et al., 1999; Kriegstein and Alvarez-Buylla, 2009; Lim and 
Alvarez-Buylla, 2016). Importantly, the developmental programs that regulate the different 





1.4 Radial Glia Progenitor Behavior and Tiling 
 
The content of this section was published as a preview article for a paper in the journal Neuron 
and was modified for this thesis. 
 
Memo1 Tiles the Radial Glial Cell Grid 
Ximena Contreras1 & Simon Hippenmeyer1 
1 Institute of Science and Technology Austria, Am Campus 1, 3400 Klosterneuburg, Austria 
 
In mice, the mature cerebral cortex consists of six cortical layers with distinct cellular 
composition. During development, it emerges from radially migrating populations of 
nascent projection neurons that coalesce into stratified laminae. 
During early cortical development RGCs exhibit bipolar morphology with an apical process 
connecting to the ventricle and a basal process that spans the entire cortical wall up to the 
pial basement membrane. The apical endfeet of RGCs are anchored within the ventricular 
adhesion belt and the branches of the basal process integrate into the basal lamina in the 
pia. An intriguing property of RGCs, especially of their apical and basal processes, is their 
regularly spaced radial arrangement in the developing cortical wall. Such grid-like 
organization is also known as tiling in analogy to the regular space-filling pattern by tiles 
on a surface. Tiling of RGCs correlates with the emergence of radial cortical columns which 
show synchronized activity and represent a characteristic feature of cortical areas (Gao et 
al., 2013; Maruoka et al., 2017; Rakic, 2007). However, the relevance of a properly tiled 
RGC grid for the correct buildup of the cortical cytoarchitecture and the assembly of 
cortical microcircuits is not clear. Even more importantly, how tiling of RGCs emerges and 
is maintained in the course of the growing cortical wall during development is unknown. 
In (Nakagawa et al. 2019), the authors shine new light on the above questions. They 
revealed that the Mediator of cell motility (Memo1) plays an essential role in the 
determination of the tiled RGC scaffold, and that an intact tiled RGC grid is essential for 
cortical development at multiple levels (Figure 3). 
In order to probe the function of Memo1 in developing RGCs the authors employed genetic 
conditional loss of function (cKO) approaches coupled with sophisticated sparse labeling 




single cell resolution in wild-type and Memo1 mutant conditions. When the authors 
deleted Memo1 from developing RGCs they observed massive morphological alterations 
including excessive branching of the basal processes. Next, the authors evaluated the 
exuberant branching phenotype upon acute knock down of Memo1 function using live-
imaging. These experiments revealed that hyperbranching of the basal RGC process is a 
highly dynamic process with new branches continuously undergoing extension and 
retraction. Given the severe morphological defects the authors next evaluated the status 
of RGC tiling. Strikingly, the excessive branching of the basal processes altered the tiling of 
RGCs dramatically resulting in a non-uniform irregular pattern of the RGC grid. Thus, 
Memo1 appears to maintain tiled RGC organization by inhibiting the formation of ectopic 
branches in the basal process. How progenitor cell-type-specific is the function of Memo1? 
The authors found major defects also in the hippocampus and cerebellum, structures with 
prominent laminated architecture. Thus, Memo1 function appears not to be restricted to 
neocortical RGCs. Even in the postnatal neurogenic progenitor niche, located in lateral 
ventricle (LV), the loss of Memo1 disrupts the morphology and integration of radial glia-
like progenitors (i.e. type B cells). However, given that the postnatal stem cell niche 
emerges from the embryonic RGCs it is not clear whether aberrant Memo1-deficient RGCs 
give rise to defective B cells or whether Memo1 has additional cell-autonomous functions 
in postnatal stem cells. Interestingly, Memo1 cKO show an increased number of cortical 
astrocytes indicating indeed additional Memo1 functions. This is intriguing since astrocytes 
exhibit precise tiling, i.e. do not overlap their fine projections. Could Memo1 function be 
involved in astrocyte production and tiling to ensure complete coverage of the local 
neuropil, and if yes how? 
What are the consequences of aberrant RGC morphology and defective tiling for the 
establishment of the laminated cortical architecture? Given the role of polarized RGCs in 
providing a migration guide for nascent projection neurons, the authors hypothesized that 
the integrity of the RGC scaffold is crucial for neuronal migration and thus the orderly 
lamination of the cortical plate. Indeed, the laminar and columnar distribution of both, 
upper and lower layer, cortical projection neurons was abnormal in adult Memo1 cKO 
mice. Strikingly, when selectively deleting Memo1 only from postmitotic neurons but not 




cytoarchitecture observed in Memo1-deficient cortices stems from abnormal RGC radial 
migration trajectories thereby indirectly perturbing radial neuron migration. 
To gain mechanistic insights into the intracellular functions of MEMO1 in regulating RGC 
morphology the authors next investigated microtubule (MT) organization in Memo1-
deficient RGCs. They observed that Memo1 depletion significantly altered the MT 
populations in the RGC processes towards a higher proportion of MTs with tyrosinated 
tubulin, a feature of unstable and dynamic MTs. Taking a closer look, they found that MT 
filaments at the tips of the radial processes were highly dynamic and branched rapidly, and 
that the MT fibers in Memo1-depleted RGCs displayed increased MT catastrophe 
frequency. Interestingly, when the authors labeled MT ends with CAMSAP2-GFP, which 
can organize non-centrosomal MT nucleation sites, they observed increased numbers of 
CAMSAP2-nucleated comets which branched from the main MT fiber. Thus, disrupted 
intracellular MT organization and deregulated non-centrosomal MT nucleation, induced 
by loss of Memo1, may directly result in basal process hyperbranching. 
Because transport of cell-surface proteins, a process highly dependent on MT organization, 
is necessary for the polarized morphology of RGCs the authors also examined vesicle and 
protein trafficking. Labeling of cargo-transporting vesicles revealed slower movement and 
higher incidence of pauses in Memo1-depleted RGCs. Interestingly, the extracellular matrix 
receptor GPR56, known to be essential for pial basement membrane integrity (Li et al., 
2008) displayed decreased transport and insertion into the RGC basal endfeet. In summary, 
the emerging mechanistic model by Nakagawa and colleagues suggests that MEMO1 
regulates subcellular localization and MT organizing function of CAMSAP2 to maintain 
proper MT organization and polarized vesicle and protein trafficking along RGC basal 
processes. 
Altogether, the study by Nakagawa et al. not only advances our general understanding of 
the mechanisms regulating cortical lamination but raises a number of outstanding 
questions and opens up exciting avenues for future research. For instance, what are the 
mechanisms that establish an orderly tiled RGC grid form the outset? The function of 
Memo1 is critical to maintain the integrity of tiled RGC organization, by preventing 
hyperbranching. However, it will be important to decipher the molecular and cellular 




the pial surface during the transformation of the early neuroepithelium into the VZ, 
intermediate zone (IZ), and emerging cortical plate (CP). While concerted trafficking of cell-
cell adhesion complexes are likely to play a critical role at the ventricular surface (Beattie 
et al., 2017) and pial basement membrane (Li et al., 2008)  it is less clear how the basal 
processes are kept in place in the IZ and growing CP. Candidates are secreted signaling 
molecules that may act locally, specifically within distinct functional areas and/or at the 
global tissue level. The aberrant lamination in Memo1 cKO is likely to cause errors in the 
wiring of cortical microcircuits (Gao et al., 2013; Juric-Sekhar and Hevner, 2019) but even 
at the single cell level Nakagawa et al. have shown that migration and positioning of 
clonally-related Memo1-deficient cells is disturbed. Thus the local wiring of clonally-related 
cells (Gao et al., 2013) and at broader scale (Maruoka et al., 2017) seems to critically 
depend on the correct tiling and integrity of the RGC grid. Interestingly, cortical 
interneuron positioning is not affected in Memo1 cKO. However, since recent studies 
implicate critical reciprocal interactions between cortical projection- and interneurons, in 
terms of numbers regulated by cell death (Wong and Marín, 2019) and laminar positioning 
(Wester et al., 2019), it will be revealing to assess connectivity profiles of interneurons and 
Memo1-deficient projection neurons. How conserved is Memo1 function in RGC tiling 
across evolution. A recent study (Nowakowski et al., 2016) has shown that in human, 
during cortical development, the radial glia scaffold undergoes transformation into two 
morphologically and molecularly distinct radial glia subtypes, truncated and outer radial 
glia. How is the tiling of these distinct RGC types achieved and are the mechanisms 
conserved? Mutations in human MEMO1 have been found in patients suffering from 
autism spectrum disorders implying a relationship between Memo1 loss of function and 
the etiology of neurodevelopmental disease. It will thus be important to delineate the 
precise function of MEMO1 in human RGCs for the better understanding of the general 
mechanisms and also to obtain insights into disease etiology. Altogether, future studies 
aimed at addressing the above questions will provide a deeper understanding into the 
mechanisms of how tiling of RGCs is established and how it contributes to the assembly 





In the absence of Memo1 RGCs exhibit loss of tiling and irregular organization. These defects lead to 
aberrant cortical lamination and could reflect the underlying basis of neurodevelopmental diseases. 
 




1.5 Trafficking of Receptors During Cerebral Cortex Development 
 
The content of this section was published as a preview article for a paper in the journal Brain 
and was modified for this thesis 
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In the early 1940s, Leo Kanner studied a group of children with unusual behavior and a 
preference for isolation rather than social interaction. Kanner used the term ‘autism’ to 
describe the children’s symptoms. Nowadays this term has been replaced by a more inclusive 
one, autism spectrum disorder (ASD), to embrace a group of syndromes characterized by 
early dysfunction in verbal communication and social interaction, plus the presence of 
repetitive or restricted behaviors. Patients diagnosed with ASD often exhibit additional 
symptoms such as intellectual disability, epilepsy, motor abnormalities and/or speech delay. 
Over the course of 40 years and through a number of twin and family studies, it became clear 
that ASD shows phenotypic variability and has a strong hereditary component. The first 
genes implicated in ASD were identified in the 1990s, and many hundreds of mutations have 
subsequently been associated with ASD (De La Torre-Ubieta et al., 2016; Sztainberg and 
Zoghbi, 2016). Although this genetic complexity seems to imply highly divergent molecular 
pathways, recent studies suggest that the genes associated with ASD are functionally less 
diverse and converge along just a few signaling pathways such as chromatin remodeling, 
transcriptional regulation and synaptic function (De La Torre-Ubieta et al., 2016; Pinto et al., 
2014). Two prominent molecular cues that have been implicated in the aetiology of 
neurodevelopmental disorders such as ASD are the receptor tyrosine kinase (RTK) FGFR2 and 
the cell adhesion molecule (CAM) NEGR1. However, the roles of FGFR2 and NEGR1 in brain 
development in general, and the cellular processes prone to malfunction in disease states, 
are not well understood. In (Szczurkowska et al., 2018), the authors combine in vivo and in 
vitro experiments to reveal a novel functional relationship between NEGR1 and FGFR2, which 
is critical for neuronal migration, morphological maturation, and the establishment of 




In order to probe the function of NEGR1 and FGFR2, the authors used in utero 
electroporation to knockdown Negr1 and Fgfr2 during critical windows of cerebral cortex 
development. This revealed that knockdown of Negr1 or Fgfr2 results in long-lasting 
neuronal migration deficits. Thus, neurons that lack NEGR1 or FGFR2 fail to migrate to their 
correct terminal locations and fail to incorporate properly into cortical microcircuits. 
Neurons with loss of NEGR1 or FGFR2 also displayed a number of morphological 
abnormalities including dendritic arborization defects and decreased spine density. Next the 
authors investigated the consequences of Negr1 or Fgfr2 knockdown at the behavioral level. 
Although in utero electroporation only allows targeting of a limited number of neurons at 
defined developmental time points and in specific brain regions, the authors observed 
significant deficits in core behaviors related to ASD upon knockdown of Negr1 or Fgfr2. 
Strikingly, 4-day-old pups vocalized less than controls and 3-week-old mice showed reduced 
social sniffing. Moreover, downregulation of either Negr1 or Fgfr2 resulted in delayed pain 
responses in 9-day-old pups. To validate their findings, the authors also tested Negr1 
knockout mice, and found that these animals displayed phenotypes consistent with those of 
mice from in utero electroporation experiments.  
Given the similar phenotypes upon downregulation of Negr1 or Fgfr2, Szczurkowska et al. 
hypothesized that these seemingly distinct signaling modules may converge in a functionally 
relevant manner. To this end they performed a series of biochemical and in vitro cell culture 
experiments. These revealed that NEGR1 and FGFR2 physically interact and that this 
interaction sustains FGFR2 downstream signaling via ERK and AKT kinases. Mechanistically, 
the NEGR1-FGFR2 interaction prevents FGFR2 from being routed to the lysosomal 
degradation compartment (and thereby removed from downstream signaling) upon 
endocytosis. Instead, the binding of NEGR1 to FGFR2 results in the maintenance of 
downstream ERK and AKT signaling, and trafficking of FGFR2 back to the plasma membrane 
via intracellular recycling pathways. The authors then performed rescue experiments, and 
showed that the neuronal migration deficits, spine defects and core behaviors related to ASD 
resulting from Negr1 downregulation could be prevented by Fgfr2 overexpression. However, 
altered dendritic morphology and pain sensitivity were not corrected under such conditions. 
In summary, NEGR1 and FGFR2 cooperate to control a common signaling pathway regulating 




behavior. In contrast, dendritic arborization and pain sensitivity appear to be regulated by 
independent NEGR1 and FGFR2 functions (Figure 4). 
The mechanistic model emerging from this study raises a number of important questions to 
address in the future. First, how cell-type specific is the interaction between NEGR1 and 
FGFR2? While FGFR2 appears to be ubiquitously expressed in the developing cerebral cortex, 
NEGR1 shows more restricted expression. Thus, distinct cortical cell types may employ other 
CAMs to regulate FGFR2 trafficking and/or signaling during neuronal migration and 
maturation. Furthermore, functional complexes of different CAMs and distinct RTKs may 
converge on ERK and AKT signaling hubs to regulate cortical development. Since not all Negr1 
loss of function phenotypes could be rescued by overexpression of Fgfr2, it will be 
particularly interesting to determine the unique roles of NEGR1 and FGFR2 in dendritic 
branching and the development of pain sensitivity behaviors. But most importantly, the 
model proposed by Szczurkowska et al. implies distinct intracellular trafficking routes for 
FGFR2 depending on the presence or absence of interaction with NEGR1. What are the 
molecular mechanisms downstream of the NEGR1-FGFR2 complex that prevent FGFR2 from 
becoming subject to lysosomal degradation? NEGR1 is a GPI (glycophosphatidylinositol)-
linked protein. Since GPI-linked proteins are thought to localize to plasma membrane 
microdomains with a high level of organization, one possibility is that the NEGR1-FGFR2 
complex may be directed to such domains to ensure sustained ERK/AKT-signaling, rather 
than routing to the lysosome for degradation. Future experiments should reveal the precise 
molecular and intracellular function of the NEGR1-FGFR2 complex in developing cortical 
neurons. In a broader context, the emerging mechanistic framework of CAM-RTK interaction 
and signaling is important because concerted intracellular trafficking of CAMs and RTKs is 
relevant to a number of developmental processes (Miaczynska, 2013). For instance, 
regulated endocytosis, intracellular trafficking and secretion of the N-cadherin (CDH2) cell 
adhesion molecule are critical for embryonic stem cell behavior (Jossin et al., 2017) and 
neuronal migration (Hippenmeyer, 2014; Kawauchi et al., 2010) during cortical 
development. Furthermore, the tuning of growth factor receptor levels at the plasma 
membrane and/or intracellular trafficking of the receptor signaling complex has been 




Szczurkowska et al. have thus uncovered a crucial molecular mechanism underlying aberrant 
cortical development and ASD-related behaviors. However, the precise nature of the deficits 
at the physiological and circuit level remain to be addressed. For instance, how do 
mispositioned neurons integrate into cortical microcircuits upon Negr1 or Fgfr2 
downregulation? Since dendritic arborization and spine density are severely affected in 
Negr1 or Fgfr2 knockdown conditions, these neurons are likely to have aberrant 
excitation/inhibition profiles, which is in fact thought to represent part of the underlying 
aetiology of ASD (Bourgeron, 2015). It will thus be important to decipher the precise 
physiological deficits at the circuit and systems levels, in mice with Negr1 or Fgfr2 loss of 
function, in order to understand the basis of the ASD-like behavioral profiles. In a broader 
context, future studies addressing the above questions will provide a deeper understanding 
of why human brain development is so sensitive to disruption of specific molecular signaling 






(A) NEGR1 exists in a soluble or membrane-bound form and regulates FGFR2 cellular trafficking by favoring 
recycling of the receptor instead of its lysosomal degradation. The majority of FGFR2 signaling occurs 
within the endocytic pathway (early endosome) and results in the phosphorylation of ERK (p-ERK) and AKT 
(p-AKT), which in turn activate essential downstream signaling pathways controlling neuronal migration 
and dendritic maturation. 
(B) Control animals display normal neuronal migration and development of dendritic spines, as well as 
normal communication, social behavior and sensitivity to pain. 
(C) In utero electroporation–mediated knockdown of Negr1 results in FGFR2 degradation as opposed to 
recycling. This leads to decreased ERK and AKT phosphorylation, which results in defective neuronal 
migration and dendrite development. 
(D) In utero electroporation–mediated knockdown of Fgfr2 results in decreased ERK and AKT 
phosphorylation, and defective neuronal migration and dendrite development. 
(E) In utero electroporation–mediated knockdown of either Negr1 or Fgfr2 results in defective cortical 
development (incomplete neuronal migration and a decreased number of dendritic spines), and deficits in 
core ASD-related behaviors (reduced ultrasonic vocalization in pups, reduced social sniffing in juvenile mice 
and reduced pain sensitivity). 
(F) Knockdown of Negr1 with concomitant Fgfr2 overexpression can rescue some of the phenotypes 
associated with Negr1 downregulation. Neuronal migration, dendritic spine formation, communication 
and social behavior are rescued. Pain sensitivity and dendritic arborization remain impaired. 
Figure 4. NEGR1-dependent Modulation of FGFR2 and Downstream AKT and EKT 




1.6 MADM for Studying NSC Cell Behavior at Single Cell Resolution 
 
MADM provides an unambiguous quantitative optical readout of the precise proliferation 
mode of dividing stem cells at single-cell and temporal resolution in vivo. MADM, in 
combination with Cre or tamoxifen (TM)-inducible CreER, can induce sparse clones of 
distinctly labeled (red/green) daughter cells originating from a single dividing progenitor in a 
temporally defined fashion. An important MADM feature is the possibility to introduce a 
candidate gene mutation allowing clonal/sparse two-color labeling with concomitant genetic 
manipulation (Gao et al., 2014; Hippenmeyer et al., 2010, 2013; Zong et al., 2005). Recently, 
by systematically applying MADM in embryonic stages, the Hippenmeyer laboratory analyzed 
neurogenesis in the mouse neocortex and found that RGP behavior has a deterministic nature 
(Beattie et al., 2017; Gao et al., 2014). They found that RGPs first divide symmetrically at a 
predictable rate before they produce a unit of about 8-9 neurons, and that about 16% of RGPs  
generate glial cells as well (Figure 5). Nevertheless, the underlying mechanisms remain 
unknown. Thus, MADM-based lineage tracing has led to an inaugural quantitative framework 
characterized by highly deterministic RGP proliferation behavior in distinct temporal 
windows, from which a number of outstanding mechanistic questions emerge. Most 
importantly, which signaling pathways control RGP proliferation behavior determining the 
unit size and therefore also the global brain size. To this end, is important to investigate the 
functional requirement of candidate genes, at sequential stages during RGP lineage 
progression, which when mutated in human lead to cortical abnormalities such as 






Figure 5. MADM for Studying NSC Cell Behavior at Single Cell Resolution. 
MADM-based lineage tracing has led to a quantitative framework characterized by highly deterministic RGP 
proliferation behavior in distinct temporal windows. RGPs first divide symmetrically at a predictable rate 
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A Genome-wide Library of MADM Mice for Single-Cell Genetic Mosaic 
Analysis 
2.2 Summary  
 
Mosaic Analysis with Double Markers (MADM) offers a unique approach to visualize and 
concomitantly manipulate genetically-defined cells in mice with single-cell resolution. MADM 
applications include the analysis of lineage; single-cell morphology and physiology; genomic 
imprinting phenotypes; and dissection of cell-autonomous gene functions in vivo in health 
and disease. Yet, MADM could only be applied to <25% of all mouse genes on select 
chromosomes thus far. To overcome this limitation, we generated transgenic mice with 
knocked-in MADM cassettes near the centromeres of all 19 autosomes and validated their 
use across organs. With this resource, >96% of the entire mouse genome can now be 
subjected to single-cell genetic mosaic analysis. Beyond proof-of-principle, we applied our 
MADM library to systematically trace sister chromatid segregation in distinct mitotic cell 
lineages. We found striking chromosome-specific biases in segregation patterns, reflecting a 







Genetic mosaic individuals contain cells of distinct genotypes. The phenomenon of genetic 
mosaicism occurs naturally and is widespread across multicellular organisms. Mosaicism may 
progressively emerge during life but remain silent with no obvious or severe phenotypic 
consequences for extended periods of time (Yizhak et al., 2019). However, mosaicism is also 
associated with a number of pathologies in human including cancer which emerges as a clone 
of one mutated single cell, or many neurological disorders affecting brain development and 
function (Biesecker and Spinner, 2013; D’Gama and Walsh, 2018) Genetic mosaic animals 
have been experimentally created in a number of species including C. elegans, Drosophila, 
and mice among others; and such mosaic analyses provided many fundamental insights in a 
variety of biological systems (Germani et al., 2018; Kim et al., 2019; Lee and Luo, 1999, 2001; 
Lozano and Behringer, 2007; Luo, 2007; Rossant and Spence, 1998; Xu and Rubin, 1993; 
Yochem and Herman, 2003; Zong et al., 2005; Zugates and Lee, 2004). 
One of the most powerful applications inherent to induced genetic mosaics is the ability to 
alter gene function at high spatiotemporal resolution. In other words, a certain tissue can 
contain homozygous mutant cells for a gene of interest and wild-type cells in the same animal 
whose phenotypes can be compared with each other directly. If the genetic mosaic is sparse, 
even essential genes can be manipulated without affecting the overall health or viability of 
the animal. Furthermore, sparse genetic mosaics provide a highly effective means to study 
the causal relationship of genetic alteration and phenotypic manifestation at the individual 
cell level. Genetic mosaics also facilitate the analysis of cell competition and provide an assay 
to create models of disease. Historically, for over a century and up to date genetic mosaics 
have been most extensively generated and used in the fruit fly by capitalizing upon mitotic 
recombination between homologous chromosomes (Bridges and Morgan, 1919; Hotta and 
Benzer, 1970; Lee and Luo, 1999; Stern, 1936; Xu and Rubin, 1993; Zugates and Lee, 2004). 
Although technically slightly more challenging, the generation of genetic mosaics in mice - 
one of the most widely used model organisms to study gene function in health and disease - 
is becoming routine. A number of experimental approaches have been established including 
Mosaic Analysis with Double Markers (MADM) which is also based on mitotic recombination 




MADM relies on Cre/LoxP-mediated interchromosomal recombination to simultaneously 
generate homozygous mutant cells for a candidate gene of interest and wild-type cells in an 
otherwise heterozygous background. The induction of genetic mosaicism can be 
spatiotemporally controlled in genetically-defined cell-types by the use of tissue-specific 
Cre/ER-driver lines. Concurrent to the generation of genetic mosaicism, two split genes, 
encoding green fluorescent protein (GFP) and tdTomato (tdT) fluorescent markers, are 
reconstituted permitting unequivocal tracing of individual cellular phenotypes in mutant, 
heterozygous and wild-type cells, each labelled in distinct colors with 100% accuracy 
(Hippenmeyer et al., 2010; Zong et al., 2005) (Figure 6A; Figure 12). 
One application of the MADM technology is lineage tracing - analysis of cell division patterns 
and distribution of clonally-related cells that constitute different parts of an organ. The 
temporally controlled induction of MADM with its dual marker property provides exact and 
unique information not only about birth dates of clones but also regarding their cell division 
patterns. Thus, MADM has been frequently utilized in the past to study the proliferation 
behavior of progenitor stem cells in a variety of tissues - including embryonic and adult neural 
stem cells (Beattie et al., 2017; Bonaguidi et al., 2011; Espinosa and Luo, 2008; Gao et al., 
2014; Kaplan et al., 2017; Liang et al., 2013; Llorca et al., 2019; Lv et al., 2019; Mayer et al., 
2015; Mihalas and Hevner, 2018; Ortiz-Álvarez et al., 2019; Picco et al., 2019; Shi et al., 2017; 
Wong et al., 2018); cardiomyocyte- (Ali et al., 2014; Devine et al., 2014; Mohamed et al., 2018) 
and pancreatic progenitor cells (Brennand et al., 2007; Desgraz and Herrera, 2009; Salpeter 
et al., 2010); progenitors in the developing kidney (Riccio et al., 2016); and mesenchymal 
progenitors in the developing lung (Kumar et al., 2014). MADM enables high resolution single 
cell/clonal labeling and permits tracing of complex morphogenetic processes in 4D by using 
live-imaging over prolonged periods besides analysis of static time points (Hippenmeyer et 
al., 2010; Riccio et al., 2016). 
MADM technology has recently emerged as a unique approach to probe genomic imprinting 
and the function of individual imprinted genes (Hippenmeyer et al., 2013; Laukoter et al., 
2020). Genomic imprinting is a prevalent epigenetic phenomenon in placental mammals and 
results in the preferential expression of either the maternal or paternal inherited allele of a 
subset of genes (Barlow and Bartolomei, 2014; Ferguson-Smith, 2011; Tucci et al., 2019). 




two copies of either the maternal or paternal chromosome) and visualize imprinting effects 
at morphological and transcriptional level with single cell resolution (Hippenmeyer et al., 
2013; Laukoter et al., 2020). 
Perhaps the most salient and unique property of the MADM technology is to create genetic 
mosaicism and thus conditional gene knockouts in single cells with 100% correlation between 
fluorescent labeling and genetic alteration (Beattie et al., 2017; Espinosa et al., 2009; Gao et 
al., 2014; Henderson et al., 2019; Hippenmeyer et al., 2010; Joo et al., 2014; Liang et al., 2013; 
Lv et al., 2019; Ortiz-Álvarez et al., 2019; Riccio et al., 2016). MADM-labeled wild-type and 
mutant cells in mosaic mice can be directly assessed by histological means, physiological 
analysis, and optical imaging in vivo. One clinically-relevant application of MADM is the tracing 
of tumor growth upon ablation of tumor suppressor genes in a small subset of cells in a 
particular tissue. Cells that are homozygous mutant for a candidate tumor suppressor gene 
are uniquely labeled and can be followed dynamically in vivo to study tumor progression and 
metastasis and/or to assay for the effects of therapeutic agents. As such, MADM has been 
used for the analysis of tumor formation and the delineation of cancer cell of origin at single 
cell level in the brain and distinct organs (Gonzalez et al., 2018; Liu et al., 2011; Muzumdar et 
al., 2016; Yao et al., 2020). MADM could in principle be exploited to systematically study the 
loss of any tumor suppressor in the entire genome and for identifying the cellular origins of a 
wide variety of cancers. 
The single cell phenotype in classic conditional or full knockout mutants often reflects a 
combination of both cell-autonomous gene function and environment-derived cues which 
may remedy or exacerbate any observed phenotype. It is thus important in genetic loss of 
function models to qualitatively and quantitatively determine the relative contributions of 
the intrinsic and extrinsic components to the overall loss of function phenotype. To this end, 
the MADM system offers an unmatched experimental solution. The candidate gene function 
can be either ablated in just very sparse mosaic and/or single clones (see above), or tissue-
wide in all cells. However in both paradigms, single cell MADM labeling enables the high 
resolution quantitative phenotypic analysis (Beattie et al., 2017; Joo et al., 2014; Laukoter et 
al., 2020). The above paradigms thus potentially permit systematic dissection of the level of 





A major current limitation of the MADM technology is that it can only be applied to study 
candidate genes located on Chr. 7, Chr. 11, Chr. 12, and distal to the Rosa26 locus on Chr. 6, 
where MADM cassettes have been introduced (Hippenmeyer et al., 2010, 2013; Zong et al., 
2005). Thus, less than 25% of all genes in the mouse genome can be subjected to MADM 
analysis as described above. Here we overcome this constraint and expanded MADM 
technology to all mouse autosomes. We provide validation of all MADM reporters and 
quantitative assessment of the efficacy of MADM labeling in a variety of organs, tissues and 
a number of clinically-relevant stem cell niches across the entire mouse. Furthermore, we 
utilized the newly engineered MADM chromosomes to systematically determine sister 
chromatid segregation patterns in several somatic cell lineages. Our analysis revealed for the 
first time in vivo that sister chromatid segregation patterns in mitotic progenitor cell divisions 
are highly biased in a chromosome-specific manner, and are further affected by cell type. 
 
2.4 Results  
 
 Expansion of MADM to all Mouse Autosomes 
For MADM, two reciprocally chimeric marker genes need to be targeted to identical loci on 
homologous chromosomes (Zong et al., 2005). The chimeric marker genes (GT and TG alleles) 
consist of N- or C-terminal halves of the coding sequences for green (enhanced green 
fluorescent protein, [G]) and red (tdTomato, [T]) fluorescent proteins interspersed by an 
intron with the loxP site (Hippenmeyer et al., 2010) (Figure 6A; Figure 12). Here we expand 
MADM to all nineteen mouse autosomes with the goal to enable MADM for the vast majority, 
nearly genome-wide, of autosomal genes in the mouse genome. Mouse autosomes consist of 
only one chromosome arm (i.e. telocentric conformation). We thus rationalized that inserting 
the MADM cassettes as close as possible to the centromere would maximize the number of 
genes located distally to the MADM cassette insertion site for prospective MADM 
experiments (Hippenmeyer et al., 2010, 2013) (Figure 6A and 6B). 
To identify suitable genomic loci for MADM cassette targeting, we applied a number of key 
criteria besides the one of closest possible distance to the centromere (Hippenmeyer et al., 




probability of disrupting endogenous gene function; and 2) permit spatially and temporally 
ubiquitous and biallelic expression of the reconstituted GFP and tdT markers. To fulfill the first 
criteria we mapped gene-by-gene the genetic landscape of the centromeric-most 20 Mbp of 
all autosomes using the UCSC Genome Browser (www.genome.ucsc.edu; GRCm38/mm10); 
except Chr 7, 11 and 12 which previously have been rendered MADM-ready by employing the 
above criteria (Hippenmeyer et al., 2010, 2013). Next, we anticipated that the broadness of 
spatial and temporal EST (expression sequence tag) expression patterns of the neighboring 
genes flanking the putative targeting site would serve as proxy for the spatiotemporal extent 
of transgene expression. The final choice of the prime targeting loci (Figure 6B, Figure 13, 
Table 1) was based upon the most ideal combination of the three above key criteria. In total, 
more than 20’000 protein-coding genes, corresponding to >96% of the entire annotated 
mouse genome (GRCm38/mm10), are located distally to the MADM targeting loci across all 
19 autosomes (Table 1). 
Next, we cloned the selected genomic targeting loci, and inserted the MADM cassettes 
(Hippenmeyer et al., 2010) by homologous recombination in mouse ES cells (Figure 14, see 
Apendix for details). For most chromosomes, MADM cassettes were inserted in centromere-
to-telomere transcriptional direction (Figure 6B, forward) except for Chr. 3, Chr. 5, Chr. 6, and 
Chr. 15 which required opposite directionality (Figure 6B, reverse) in order to best fulfill our 
locus choice criteria. The direction of reconstituted MADM marker gene transcription, upon 
interchromosomal recombination, has consequences for the coupling of mutant and wildtype 
genotypes with fluorescent labeling upon mitosis (Figure 6C-D). In a typical MADM 
experiment for the phenotypic characterization of the single cell loss of a candidate gene the 
homozygous mutant cells are routinely labelled in green fluorescent color (i.e. GFP+). For 
chromosomes with ‘forward’ MADM cassette configuration the mutant allele of a candidate 
gene must therefore be linked to the T-G MADM cassette. In such arrangement homozygous 
mutant cells will be labeled in green (GFP+) and wild-type cells in red (tdT+) (Figure 6C, Figure 
12) upon a G2-X MADM event. Conversely, for chromosomes with ‘reverse’ MADM cassette 
configuration the mutant allele has to be linked to the G-T MADM cassette for the same 
genotype-labeling pattern (Figure 6D). In order to genetically link a mutant allele of a 
candidate gene to the corresponding chromosome containing the MADM cassette, meiotic 




2020)] (Figure 6E-F). The probability for meiotic recombination that results in the linkage of 
the mutant allele with the MADM cassette can be estimated (Figure 6F) once the location 
(cM) of the mutant allele (genomic locus) has been determined by using for example Mouse 
Genome Informatics (MGI) database (www.informatics.jax.org). 
Interestingly, homologous recombination frequencies in ES cells were relatively high for all 
selected loci (for some >50%), hinting at open chromatin structure which should be an 
advantage for prospective mitotic Cre-mediated interchromosomal recombination. Next, 
chimeric founder mice were generated by blastocyst injection. Homozygous MADMGT/GT and 
MADMTG/TG stock lines were established upon successful germline transmission of the 
respective MADM cassettes (Figure 14) by using specific genotyping primers (STAR Methods). 
 
 Ubiquitous MADM Labeling in all MADM Strains Across Different Organs 
Next, we systematically analyzed the MADM labeling pattern upon Cre-mediated 
interchromosmal recombination in all MADM lines by introducing Cre driver lines (Figure 
14E). First, we crossed all MADMGT/GT lines to mice that carry the Cre transgene within the X-
linked Hprt (encoding hypoxanthine guanine phosphoribosyl transferase) genomic locus 
(Tang et al., 2002). HprtCre is spatiotemporally ubiquitously and constitutively expressed (Tang 
et al., 2002). In female mice inactivation of the X chromosome results in mosaic Cre expression 
from the Hprt locus within tissues, and thus highly variable MADM labeling patterns 
(Hippenmeyer et al., 2013; Zong et al., 2005). We therefore analyzed male experimental 
MADM (MADMGT/TG;HprtCre/Y) animals for first pass comparative assessment of all MADM 
lines. We detected MADM labeling in all organs analyzed - including brain, spinal cord, eye, 
heart, lung, liver, kidney, thyme, and spleen (Figure 7A) - and in all MADM lines. The relative 
recombination frequency at least at this superficial qualitative level (see below for 
quantitative assessment) appeared to correlate in distinct selected organs across all 19 






 MADM Labeling in Clinically Relevant Adult Stem Cell Niches 
MADM has been frequently utilized in the past to study lineage progression of progenitor 
stem cells in a variety of tissues. Furthermore, MADM has been used for the analysis of 
diseases with clonal origin. Most prominently, tumor formation and the delineation of cancer 
cell of origin at single cell level upon the introduction of mutations in tumor suppressor genes 
and/or loss of heterozygosity has been studied (Gonzalez et al., 2018; Liu et al., 2011; 
Muzumdar et al., 2007, 2016; Yao et al., 2020). Given the enormous genome-wide potential 
inherent to the library of new MADM lines we next evaluated a number of stem cell niches 
with high clinical relevance. Since it is important to know the approximate scale of labeling 
for determining sample size in a MADM experiment, we chose two different new MADM 
models in combination with HprtCre for these analyses: MADM-19 which shows relatively 
dense MADM-labeling, and MADM-4 which represents one of the sparsest MADM. 
First, we focused on the mammary gland (Figure 7B), the site where breast cancer initiates. 
The mammary gland harbors two types of unipotent stem cell lineages, the K14+ 
myoepithelial (or basal) cells and the K8+ luminal cells (Van Keymeulen et al., 2011). 
Myoepithelial and luminal stem cell populations are derived from a multipotent progenitor 
during embryonic development (Wuidart et al., 2018) , become unipotent at birth and can 
both give rise to mammary tumors upon transformation. For example, the frequently 
detected oncogenic Pik3ca (H1047R) mutation induces reprogramming of the unipotent 
progenitors to become multipotent cancer stem cells, thereby catalyzing the formation of 
heterogeneous, multi-lineage mammary tumors (Van Keymeulen et al., 2015; Koren et al., 
2015). We evaluated MADM-labeling pattern in the postnatal mammary gland in adult 
lactating four month old female MADM-19GT/TG;HprtCre/+ (Figure 7B) and MADM-
4GT/TG;HprtCre/+ (Figure 17A) mice and could readily detect GFP+ (green), tdT+ (red), and 
GFP+/tdT+ (yellow) cells in both K14+ basal and the K8+ luminal cells. 
Next, we analyzed pancreatic epithelial cells which can be divided into secretory acinar cells 
and ductal epithelial cells. Although the tumor cell of origin for pancreatic cancer remains 
controversial, oncogenic drivers can trigger pancreatic ductal adenocarcinoma (PDAC) from 
both ductal and acinar cells (Ferreira et al., 2017; Lee et al., 2019). In both, MADM-
19GT/TG;HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice at P21 we noticed MADM-labeled cells in the 




Hair follicles are a prime stem cell model for the study of tissue regeneration but also for skin 
cancer including melanoma (Sun et al., 2019). Hair follicles are appendages of the epidermal 
lineage and undergo cycling rounds of stem cell activation in order to generate new hair 
(Fuchs and Nowak, 2008). The stem cells are located in the secondary hair germ (2° HG) and 
lower part of the bulge (Bu) of a resting follicle (so called telogen follicle) (Figure 7D). They 
become activated, start to proliferate and expand the hair follicle deep down into the dermis. 
Progenitors located at the bottom of the activated follicle (so called anagen follicle) form the 
matrix, from where epithelial hair lineages are specified (Hsu et al., 2014b). Such 
differentiated hair lineages comprise the companion layer (CP), distinct layers of inner root 
sheath (IRS), cuticle and cortex of the hair shaft (HS), as well as the innermost hair layer, the 
medulla (Me). Once hair regeneration is completed, the follicles undergo a destructive phase 
(so called catagen) and enter the quiescent resting phase again. In the skin of MADM-
19GT/TG;HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice we observed prominent MADM labeling in all 
compartments of the hair follicle and importantly in the hair follicle stem cells (Figure 7D and 
Figure 17C). 
Lastly, we analyzed MADM labeling in the small intestine which represents another critical 
model for the study of stem cell mediated regeneration but also intestinal cancer (Barker et 
al., 2009). Intestinal stem cells replenishing the epithelium are LGR5+ and located in the crypt 
base (Barker et al., 2007). They are intermingled with secretory Paneth cells and divide 
constantly in order to rejuvenate the epithelial cell layer on the villus surface. Interestingly, 
LGR5+ stem cells mostly divide symmetrically and undergo neutral competition within the 
crypt, thus driving the crypt towards monoclonality (Snippert et al., 2010). In order to evaluate 
the potential for MADM-based lineage tracing, the study of loss of gene function, and analysis 
of stem cell behavior in the intestinal crypts we dissected the intestine of MADM-
19GT/TG;HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice at P21. We observed MADM-labeled cells in 







 Genomic Imprinting Phenotypes in Liver Cells with Uniparental 
Chromosome Disomy 
MADM can create uniparental chromosome disomy (UPD, cells that carry two chromosomes 
from mother and maternally expressed imprinted genes are thus overexpressed whereas 
paternally expressed genes are not expressed and vice versa) (Figure 8A). This feature has 
been utilized to analyze imprinting phenotypes at single cell level that result from the 
imbalanced expression of imprinted genes in UPD (Hippenmeyer et al., 2013; Laukoter et al., 
2020). Importantly, the analysis of candidate gene function, i.e. loss of function phenotypes, 
can be separated from UPD-mediated imprinting phenotypes by reverse MADM breeding 
schemes (Beattie et al., 2017; Hippenmeyer et al., 2010, 2013; Joo et al., 2014; Laukoter et al., 
2020). So far, prominent imprinting phenotypes have mostly been observed in liver where for 
instance cells with MADM-induced UPD of Chr. 7 exhibit paternal overgrowth (Hippenmeyer 
et al., 2013), in accordance with the kinship hypothesis that stipulates a major growth 
regulatory function of genomic imprinting (Haig, 2004; Tucci et al., 2019). Since imprinted 
genes are located throughout the genome, we analyzed the livers in all 19 new MADMs in 
combination with Hprt-Cre (Figure 8B-U) for potential additional imprinting phenotypes. We 
readily observed the paternal growth advantage of hepatocytes with paternal UPD of Chr. 7 
(Figures 8H and 8V) but also noticed that cells with paternal UPD of Chr. 11 (Figures 8L and 
8V) and Chr. 17 (Figure 8R and 8V) showed significant overrepresentation in comparison to 
cells with maternal UPD. Interestingly, the maternally expressed growth inhibitory imprinted 
genes Grb10 and Igf2r are located on Chr. 11 and Chr. 17, respectively. Thus, while 
overexpression of growth promoting Igf2 in UPD of Chr. 7 leads to paternal growth dominance  
(Hippenmeyer et al., 2013) the absence of growth antagonizing Grb10 or Igf2r (Smith et al., 
2006) may result in the growth advantage of cells with paternal UPD of Chr. 11 or Chr. 17 over 
cells with maternal UPD. We did not find significant UPD-mediated phenotypes in the livers of 
any other MADM besides MADM-7, MADM-11 and MADM-17 (Figure 8B-U), nor an indication 






 Quantification of Recombination Efficiency of all MADM Chromosomes 
The new MADM reporter mice appeared to exhibit distinct frequencies of Cre-mediated 
interchromosomal recombination albeit relative abundance of MADM labeling appears similar 
across different organs such as for instance brain (Figure 9 and 18), kidney (Figure 15) or spleen 
(Figure 16). To more rigorously and systematically determine recombination frequencies 
comparatively in all MADMs we quantified the absolute densities of MADM-labeled neurons 
in the cerebral cortex of P21 mice by using Emx1-Cre driver (Figures 10A-B and 18). We first 
assessed MADM-labeling originating from G2-X events and quantified the numbers of green 
GFP+ and red tdT+ projection neurons per cubic millimeter (Figure 10A-B). The relative 
numbers of red tdT+ versus green GFP+ projection neurons was not significantly different 
across MADM lines (Figures 10B). Based on the density values we classified all the MADMs 
into three categories: 1) sparse with <25 cells/mm3; 2) intermediate with 25-100 cells/mm3 
and 3) dense with >100 cells/mm3. The density of MADM-labeled cortical projection neurons 
in the densest MADM-11 was almost 2 orders of magnitude higher than in the sparsest 
MADM-4 (Figures 10B). There was no correlation of the MADM recombination frequency with 
the size of the chromosome nor the density of genes located on a particular chromosome. 
Since all new MADM targeting loci have been selected by using the same criteria, the origin of 
the variability in recombination frequency across all MADMs is currently not clear. In mice, the 
pairing of homologous chromosomes in somatic cells is infrequent and under tight regulation, 
unlike in the fruit fly Drosophila (Apte and Meller, 2012). Thus the spatial and/or dynamic 
organization of homologous chromosomes within the nucleus may result in distinct 
probabilities of Cre-mediated interchromosomal recombination in different MADM 
chromosomes. Regardless of the precise mechanism, all MADM reporters do work as 
predicted from the MADM principle (Figures 6 and 12) in the brain (Figures 9, 10A-B and 18) 
and all organs analyzed (Figures 7A, 8 and 15-16). Importantly even the sparsest MADM-4 
reliably permits functional genetic mosaic analysis of candidate genes (Hansen and 





 MADM Reveals Chromosome-specific Biases in Mitotic Sister Chromatid 
Segregation Patterns 
Previous in vitro studies have employed mitotic recombination in embryonic stem (ES) cells 
(and derived lineages) to monitor the randomness of sister chromatid segregation patterns 
upon mitosis (Armakolas and Klar, 2006; Liu et al., 2002) . Against common belief, initial results 
indicated that sister chromatids derived from a homologous pair of chromosomes did not 
segregate randomly to daughter cells. Instead, G2-X segregation (two recombinant 
chromosomes segregate away from each other), thus reflecting one particular pattern of sister 
chromatid segregation, prevailed in ES cells for Chr. 7 (Liu et al., 2002) . Furthermore, ES cell-
derived endoderm cell lines exhibited complete bias towards G2-X (Armakolas and Klar, 2006). 
Conversely, ES cell-derived neuroectoderm cell lines never showed G2-X at all (Armakolas and 
Klar, 2006). Although these results indicated that cell type may influence selective segregation 
of sister chromatids, such hypothesis is based on the analysis of only one chromosome and 
has not been examined in intact tissue in vivo. To this end we utilized the entire library of 
MADM-rendered homologous chromosomes to systematically trace sister chromatid 
segregation patterns of all 19 mouse autosomes in a number of somatic cell lineages in vivo. 
We exploited the inimitable feature provided by the MADM principle (Figure 10C and 
12) – the differential fluorescent labeling of pairs of nascent sister cells upon mitosis which is 
dependent on how recombinant chromosomes segregate during cell division. G2-X 
segregation of recombinant MADM chromosomes can be unambiguously identified (by the 
presence of red and green cells). However, G2-Z segregation, producing yellow cells, cannot 
be identified without ambiguity because G1 and/or postmitotic G0 events also result in yellow 
cells (Zong et al., 2005) (Figure 10C and 12). Therefore, we capitalized upon the power of 
unequivocal G2-X identification - but also taking into consideration the caveat of yellow cells 
potentially reflecting a mix of G2-Z and G1/G0 - and defined ‘yellow-green-red-index’ (YGRI) as 
a proxy for sister chromatid segregation patterns (Figure 10D). 
First, we systematically determined the YGRI of pyramidal projection neurons in the P21 
neocortex for all 19 MADM reporters in combination with Emx1-Cre driver (expressed in 
cortical progenitor cells and thereby limiting G0 events) (Figure 10). Contrary to the prediction 
and expectation based on cell culture data [no G2-X in neuroectodermal lineage (Armakolas 




~1 for MADM-2 and MADM-17 to ~10 for MADM-15 (Figure 10E, top). The values of the YGRI 
did not correlate with the sizes of the respective MADM chromosomes. Next we compared 
the values of the YGRI with the absolute recombination frequencies (RFI, recombination 
frequency index), i.e. density of G2-X MADM labeling as indicated in Figure 10B. In the ranking 
plot where axes indicate YGRI versus RFI, there was no apparent correlation (Figure 10E, 
bottom) of YGRI with RFI. In other words, MADM chromosomes that showed a high 
recombination frequency did not necessarily present with a high YGRI and vice versa (Figure 
10E, bottom). In summary, we detected highly distinct YGRI for different MADM 
chromosomes, suggesting distinct sister chromatid segregation patterns in cortical Emx1+ 
projection neuron lineage. 
 
 Chromosome-specific Biases of Sister Chromatid Segregation Differ in 
Distinct Cell Types 
To determine the influence of cell type on biased, chromosome-specific, sister chromatid 
segregation patterns we first analyzed cortical astrocytes and hippocampal CA1 pyramidal 
cells, both of which are derived from Emx1+ progenitor cells. The YGRI for cortical astrocytes 
was markedly different from the YGRI for cortical projection neurons or hippocampal CA1 
pyramidal cells for a representative set of ten MADM chromosomes analyzed (Figure 11A). 
Interestingly, YGRI of all 10 chromosomes in astrocytes were rather constant and low, 
indicating a uniformly high relative frequency for G2-X events in astrocyte progenitors. Next 
we introduced Nestin-Cre into the same ten MADM reporters to label neural lineages beyond 
forebrain projection neurons and astrocytes. We focused on cerebellar Purkinje cells which 
can be unambiguously identified by their characteristic morphology and determined the YGRI 
for these cells. Strikingly, the YGRI for Purkinje cells was also markedly different in most 
MADMs when compared to the YGRIs for cortical projection neurons and astrocytes, and 
hippocampal CA1 pyramidal cells (Figure 11A). Moreover, chromosomes that have high YGRI 
in one cell type would not necessarily show high YGRI for a different cell type. 
Finally, we assessed sister chromatid segregation patterns for a non-neural somatic 
cell type. We focused on T-cells (CD3+) and B-cells (CD19+) within the hematopoietic lineage, 
isolated MADM-labeled cells by FACS, and determined the YGRI for six different MADM 




different YGRI values, the YGRI for T-cells in comparison to B-cells was not significantly 
different for all six chromosomes analyzed. No significant correlation could be established 
when the YGRI of T/B-cells was compared to the YGRI of the neural lineages. Altogether, these 
data indicate that the highly biased and chromosome-specific sister chromatid segregation 











(A) Summary of the MADM principle. MADM enables the concomitant fluorescent labeling 
and genetic manipulation of genetically-defined cellular populations at clonal and single cell 
resolution. For MADM, two chimeric split marker genes containing partial coding sequences 
of eGFP and tdT are inserted into identical genomic loci of homologous chromosomes. 
Following Cre recombinase-mediated interchromosomal (trans) recombination during 
mitosis the split marker genes are reconstituted and functional green and red fluorescent 
proteins expressed. As a result, green GFP+, red tdT+ and yellow GFP+/tdT+ cells appear 
sparsely, due to inherently low stochastic interchromosomal recombination rate, within the 
genetically-defined cell population expressing Cre recombinase. Introduction of a mutant 
allele distal to the MADM cassette results in a genetic mosaic with homozygous mutant cells 
labeled in one color (eg. green GFP+) and homozygous wild-type sibling cells in the other (eg. 
red tdT+). Heterozygous cells appear in yellow (GFP+/tdT+). 
(B) Expansion of MADM to all mouse autosomes. Transgenic mice with MADM cassettes 
inserted close to the centromere have been for all 19 mouse autosomes. The directionality 
(forward, centromere-telomere and reverse, telomere-centromere) of marker gene 
transcription is indicated. 
(C) MADM labeling scheme for cassettes inserted in forward direction. MADM experiments 
involving forward cassettes require that the mutant allele of a candidate gene must be 
linked to the T-G MADM cassette in order for mutant cells to be labelled in green upon a 
G2-X MADM event. 
(D) MADM labeling scheme for cassettes inserted in reverse direction. MADM experiments 
involving reverse cassettes require that the mutant allele of a candidate gene must be linked 
to the G-T MADM cassette in order for mutant cells to be labelled in green upon a G2-X 
MADM event. 
(E) Generation of recombinant MADM chromosomes. To genetically link a mutant allele of 
a candidate gene of interest to the corresponding chromosome containing the T-G MADM 
cassette (i.e. forward orientation) it is necessary to first cross mice bearing the T-G MADM 
cassette with mice bearing the mutant allele. Resulting F1 transheterozygous offspring are 
then backcrossed to mice homozygous for T-G MADM cassette. In F2 recombinant offspring 
emerge from meiotic recombination events in the germline. These F2 recombinants now 
contain both the MADM cassette (in homozygous configuration) and the mutant allele 
linked on the same chromosome. For experimental MADM mice F2 recombinants are 
crossed with mice bearing G-T MADM cassette and a Cre driver of interest. 
(F) Calculation of predicted meiotic recombination frequency. The probability for meiotic 
recombination resulting in the linkage of the MADM cassette with the mutant allele can be 
estimated by the genetic distance of the MADM cassette to the location of the mutant allele 
divided by two.  
 










(A) Overview of MADM labeling (green, GFP; red, tdT; yellow, GFP/tdT) in MADM-19GT/TG in 
combination with Hprt-Cre at P21. Diverse tissues and organs including eye, brain, lung, spinal 
cord, kidney, spleen, liver, heart, and thyme are illustrated. Scale bar: 50µm. 
(B) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; yellow, GFP/tdT) 
in mammary gland of lactating MADM-19GT/TG;Hprt-Cre female at four months of age. 
Basal/myoepithelial (middle) and luminal (right) cells are stained with antibodies against K14 
and K8 (white), respectively.  
(C) Schematic (left) MADM labeling (right; green, GFP; red, tdT; yellow, GFP/tdT) in MADM-
19GT/TG;Hprt-Cre pancreas, acinus and duct, at P21. Epithelial cells are visualized by antibody 
staining against β-Catenin (white, β-Cat). Acinar cells are identified by the presence of 
intracellular secretory granules.  
(D) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; yellow, GFP/tdT) 
in telogen (middle) and anagen (right) hair follicles in MADM-19GT/TG;Hprt-Cre at P21 (telogen) 
and P28 (anagen). Bu, bulge; 2° HG, secondary hair germ; SG, sebaceous gland; IRS, inner root 
sheath; CP, companion layer; ORS, outer root sheath; Mx, matrix.  
(E) Schematic (left) and MADM labeling (right; green, GFP; red, tdT; yellow, GFP/tdT) in small 
intestine in MADM-19GT/TG;Hprt-Cre at P21. Epithelial cells are visualized by antibody staining 
against β-Catenin (white, β-Cat). Asterisk marks a Paneth cell, identified by the presence of 
intracellular granules. TAC, transit-amplifying cell; LGR5, leucine-rich repeat-containing G-
protein coupled receptor 5. 
Nuclei are stained using DAPI. 
Scale bar (B-E): 20µm. 
 








(A) MADM scheme for imprinted genes. G2-X MADM events can generate differentially-
labeled cells with near complete uniparental chromosome disomy [UPD, cells with two copies 
of either the maternal (matUPD) or the paternal (patUPD) chromosome], for details see also 
(Hippenmeyer et al., 2013; Laukoter et al., 2020). (Top) The GT MADM cassette is inherited 
from the mother (M, pink) and the TG MADM cassette from the father (P, blue). Consequently, 
green cells show patUPD (PP) and red cells matUPD (MM). In such scenario, imprinted 
maternally expressed genes are expressed at twice the normal dose and paternally expressed 
genes are not expressed in cells with matUPD (red). In contrast, paternally expressed genes 
are overexpressed by factor two and maternally expressed genes are not expressed in cells 
with patUPD (green). (Bottom) Reverse scheme where GT MADM cassette is inherited from 
father and TG MADM cassette inherited from mother. Here cells with matUPD are labelled in 
green and cells with patUPD in red fluorescent color. 
(B-U) Representative images of horizontal liver cryosections with MADM labeling (GFP, green; 
tdT, red) in MADM-1 (A) to MADM-19 (T-U) in combination with Hprt-Cre driver at P21. Higher 
resolution image (U) represents inset in (T) in left lateral lobe of liver in MADM-19. 
(V) (Top) Representative images (left, middle) of liver in MADM-7GT/TG;Hprt-Cre with green 
GFP+ patUPD and red tdT+ matUPD (left) or red tdT+ patUPD and green GFP+ matUPD (middle) 
at P21; and quantification (right) of absolute (#cells/mm3) and relative (PP/MM) numbers of 
MADM-labeled cells with UPD. (Middle) Representative images (left, middle) of liver in 
MADM-11GT/TG;Hprt-Cre with green GFP+ patUPD and red tdT+ matUPD (left) or red tdT+ 
patUPD and green GFP+ matUPD (middle) at P21; and quantification (right) of absolute 
(#cells/mm3) and relative (PP/MM) numbers of MADM-labeled cells with UPD. (Bottom) 
Representative images (left, middle) of liver in MADM-17GT/TG;Hprt-Cre with green GFP+ 
patUPD and red tdT+ matUPD (left) or red tdT+ patUPD and green GFP+ matUPD (middle) at 
P21; and quantification (right) of absolute (#cells/mm2) and relative (PP/MM) numbers of 
MADM-labeled cells with UPD. Nuclei are stained using DAPI. 
Scale bar: 200µm. 
 
Figure 8. MADM-induced Uniparental Chromosome Disomy Results in Paternal Growth 









(A-S) Representative images of sagittal brain cryosections with MADM labeling (GFP, green; 
tdT, red) in MADM-1 (A) to MADM-19 (S) in combination with Hprt-Cre driver at P21. (T-U) 
Higher resolution images of cerebral cortex (T) and cerebellum (U) in MADM-7. Nuclei are 
stained by using DAPI (blue). Scale bar: 500µm. 
 
Figure 9. MADM Labeling Pattern in Brain across all 19 MADM Reporters. 
 
 







(A) Representative images of MADM labeling pattern (green, GFP; red, tdT) in cerebral cortex 
in three exemplary MADM lines in combination with Emx1-Cre driver at P21. Top, MADM-
9GT/TG;Emx1Cre/+; middle, MADM-17GT/TG;Emx1Cre/+; bottom, MADM-19GT/TG;Emx1Cre/+. Scale 
bar:100 µm. 
(B) Classification of MADM lines. The 19 different MADM lines were classified by the 
efficiency of mitotic recombination reflected by the density of MADM labeling per mm3. Lines 
with less than 25 labeled cells per mm3 belong to the sparse category (top), lines with a 
density of labeled cells between 25 to 100 labeled cells per mm3 are in the intermediate 
category (middle), and lines with more than 100 labeled cells per mm3 belong to the dense 
category (bottom). 
(C) MADM principle for the monitoring of G2-X and G2-Z segregation patterns. Upon Cre-
mediated interchromosomal recombination, at the LoxP site in the MADM cassettes, in G2 
phase of the cell cycle recombinant chromosomes can either segregate together to the same 
daughter cell (G2-Z segregation; yellow, GFP/tdT and unlabeled cell) or each recombinant 
chromosome may segregate to distinct daughter cells (G2-X segregation; green, GFP and red 
tdT cells) upon mitosis. 
(D) Definition of YGR Index (YGRI). The YGRI is calculated from the number of yellow cells 
divided by the average of green and red cells to compensate for G2-Z events which leads to 
labeling of only one daughter cell (yellow) and an (invisible) unlabeled cell. Note that yellow 
cells emerging from G1/G0 events contribute to the total number of yellow cells. 
(E) YGR index in neuronal lineages. (Top) YGRI for cortical projection neurons in P21 
neocortex of all 19 MADM reporter lines in combination with Emx1-Cre driver. Note that 1) 
YGRI varies from 1 to 10 but is never below 1; and 2) YGRI do not correlate with the sizes of 
the respective MADM chromosomes. (Bottom) YGRI ranking in correlation (red line) to 
recombination frequency index (RFI). Note that MADM chromosomes with a high 
recombination frequency do not necessarily present high YGRI and vice versa.  
 
Figure 10. Mitotic Interchromosomal Recombination Efficiency and Sister Chromatid 









(A) YGRI for selected MADM reporters in different neuronal lineages. YGRI of cortical 
astrocytes and hippocampal CA1 pyramidal cells derived from Emx1+ progenitors and 
cerebellar Purkinje cells derived from Nestin+ progenitors significantly differs from the YGRI 
of cortical pyramidal neurons for most MADM chromosomes analyzed. 
(B) (Left): White blood cell preparations from spleen in diverse MADM reporters in 
combination with Hprt-Cre at P21 were subjected to FACS. The number of green GFP+, red 
tdT+, and yellow GFP+/tdT+ CD3+ T cells (black) and CD19+ B cells (blue) were quantified. 
(Right) YGRI for six different MADM chromosomes including sparse (MADM-4), intermediate 
(MADM-8, MADM-15, MADM-17) and dense (MADM-18, MADM-19) lines. While the distinct 
MADM recombinant chromosomes displayed different YGRI values, the YGRI for T cells and 
B cells was not significantly different for all MADM chromosomes analyzed. Two-tailed 
Student’s t-test, pM4=7.4E-01, pM8=7.9E-01, pM15=7.7E-01, pM17=6.3E-01, pM18=9.8E-01, 
pM19=5.0E-01. 
(C) Models of biased sister chromatid segregation patterns in ES cells in vitro and in mouse 
in vivo. (Left) Previous studies (Armakolas and Klar, 2006; Liu et al., 2002) employing mitotic 
recombination and in combination with restriction-site sensitivity for genotyping in ES cell 
cultures reported that in ES cell-derived neuroectodermal lineages no G2-X (recombinant 
chromosomes segregate away from each other during cell division) events could be 
observed. In contrast, lineages derived from endodermal stem cells showed exclusively G2-
X segregation patterns. Based on these findings it could be anticipated that in MADM there 
would be no red and green cells in neural lineages (e.g. in the brain) which was not the case 
for all MADM chromosomes. (Right) In vivo analysis of the prevalence of G2-X events (red 
and green cells) in comparison with total number of yellow cells (G2-Z, G1 and G0 events) for 
all MADM chromosomes and in several somatic cell lineages revealed significant bias in 
recombinant chromosome, and thus sister chromatid segregation patterns. The segregation 
bias showed marked chromosome specificity: was distinct for different chromosomes in the 
same cell type in both brain and hematopoietic systems. The segregation bias appears also 
to be affected by cell type: the level of bias was distinct for the same chromosome in 
different cell types. 
 









(A) For MADM, two reciprocally chimeric marker genes are targeted to identical loci on 
homologous chromosomes. The chimeric marker genes (GT and TG alleles) consist of partial 
coding sequences for green (eGFP[G]) and red (tdT[T]) fluorescent proteins separated by 
an intron containing the loxP site. Following Cre recombinase-mediated interchromosomal 
recombination during mitosis, functional green and red fluorescent proteins are 
reconstituted resulting in two daughter cells each expressing one of the two fluorescent 
proteins upon G2-X events (recombination in G2 of the cell cycle followed by X 
segregation). Introduction of a mutation distal to one MADM cassette allows the 
generation of genetic mosaics with single cell resolution, with wild-type daughter cells, 
labeled with one color (e.g. red) and homozygous mutant siblings with the other (e.g. 
green) in an unlabeled heterozygous environment. G2-Z segregation results in yellow cell 
labeling with no genotype alteration. 
(B) G1 and G0 events also result in yellow cell labeling without change in genotype. 
Reproduced and adapted with permission from (Hippenmeyer et al., 2010). 
 









For each MADM targeting site: in the panel on the left the schematic indicates the 
corresponding chromosome, insertion site of the MADM cassettes, and flanking genes. In 
each panel on the right a schematic illustrates the MADM cassette insertion site with 
genomic locus information (top) and the targeted locus with the G-T (middle) and T-G 
(bottom) MADM cassettes, respectively. 
 
 
            
       
               
            
              
              
    
 
Figure 13. Genomic Targeting of GT and TG MADM Cassettes. 
 
 





(A) Identification and selection of genomic targeting locus. The 3 key criteria for a suitable 
locus were 1) closest possible proximity to centromere to maximize the number of genes 
located distally to the MADM cassettes 2) intergenic location to minimize the probability of 
disrupting endogenous function and 3) permit spatially and temporally ubiquitous and 
biallelic expression of reconstituted GFP and tdT markers based on EST (expression sequence 
tag) data from UCSC Genome Browser. 
(B) Cloning of targeting vectors. Both GT-MADM cassette and TG-MADM cassette sequences 
were cloned separately into plasmids containing the 5’ and 3’ targeting arms. 
(C) ES cell targeting by electroporation. Targeting constructs for both GT-MADM cassettes 
and TG-MADM cassettes containing a diphtheria toxin A fragment and a positive selection 
marker (neomycin resistance cassette) were electroporated separately into ES cells. After 
selection, ES clones were picked and tested for integration of the MADM cassette by 
Southern blot. 
(D) Blastocyst injection of targeted ES cells. Targeted ES cells were injected into wild-type 
blastocysts, allowed to further develop, and embryos were injected into pseudo pregnant 
dams. F1 chimeric offspring was bred with wild-type animals to obtain germline transmission 
of the MADM transgenes. 
(E) Generation of experimental MADM mice. In order to generate experimental MADM 
animals, homozygous stocks for the MADM cassettes in combination with various Cre driver 
lines were generated first. A typical breeding example generating MADM experimental 
animals would be to breed a male MADMTG/TG with a female MADMGT/GT;DriverCre/+ in order 
to obtain MADMGT/TG; DriverCre/+ mice for analysis. 
 






(A-S) Representative images of sagittal kidney cryosections with MADM labeling (GFP, 
green; tdT, red) in MADM-1 (A) to MADM-19 (S) in combination with Hprt-Cre driver at P21. 
Inset in S depicts higher resolution image of cortex area (S’). Nuclei are stained by using 
DAPI (blue). Scale bar: 500µm. 
 






(A-S) Representative images of horizontal spleen cryosections with MADM labeling 
(GFP, green; tdT, red) in MADM-1 (A) to MADM-19 (S) in combination with Hprt-Cre 
driver at P21. Areas of white pulp are in the center of the microscopic images. Inset in S 
shows higher resolution image (S’) of white pulp. Nuclei are stained by using DAPI (blue). 
Scale bar: 50µm. 
 









(A) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; yellow, GFP/tdT) 
in mammary gland of lactating MADM-4GT/TG;Hprt-Cre female at four months of age. 
Basal/myoepithelial (middle) and luminal (right) cells are stained with antibodies against K14 
and K8 (white), respectively.  
(B) Schematic (left) MADM labeling (right; green, GFP; red, tdT; yellow, GFP/tdT) in MADM-
4GT/TG;Hprt-Cre pancreas, acinus and duct, at P21. Epithelial cells are visualized by antibody 
staining against β-Catenin (white, β-Cat). Acinar cells are identified by the presence of 
intracellular secretory granules. 
(C) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; yellow, GFP/tdT) 
in telogen (middle) and anagen (right) hair follicles in MADM-4GT/TG;Hprt-Cre at P21 (telogen) 
and P28 (anagen). Bu, bulge; 2° HG, secondary hair germ; SG, sebaceous gland; IRS, inner 
root sheath; CP, companion layer; ORS, outer root sheath; Mx, matrix. 
(D) Schematic (left) and MADM labeling (right; green, GFP; red, tdT; yellow, GFP/tdT) in small 
intestine in MADM-4GT/TG;Hprt-Cre at P21. Epithelial cells are visualized by antibody staining 
against β-Catenin (white, β-Cat). Asterick marks a Paneth cell, identified by the presence of 
intracellular granules. TAC, transit-amplifying cell; LGR5, leucine-rich repeat-containing G-
protein coupled receptor 5. 
Nuclei are stained using DAPI. Scale bar: 20µm. 
 






(A-S) Representative images of coronal brain cryosections with MADM labeling (GFP, 
green; tdT, red) in MADM-1 (A) to MADM-19 (S) in combination with Emx1-Cre driver at 
P21. Insets in S show higher resolution images in neocortex (S’, Ctx) and hippocampus (S’’, 
Hipp). Scale bar: 200µm. 
 










Table lists the insertion sites, genes flanking the MADM cassette insertion site, distance 
between neighboring genes, number of genes located distally to the MADM cassettes, 
and percentage of access of genes that can be subjected to MADM analysis in all 19 
MADM lines. In total 20’160 protein coding mouse genes, or 96.8% of them, are located 
distally to the MADM cassettes. 
 




2.5 Discussion  
The analysis of gene function in multicellular systems in vivo requires quantitative and high-
resolution experimental tools and assays to analyze the cellular phenotype. MADM 
technology offers a genetic approach in mice to visualize and concomitantly manipulate 
genetically defined cells at clonal level and with single cell resolution. Here we expanded the 
MADM technology in order to enable the genetic dissection of cell-autonomous gene function 
of most genes (>96%) across the entire mouse genome. While functional genetic mosaic 
analysis clearly represents the most salient utility of MADM (Figure 6 and Table 1) here we 
also extended the application spectrum, and utilized MADM as a proxy to trace randomness 
of mitotic sister chromatid segregation patterns for the first time in vivo. We first discuss these 
findings in a more general context before we elaborate on the overarching potential of the 
genome-wide MADM resource for future genetic mosaic analysis. 
 
Non-random Mitotic Sister Chromatid Segregation in Mouse in vivo 
Asymmetric stem cell division requires the non-equivalent distribution of cell-fate 
determinants including proteins, mRNA or intracellular organelles (Gönczy, 2008; Knoblich, 
2008; Taverna et al., 2014). Recently, an intriguing model has been postulated whereby 
asymmetric cell division might be also promoted by differentiation of sister chromatids by 
epigenetic means, followed by selective segregation of ‘unequal’ sister chromatids to 
daughter cells (Armakolas et al., 2010; Bell, 2005; Yamashita, 2013). However, experimental 
evidence supporting such a model in mice was thus far obtained solely from in vitro studies in 
ES cells and derived lineages, and only for one chromosome (Chr. 7; Figure 11C, left) 
(Armakolas and Klar, 2006; Liu et al., 2002). In our study we systematically traced sister 
chromatid segregation patterns of the entire set of mouse autosomes, for the first time to our 
knowledge in a mammalian species in vivo. By capitalizing on the distinct fluorescent labeling 
of daughter cells upon MADM-based mitotic recombination we could unambiguously identify 
G2-X segregation (recombinant MADM chromosomes segregate away from each other), 
reflecting one particular pattern of sister chromatid segregation. Interestingly, we observed 
that the prevalence of G2-X events, reflected in the value of YGRI, in the same cell type 
(cortical projection neurons) and by using identical Emx1-Cre driver vastly differed, up to one 




biased in a chromosome-specific manner in mitotic cortical Emx1+ progenitors. Furthermore, 
the rank orders of YGRI for each chromosome in different cell types were not the same, 
suggesting that the bias of sister chromatid segregation patterns results from a complex 
combination of chromosome and cell type specific mechanisms (Figure 11C, right). 
Previous studies found that cultured ES cell clones that were differentiated into 
neuroectoderm lineage never showed G2-X segregation (Armakolas and Klar, 2006; Liu et al., 
2002). These findings are in stark contrast to our in vivo results demonstrating for all 19 mouse 
autosomes a substantial amount of G2-X segregation, and in at least four distinct neural cell 
lineages. While we cannot fully explain the cause of the differences in results obtained in cell 
culture or in vivo, respectively, systemic and/or tissue-wide acting mechanisms could be 
involved (Knouse et al., 2018). For our MADM-based analysis we used Emx1- and Nestin-Cre 
drivers which are mostly active in dividing neural stem cells and turned off in postmitotic cells. 
Contribution of G0 recombination is thus expected to be minimal. Still, all YGRIs in neural 
lineages were ≥1 (with some up to an order of magnitude higher) indicating increasing rates 
of G2-Z segregation. However, a certain rate of G1 recombination (also producing yellow cells 
that increase the YGRI) besides G2-Z segregation may add to the overall YGRI. Although G1 
recombination events did not occur in cultured ES cells (Armakolas and Klar, 2006; Liu et al., 
2002), we cannot currently exclude that interchromosomal recombination efficiency could be 
distinct in G1 versus G2 phases of the cell cycle for different cell types in vivo. However, for 
any given cell division cycle, the relative recombination events in G1 versus G2 should be the 
same; thus, different YGRIs for different chromosomes must reflect chromosome-specific 
sister chromatid segregation patterns. It will be interesting in future to test whether the bias 
of sister chromatid segregation could be influenced by the location of the genomic 
recombination loci for particular chromosomes. 
The putative underlying molecular mechanisms of biased sister chromatid segregation 
have been previously explored using in vitro assays. As such, the left-right dynein (LRD) protein 
was implicated in the selective sister chromatid segregation process (Armakolas and Klar, 
2007). These results are insofar intriguing since mutation of the gene (Dnah11) encoding LRD 
causes randomization of left-right laterality mice (half of the animals develop with mirror-




assess the role of Dnah11 in biased sister chromatid segregation in vivo across distinct somatic 
cell lineages by using the MADM approach. 
The phenomenon of biased sister chromatid segregation appears to be evolutionarily 
conserved (Beumer et al., 1998; Pimpinelli and Ripoll, 1986). Interestingly, in asymmetrically 
dividing male germline stem cells in Drosophila, sister chromatids of X and Y, but not 
autosomes are segregated non-randomly (Yadlapalli and Yamashita, 2013). In such context, 
SUN-KASH proteins, proposed to anchoring of sister chromatids to centrosome, seem to be 
involved, besides regulators of DNA methylation (Yadlapalli and Yamashita, 2013) . While the 
underlying molecular mechanisms may or not be conserved, it will be intriguing to assess the 
physiological function in future studies, and experimentally approach the hypothesis 
postulating that biased sister chromatid segregation could be a mechanism to instruct cell fate 
of nascent daughter cells during asymmetric stem cell division (Armakolas et al., 2010; Bell, 
2005; Yadlapalli and Yamashita, 2013). Since MADM enables both clonal lineage tracing with 
concurrent genetic manipulation, such approach promises high potential to systematically 
address the physiological role of biased sister chromatid segregation in future. 
 
Genetic dissection of cell-autonomous gene function and system-wide effects 
The MADM technology enables a variety of genetic in vivo paradigms to study a broad 
spectrum of cell and developmental processes (Hippenmeyer, 2013; Hippenmeyer et al., 2013; 
Luo, 2007; Muzumdar et al., 2007; Zong et al., 2005). Here we expanded the most salient 
property of MADM, functional analysis of candidate gene function at single cell level, for the 
study of nearly all genes encoded in the mouse genome. One exclusive application of the 
MADM system is the feature enabling the genetic dissection of the relative contributions of 
cell-autonomous and extrinsic systemic and/or tissue-wide components to the overall cellular 
phenotype upon the loss of candidate gene function. Importantly, the single cell phenotype in 
conditional or full knockout mutants reflects a combination of both cell-autonomous gene 
function and environment-derived cues which may remedy or exacerbate any observed 
phenotype. In fact, recent genetic mosaic studies indicate that non-cell-autonomous 
mechanisms fundamentally impact developmental processes. For instance, MADM-based 
analysis of the genes encoding components of the cytoplasmic LIS1/NDEL complex in 




functions for Lis1 and Ndel1 genes. In contrast, non-cell-autonomous effects resulting from 
whole tissue Lis1/Ndel1 ablation appear to impact neuronal migration much more profoundly 
and throughout the entire process of cortex development (Hippenmeyer, 2014). Furthermore, 
while Lgl1, encoding a regulator of cellular polarity, cell-autonomously controls cortical glia 
production, its function is also required at the global tissue level during embryonic 
neurogenesis and to prevent emergence of periventricular heterotopia (a.k.a. double cortex 
syndrome in human) (Beattie et al., 2017). Thus, insights at single cell resolution as obtained 
from MADM-based approaches in combination with systematic candidate gene interrogation 
(Beattie et al., 2017; Laukoter et al., 2020) likely will have implications for our general 
understanding of neurodevelopmental disorders such as Lissencephaly and related cortical 
malformations including microcephaly and hemimegancephaly among others (Buchsbaum 
and Cappello, 2019; D’Gama and Walsh, 2018; Jayaraman et al., 2018; Pinson et al., 2019; 
Subramanian et al., 2020). 
 
Single cell analysis of imprinting phenotypes in uniparental chromosome disomy 
A unique MADM application includes the property to generate cells with uniparental 
chromosome disomy (UPD) and thus enable the study of imprinting phenotypes at single cell 
level (Hippenmeyer et al., 2013; Laukoter et al., 2020). In fact, technical limitations so far only 
allowed the investigation of UPD at the whole animal level but lacked the resolution to obtain 
insights at the cellular level. Another major drawback in the analysis of UPD in whole animals 
is reflected in the key importance of many imprinted genes in nutrient transfer during 
pregnancy (Barlow and Bartolomei, 2014). Thus, the phenotypic interpretation of UPD at the 
individual cell level is confounded by putative whole animal wide systemic effects. MADM 
technology provides a solution and is to date the sole technology that can produce UPD 
sparsely in genetic mosaic animals and within genetically-defined cell populations 
(Hippenmeyer et al., 2013; Laukoter et al., 2020). It will be revealing in future studies to 
systematically probe the cell-autonomous consequences of UPD at single cell level and 
without inducing global changes in imprinted gene expression affecting the whole animal. The 
library of all nineteen MADM reporters will in principle enable the systematic analysis of UPD-
associated cellular phenotypes in any organ, tissue and cell-type in the mouse, provided the 




since UPD in human is associated with a variety of diseases (Buiting et al., 2016; Feinberg, 
2007; Tuna et al., 2009; Yamazawa et al., 2010) MADM-based analysis will also contribute to 
our general understanding of the underlying etiology of imprinting disorders at single cell 
level. 
Analysis of cellular competition at single cell level in health and disease 
MADM can be exploited for the study of cellular competition in developmental context. For 
instance, when the TrkC Neurotrophin receptor is removed sparsely with MADM from just a 
few individual Purkinje cells in the cerebellum, their dendrites have fewer and shorter 
branches. In contrast, when TrkC is ablated from all Purkinje cells, the dendrite trees look 
normal again. Thus a competitive mechanism could be involved whereby the shape of the 
dendrite tree depends on relative differences in Neurotrophin/TrkC signaling between 
Purkinje cell neighbors (Joo et al., 2014). Cell competition has not only been implicated in cell 
morphogenesis but extensively studied in a variety of contexts. Cell competition is particularly 
critical for overall tissue homeostasis during growth and regeneration but also for cell mixing 
and tissue invasion in cancer (Brás-Pereira and Moreno, 2018; Ellis et al., 2019; Madan et al., 
2018; Merino et al., 2016). With the availability of MADM for all mouse autosomes the 
phenomenon of cell competition can be studied holistically and for virtually any candidate 
gene function associated with it in diverse biological contexts in health and disease. 
 
Expansion to other species and future development of the MADM technology 
While MADM technology currently is available only in mice future expansion of the system to 
other species by for instance CRISPR/Cas9-enabled transgenesis can be anticipated. The range 
of species suited for MADM depends however on a number of factors such as the ease of 
breeding and generation time. The study of genetic mosaicism in human context is another 
prospective application for the MADM system. The MADM cassettes could be inserted in 
human embryonic stem cell lines which then could be used for differentiation, generation and 
the study of cellular organoids in broad applications. With the implementation of numerous 
protocols for next generation sequencing, gene expression can be monitored in MADM-
labeled cells in bulk and also at single cell level [Pauler and Hippenmeyer, unpublished 
observation, (Laukoter et al., 2020)]. Thus MADM-based cell lineage tracing in combination 




reconstruct cell lineages across all organs in the mouse. Lastly, the MADM reporter genes can 
be adapted for the monitoring of physiological processes by for instance intrinsic calcium 
imaging and/or optogenetic manipulation. Altogether, the whole mouse genome MADM 
resource presented in this study likely will catalyze the genetic dissection of the cellular and 
molecular mechanisms with single cell resolution across a broad spectrum of biological 
questions in health and disease. 
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Generation, Breeding and Husbandry of Mouse Lines 
Experimental procedures were discussed and approved by the institutional ethics and animal 
welfare committees at IST Austria, Stanford University, and at University of Veterinary 
Medicine Vienna in accordance with good scientific practice guidelines and national legislation 
(license number: IST Austria: BMWF-66.018/0007-II/3b/2012 and BMWFW-66.018/0006-
WF/V/3b/2017; University of Veterinary Medicine Vienna: BMWF-68.205/0023-II/3b/2014 
and BMBWF-68.205/0010-V/3b/2019). Mice with specific pathogen free status according to 
FELASA recommendations (Mähler et al., 2014) were bred and maintained in experimental 
rodent facilities (room temperature 21 ± 1°C [mean ± SEM]; relative humidity 40%-55%; 
photoperiod 12L:12D). Food (V1126, Ssniff Spezialitäten GmbH, Soest, Germany) and tap 
water were available ad libitum. 
Mouse lines with MADM cassettes inserted in Chr. 7 (Hippenmeyer et al., 2013), Chr. 
11 (Hippenmeyer et al., 2010), and Chr. 12 (Hippenmeyer et al., 2013), Emx1-Cre (Gorski et al., 
2003), Nestin-Cre (Petersen et al., 2002), Hprt-Cre (Tang et al., 2002) have been described 
previously. All analyses were carried out in a mixed genetic background. The two lines of each 
chromosome, with the exception of Chr. 7, 11 and 12, were designated as C57BL/6N;CD1-
MADM-GTtm1(Chr1)Biat and C57BL/6N;CD1-MADM-TGtm1(Chr1), as indicated here for Chr. 1. No sex 
specific differences were observed under any experimental conditions or in any genotype. 
 
Molecular Biology 
Generation of MADM Targeting Constructs 
Molecular cloning and generation of recombinant DNA to construct all plasmids (incl. targeting 
vectors, plasmids with southern probes etc.), and all nucleic acid procedures as described 
below were carried out according to standard cloning protocols (Sambrook et al., 1989). 
 
Genomic DNA Isolation from Mouse ES Cells 
Mouse ES cells were lysed in Lysis Buffer (1M Tris-HCl pH=7.5, 0.5M EDTA, 5M NaCl, 20% 
Sarcosyl, 20 mg/ml Proteinase K) overnight at 55°C. Next day, the DNA was precipitated with 




a fresh tube containing TE-buffer. The lids of the tubes were left open for 10 min to allow 
residual isopropanol to evaporate. The DNA was then incubated for 3 hrs at 37°C. 
 
Southern Blot 
DIG-labelled probes were generated via PCR amplification of plasmid templates containing the 
probe sequence using a mix of nucleotides containing Digoxigenin-11-dUTP (DIG-dUTP). The 
PCR reaction was next separated by electrophoresis and the corresponding band was cut and 
gel purified using the Monarch DNA gel extraction Kit-NEB. 
Genomic DNA was digested with the corresponding enzymes overnight at 37°C and 
electrophoresed in 0.8% agarose gels for 6 hrs at low voltage together with Lambda Hind III 
marker. Next day, the agarose gels were depurinized in 0.25M HCl, denaturated in 0.4 NaOH 
and transferred overnight into a positively charged nylon membrane. Next day, the agarose 
gels were assessed under UV light to verify complete transfer of DNA to the membrane. The 
nylon membrane was then neutralized in 0.5M Tris-HCl (pH=7.5) and crosslinked with UV light. 
The membrane was incubated in hybridization buffer (5x SSC, 2% Blocking reagent, 50% 
Formamide, 0.1% Sarcosyl, 0.02% SDS) for 4 hrs at 42°C in glass tubes in a rotating oven. In the 
meantime, the DIG-labelled probe was denaturated at 95°C for 10 min and then quickly chilled 
on ice for 5 min. The DIG-labeled probe in Hybridization buffer was added to the membrane 
and incubated overnight at 42°C in glass tubes in a rotating oven. Next day, stringency washes 
were performed with Wash Solution I (2xSSC, 0.1% SDS) at room temperature, followed by 
Wash Solution II (0.2x SSC, 0.1% SDS) at 68°C. Next day, the membrane was blocked in blocking 
solution (1% blocking reagent, 0.1M Maleic acid, 0.15M NaCl) for 1 hr. Then anti-DIG AP 
antibody (1:20,000) in Blocking Solution was added to the membrane, incubated for 30 min at 
room temperature and then washed with Wash buffer (0.1M Maleic acid, 0.15M NaCl, 0.3% 
Tween) for 15 min. Finally the membrane was incubated with CDP-Star (1:100) 
chemiluminescent substrate in CDP-Star detection buffer (0.1M Tris-HCl, 0.1M NaCl, pH=9.5) 
for 5 min, wrapped in transparent film and kept in the dark for 1 hr. The pattern of probe 







Generation of Transgenic MADM Mice 
Targeting of MADM Constructs to Mouse ES Cells by Electroporation 
The linearized MADM targeting constructs were introduced into C57BL/6N embryonic stem 
cells (Parental ES cell line C2, Stock Number: 011989-MU, Citation ID: RRID: MMRRC_011989-
MU, A. Nagy Basic ES Cell line) by electroporation using a Bio-Rad Gene Pulser Xcell. After 
selection with 150µg/ml G418, surviving clones were analyzed for correct targeted integration 
by southern blot hybridization (see above). Metaphase spread chromosome counting was 
performed on ES cells of clones with confirmed correct targeting of the MADM cassettes 
before they were prepared for blastocyst injection. 
 
Production of Chimeras 
Host blastocysts were produced by superovulation of BALB/cRj females by intraperitoneal (IP) 
injection with 5.0 IU of equine chorionic gonadotropin (Folligon; Intervet) and, 48 hrs later, 
with 5.0 IU of human chorionic gonadotropin (Chorulon; Intervet) followed by mating with 
males of the same strain. Morula stages were harvested from isolated oviducts at day 2.5 days 
post coitum (dpc) and cultured in M16 medium overnight in an incubator at 37°C and 5% CO2 
to produce host blastocysts. About 10-15 ES cells were injected into a single blastocyst. The 
injected embryos were cultured for 2-3 hrs to recover and then transferred into the right 
uterus horn of 2.5 dpc pseudopregnant RjOrl:Swiss surrogate mothers as described earlier in 
detail (Rülicke, 2004; Rülicke et al., 2006). The offspring were selected based on their chimeric 
coat color. High-percentage male chimeras (>80%) were bred with C57BL/6NRj females and 
the offspring were selected by coat color and genotyped by PCR for the respective GT or TG 
MADM transgenes. 
 
Genotyping of MADM Reporters 
For primer sequences see Key Resources Table. Forward and reverse primer 1 is specific for 
each MADM reporter. In the absence of MADM cassettes the forward/reverse primer 1 PCR 
will result in the WT band as indicated. The reverse primer 2 is generic and located in the 
MADM cassette. The forward/reverse primer 2 PCR will result in the MADM band as indicated. 
The combined use of all three (forward, reverse primer 1, and reverse primer 2) in a single PCR 




one at WT and one at MADM size), and homozygous MADM (single band at MADM size) stock 
mice. Note that MADMGT/GT and MADMTG/TG stock mice should be maintained individually. The 
distinction of MADM-GT versus MADM-TG is possible by using GT-cassette (GT-for and GT-
rev) and TG-cassette (TG for and TG rev) specific primers, respectively. Male mice can be 
identified by using Y chromosome (Ychrom for and Ychrom rev) specific primers. Presence of 
transgenes encoding Cre recombinase can be confirmed by using Cre primers (Cre for and Cre 
rev) as indicated. 
 
Isolation of MADM-Labeled Tissue 
Mice were deeply anesthetized through injection of a ketamine/xylazine/acepromazine 
solution (65 mg, 13 mg and 2 mg/kg body weight, respectively), and confirmed to be 
unresponsive through pinching the paw. Perfusion was performed with PBS followed by ice-
cold 4% PFA. Tissue was further fixed in 4% PFA overnight at 4°C. Brain, thymus, heart, lung, 
liver, kidney, spleen, eye and spinal cord were surgically removed and cryopreserved in 30% 
sucrose for approximately 48 hrs and then embedded in Tissue-Tek O.C.T. (Sakura). All 
samples were stored at -20°C or -80°C until further usage. Samples were sectioned in a cryo 
microtome at a 45µm thickness. Brain samples were collected in 24 multi-well dishes and then 
mounted onto Superfrost Glass Slides (Thermo Fisher Scientific), all other samples were 
directly mounted on glass slides. 
For isolation of skin, pancreas, mammary gland and intestine, no perfusion was 
required. Mice were sacrificed by cervical dislocation and back skin was prepared for histology 
as previously described (Amberg et al., 2015). Briefly, back skin was shaved and surgically 
removed above the spine and placed on lint-free surface. Abdominal mammary glands, 
pancreas and small intestines were surgically removed. Small intestines were cut open 
longitudinally and made into Swiss rolls. All samples were incubated in 4% PFA at room 
temperature for 4hrs, then cryoprotected in 30% sucrose overnight at 4°C and embedded into 
Tissue-Tek O.C.T. (Sakura). All samples were stored at -20°C. Samples were sectioned at a 







Histology and Immunostaining of MADM-Labeled Tissue 
For immunofluorescence staining in skin, pancreas, mammary gland and intestine, sections 
were thawed at room temperature for 15 min and encircled with DAKO hydrophobic pen. 
Then, they were washed 3x for 5 min with PBS. Antigen retrieval was performed by adding 
pre-warmed citrate buffer pH=6.0 to the samples and incubating them at 85°C for 30 min. 
Samples were washed 3x for 5 min with PBS. Samples were incubated in blocking solution 
(10% horse serum, 0.5% Triton X-100 in PBS) for 1h at room temperature. Primary antibodies 
were diluted in staining solution (5% horse serum, 0.5% Triton X-100 in PBS) and added to the 
samples over night at 4°C. Next day, the samples were washed 3x for 5min with PBS and 
incubated with secondary antibodies (1:1000) and Hoechst (Sigma, 1mg/ml stock, 1:1000) 
diluted in staining solution for 2hrs at room temperature. After washing 3x for 5min with PBS, 
samples were mounted with Mowiol and stored at 4°C until they were imaged at a Zeiss 
LSM800. Primary antibodies: Keratin 8 (Abcam), Keratin 14 (BioLegend), beta-Catenin (Cell 
Signaling). Secondary antibody: donkey anti-rabbit Alexa647 (Molecular Probes). Mounted 
sections were washed 3x for 5 min in PBS, DAPI stained (1:20’000) for 10 min and then 




Mice were sacrificed by cervical dislocation and spleens were collected in ice-cold PBS. Spleens 
were then placed on a 70µm cell strainer on top of a 50ml Falcon tube and minced through 
the strainer. The strainers were flushed with 10ml PBS-FBS (1x PBS, 2% FBS) and cell 
suspensions were centrifuged for 6min at 1,200rpm. Cell pellets were resuspended in 1ml ACK 
lysis buffer (Gibco) and incubated for 30sec. Lysis reaction was stopped by adding 10ml PBS-
FBS. The cell suspension was transferred to a 15ml Falcon tube for better visibility of pellet. 
Cells were centrifuged for 6 min at 1,200 rpm. Pellets were resuspended in 1ml PBS-FBS and 
transferred to 5ml round-bottom FACS tube via a 70µl cell strainer. Tubes were filled up with 
PBS-FBS and centrifuged for 6 min at 1,200 rpm. Cells were incubated with Fc block (BD 
Biosciences) for 5 min and then incubated with 100µl of antibody mastermix for 30min on ice. 
Antibodies CD3 HorizonV451 (eBioscience) and CD19 APC (eBioscience) were diluted 1:200. 




cytometric sorting of GFP+, tdT+ and GFP+ tdT+ cells was performed on a BD AriaIII. Analysis 
was performed using FlowJo. 
 
Analysis of MADM-Labeled Brains and Peripheral Tissue 
Representative images were acquired using either an inverted LSM800 or LSM880 with airy 
scan confocal microscope (Zeiss) and processed using Zeiss Zen Blue software and Photoshop 
(Adobe). Images for quantification were acquired using a SlideScanner VS120 (Olympus) and 
processed via custumed scripts in ImageJ. Tiled images, encompassing the entire region of 
interest, were taken for a minimum of 8 brain sections per animal. Images were imported into 
Photoshop software (Adobe) and the boundaries for the region of interest were traced. 
MADM-labeled cells were manually counted based on respective marker expression. 
 
Quantification and Statistical Analysis 
See Table S1 for complete information regarding quantifications and statistics used in this 
study. This table includes all graphed values, including SEMs, p values, and exact values of n. 
Statistical analysis was performed in the software Prism8 (GraphPad). Evaluation of data was 
performed by the two-tailed paired Student’s t-test (Figure 10B), paired ratio t-test (Figure 
8V), one-way ANOVA (Figure 10E, 11B) or two-way ANOVA (Figure 11A). Data expressed as 
ratio was log-transformed previously to the statistical test. For Figure 8V and Figure 10B, n 
was defined as the density of green/red cells per mm3 from one animal resulting from the 
quantification of 4-20 sections. For Figure 10E and 11A-B, n was defined as the YGR index for 
one animal resulting from the quantification of 20-24 sections (Figure 10E and 11A), or from 
cells sorted from one animal for Figure 11B. The YGRI was defined as the ratio of yellow cells 
divided by the average of green and red cells. 
 
Resources 
All MADM lines will be made publicly available through The European Mouse Mutant Archive 
(EMMA) and distributed from the University of Veterinary Medicine in Vienna or the Institute 
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Lineage Tracing and Clonal Analysis in Developing Cerebral Cortex Using 
Mosaic Analysis with Double Markers (MADM) 
 
 Summary 
Beginning from a limited pool of progenitors, the mammalian cerebral cortex forms highly 
organized functional neural circuits. However, the underlying cellular and molecular 
mechanisms regulating lineage transitions of neural stem cells (NSCs) and eventual 
production of neurons and glia in the developing neuroepithelium remains unclear. Methods 
to trace NSC division patterns and map the lineage of clonally related cells have advanced 
dramatically recently. However, many contemporary lineage tracing techniques suffer from 
the lack of cellular resolution of progeny cell fate, which is essential for deciphering progenitor 
cell division patterns. Presented is a protocol using mosaic analysis with double markers 
(MADM) to perform in vivo clonal analysis. MADM concomitantly manipulates individual 
progenitor cells and visualizes precise division patterns and lineage progression at 
unprecedented single cell resolution. MADM-based interchromosomal recombination events 
during the G2-X phase of mitosis, together with temporally inducible CreERT2, provide exact 
information on the birth dates of clones and their division patterns. Thus, MADM lineage 
tracing provides unprecedented qualitative and quantitative optical readouts of the 
proliferation mode of stem cell progenitors at the single cell level. MADM also allows for 
examination of the mechanisms and functional requirements of candidate genes in NSC 
lineage progression. This method is unique in that comparative analysis of control and mutant 
subclones can be performed in the same tissue environment in vivo. Here, the protocol is 
described in detail, and experimental paradigms to employ MADM for clonal analysis and 
lineage tracing in the developing cerebral cortex are demonstrated. Importantly, this protocol 
can be adapted to perform MADM clonal analysis in any murine stem cell niche, as long as 







The cerebral cortex is a highly organized structure composed of six distinct layers. The cortex 
contains a diverse array of cell types including neurons and glia which interact to form 
functional neural circuits. Most if not all cortical excitatory projection neurons and glia are 
derived from a common pool of neural stem cells (NSC) known as the radial glial progenitor 
(RGP)(Malatesta et al., 2003; Miyata et al., 2001; Noctor et al., 2001). RGPs themselves are 
derived from neuroepithelial stem cells (NESCs) composing the early embryonic 
neuroepithelium. By embryonic day (E) 9 in mice, NESCs begin to transition into RGPs (Taverna 
et al., 2014). RGP lineage progression requires precise temporal and spatial regulation and 
when problems occur in this process it can result in severe neurological disorders such as 
megalencephaly, microcephaly, lissencephaly, or impairments such as schizophrenia and 
autism (Desikan and Barkovich, 2016; Gao and Penzes, 2015). At E10, most RGPs undergo 
symmetric proliferative divisions resulting in an expansion of the neural progenitor pool 
(Beattie et al., 2017; Desikan and Barkovich, 2016; Gao and Penzes, 2015; Taverna et al., 2014). 
RGPs eventually begin to divide asymmetrically, producing cortical projection neurons in a 
temporally defined manner. Through consecutive waves of neurogenesis, newborn neurons 
migrate into the cortical plate forming cortical laminae with early born neurons occupying 
deep layers and late born neurons residing in the superficial layers (Hansen et al., 2017; 
Hippenmeyer, 2014; Lodato and Arlotta, 2015). Since clonally related pyramidal neurons 
migrate radially into the cortex with very little tangential dispersion, daughter cells tend to 
form a column or cone-like shape referred to as a neuronal radial unit (Gao et al., 2014; Llorca 
et al., 2019; Ma et al., 2018; Taverna et al., 2014). By E17, embryonic neurogenic expansion is 
completed in mice (Caviness et al., 1995). RGPs can also produce ependymal cells and some 
classes of glia, including astrocytes and oligodendrocytes (Anthony et al., 2004; Kessaris et al., 
2006; Magavi et al., 2012; Malatesta et al., 2003; Schmechel and Rakic, 1979; Voigt, 1989). 
The potential of RGP to give rise to both neurons and astrocytes seems to be consistent across 
all cortical regions (Anthony et al., 2004) with approximately 1/6 of neurogenic RGP also 





Currently, the genetic and epigenetic factors regulating temporal progression of a stem cell 
along its lineage is mostly unknown. Recent work has demonstrated that temporal patterns of 
gene expression may have substantial impact on lineage decisions in RGPs (Amberg et al., 
2019; Beattie and Hippenmeyer, 2017; Oberst et al., 2019; Telley et al., 2016, 2019). How this 
tightly knit relationship between temporal and spatial patterning leads to the molecular 
diversity of adult neuronal types across cortical areas is not known. Likewise, how the 
individual stem cell potential and its cellular output is modulated at the cellular and molecular 
level is an important outstanding question. Future studies will hopefully address some of these 
open questions, ultimately expanding our understanding of functional cortical circuit 
formation. 
 
It has long been a goal of developmental neurobiology to understand the lineage relationship 
that cells in the brain share with one another. Initially, very few tools existed and many early 
studies relied on visual observations of division patterns in transparent organisms such as 
Caenorhabditis elegans (Deppe et al., 1978). Recent decades have seen a dramatic increase in 
the number and level of sophistication of techniques available to researchers (Legué and 
Joyner, 2010; Ma et al., 2018; Masuyama et al., 2019; Woodworth et al., 2017). The 
emergence of CRISPR-Cas9 genome editing systems now allows for synthetic reconstruction 
of cell lineage relationships by introducing evolving DNA barcodes (Espinosa-Medina et al., 
2019; Masuyama et al., 2019). Two recent examples of barcoding strategies include the use of 
homing guide RNA that direct CRISPR-Cas9 to specific DNA barcode loci or a cytidine 
deaminase fused with nickase Cas9 to target endogenous interspersed repeat regions (Hwang 
et al., 2019; Kalhor et al., 2018). These technologies provide highly multiplexed approaches 
through the introduction of barcodes that progressively and stably accumulate unique 
mutations over time. Genome editing approaches are highly valuable since they allow one to 
retroactively infer the relationship between any two cells based on the shared inheritance of 
these barcodes. However, in order to read the barcodes in individual cells, the tissue usually 
must be disrupted and therefore information regarding position, morphology and absolute 





Combinatorial labelling paradigms provide a means to preserve spatial information and in 
principle also allow for the distinction between closely localized or even overlapping clones 
(Clavreul et al., 2019; García-Moreno et al., 2014). One fundamental characteristic for a 
lineage tracing method to be informative, is that it should label individual progenitors and 
their progeny in a sparse and indelible manner. Notably, the Brainbow (Fried, 2007) and 
Confetti (Amitai-Lange et al., 2015; Snippert et al., 2010) approaches make use of stochastic 
multicolor Cre recombinase based reporters that express a combination of fluorescent 
proteins from a single locus. The extensive number of simultaneous color combinations that 
can be achieved in vivo have made this a powerful tool when tracing cortical RGP clones and 
astrocytes (Clavreul et al., 2019). A number of transposon-based systems have also been 
developed, providing stable genomic integration of transgenes encoding fluorescent reporters 
and permitting lineage tracing of cortical progenitors (Chen and LoTurco, 2012; García-
Moreno et al., 2014; Siddiqi et al., 2014; Vasistha et al., 2015; Yoshida et al., 2010). 
Transposon-based systems have the added advantage that the reporter constructs stably 
integrate into the genome, and thereby reliably label lineally related daughter cells. To trace 
astrocyte lineages specifically, a number of methods have been developed that involve 
electroporation of piggyBac transposases including Star Track, which makes use of a 
combination of constructs encoding different fluorescent proteins (García-Marqués and 
López-Mascaraque, 2013; Siddiqi et al., 2014). Another approach, termed MAGIC markers 
introduces Brainbow vectors as transposable transgenes, which has been successfully used to 
trace embryonic neural and astrocyte progenitors (Clavreul et al., 2019). Recently, mosaic 
analysis by dual recombinase-mediated cassette exchange (MADR) has been demonstrated to 
permit stable labeling of mutant cells expressing transgenic elements from precisely defined 
chromosomal loci (Kim et al., 2019). To date, these powerful in vivo combinatorial labelling 
techniques have provided numerous insights into the lineage dynamics of progenitor cells. 
However, one general limitation is that most analysis are performed on fixed tissue, providing 
a snapshot of individual clones at a defined developmental stage. In order to observe changes 
in the lineage dynamics of single clones over time, chronic in vivo imaging methods similar to 





Mosaic analysis with double markers (MADM) is a powerful dual-color labelling method that 
enables in vivo lineage tracing of individual progenitor cells in mice (Hippenmeyer et al., 2010; 
Zong et al., 2005). Two components are necessary for MADM labelling events to occur. First, 
MADM cassettes must be targeted to identical loci on homologous chromosomes. Cassettes 
consist of two chimeric fluorescent reporter genes, eGFP (green, [G]) and tandem dimer 
Tomato (red, tdT[T]). The GT cassette contains the N-terminus of eGFP and the C-terminus of 
tdT, separated by an intron containing a loxP site. The TG cassette is constructed inversely, 
with the N-terminus of tdT and the C-terminus of eGFP. The second essential component is 
the expression of Cre recombinase in the same cell containing the targeted MADM cassettes. 
In the absence of Cre, the chimeric cassettes do not express functional eGFP or tdT since their 
coding sequences are disrupted. The loxP sites serve as a target for Cre-mediated 
interchromosomal recombination, resulting in the reconstitution of both expression cassettes 
simultaneously. If recombination occurs during the G2 phase of cell cycle followed by X 
segregation (G2-X), two daughter cells will each express one of the two fluorescent proteins. 
Temporal regulation of CreERT2 activity using tamoxifen (TM) provides precise information on 
birth date of MADM clones and the division patterns of their progeny (Figure 19A) 
(Hippenmeyer et al., 2010; Zong et al., 2005). 
MADM holds the potential for systematic labeling of individual clones with high single cell 
resolution in the mouse brain similar to traditional but non-specific and laborious methods 
like Golgi staining  or dye filling (Cowan, 1998). Because only the promoter driving CreERT2 
determines the cell-type specificity of clonal MADM labeling, MADM can in principle be 
applied for clonal lineage tracing throughout any organ and tissue in the mouse(Ali et al., 2014; 
Hippenmeyer et al., 2013; Riccio et al., 2016; Zong et al., 2005). A number of studies have 
already used MADM to reveal lineage relationships in clones derived from diverse tissues (Ali 
et al., 2014; Bonaguidi et al., 2011; Brennand et al., 2007; Hippenmeyer et al., 2013; Mayer et 
al., 2015; Muzumdar et al., 2016; Riccio et al., 2016; Shi et al., 2017; Wong et al., 2018; Xu et 
al., 2014; Zong et al., 2005). MADM experimental paradigms have been applied to study 
lineage relationships of cortical projection neurons, glia and postnatal stem cells in the 
developing neocortex (Beattie et al., 2017; Gao et al., 2014; Hippenmeyer et al., 2010; Johnson 
and Ghashghaei, 2020; Kaplan et al., 2017; Llorca et al., 2019; Lv et al., 2019; Mihalas and 




dentate gyrus, thalamus, cerebellar granule cells and interneurons have also been explored at 
the clonal level using MADM (see Table 1 for complete list) (Bonaguidi et al., 2011; Espinosa 
and Luo, 2008; Mayer et al., 2015; Shi et al., 2017; Wong et al., 2018; Zong et al., 2005). 
 
A unique feature of MADM is the ability to genetically link mutations distal to one MADM 
cassette, and thereby creating a genetic mosaic (Figure 19B and Figure 20). This results in wild-
type daughter cells labeled with one fluorescent marker (tdT in Figure 19B) and homozygous 
mutant siblings with the other (eGFP in Figure 19B) in an unlabeled heterozygous 
environment. MADM is unique in that comparative analysis of control and mutant subclones 
can be performed in the same tissue environment in vivo. Originally, MADM cassettes were 
targeted into the Rosa26 locus (Zong et al., 2005) but MADM analysis of gene function was 
limited to genes distal to the locus. To overcome (at least partly) this limitation and expand 
the possibilities for MADM-based gene analyses, MADM cassettes were knocked in close to 
the centromeres of Chr. 7 (Hippenmeyer et al., 2013), Chr. 11 (Hippenmeyer et al., 2010) and 
Chr. 12 (Hippenmeyer et al., 2013). Targeting of all 19 mouse autosomes with MADM cassettes 
is in process and will in the future allow for virtually any gene to be studied, providing an 
unparalleled platform for the study of developmental lineage relationships in combination 







Mouse protocols were reviewed by institutional preclinical core facility (PCF) and internal 
ethical committee at IST Austria. All breeding and experimentation were performed under a 
license approved by the Austrian Federal Ministry of Science and Research in accordance with 
the Austrian and EU animal laws. 
 
1. Breeding of experimental mice for MADM clonal analysis 
1.1. Set up timed experimental MADM matings (>P56; CD-1) in the late afternoon (5:00 PM) 
and check for vaginal plugs the proceeding morning (8:00 AM). The morning the plug is 
present counts as day 0.5. See Figure 20 for an overview of the experimental mouse mating 
setup. Ensure that timepoints for TM induction of CreERT2 activity and analysis are appropriate 
to address experimental questions.  
NOTE: For more information refer to Figure 21 and representative results below. 
1.2. For postnatal sampling, set up breedings to generate foster mothers in parallel. 
NOTE: These should be started up to 1−2 days prior to setting up experimental breedings. 
 
2. TM induction in MADM mice 
2.1. Prepare a working 20 mg/mL TM solution by dissolving it in corn oil in a 15 mL or 50 mL 
conical centrifuge tube and placing it on a rocking platform for ~4 h at room temperature (RT), 
ensuring TM is completely dissolved. Store working solution at 4 °C covered with aluminum 
foil and use within 2 weeks. 
2.2. To induce MADM recombination events, deliver a single injection of TM intraperitoneally 
(IP) using a 1 mL tuberculin syringe and a 25 G needle into a timed pregnant dam. Depending 
on the stage of cortical neurogenesis, inject TM between E10−E15 at a dose of 1−2 
mg/pregnant dam. For early timepoints (i.e., E10) use a maximum of 1 mg/pregnant dam (25 
mg/kg) to prevent complications during pregnancy (Gao et al., 2014). For timepoints between 
E11–E15 use 2 mg/pregnant dam (50 mg/kg). 
NOTE: Alternatively, TM can be administered with an oral gavage for late pregnancies. 
2.3. For MADM clonal analysis to postnatal timepoints, recover live embryos at E18−E19 




NOTE: Depending on the health status of the pregnant female, it may not be necessary to 
perform a Caesarean section but raising pups with a foster mother is still required because 
the original TM-treated mother may have trouble lactating.  
2.4. To recover live embryos by Caesarean section or to retrieve embryonic timepoints for 
analysis, sacrifice the pregnant dam by cervical dislocation. 
2.5. Place the animal in a supine position and disinfect fur with 70% ethanol. Make a small 
incision in the skin in the lower abdomen above the uterus using surgical forceps and scissors. 
Make a second incision through the muscles and the abdominal muscular wall to reveal the 
peritoneum. 
2.6. Remove the uterus by separating from the surrounding tissues with scissors. Transfer 
intact uterus onto a glove with warm water to increase the embryo survival rate until each is 
removed from the amnion individually. 
2.7. Use fine tipped scissors and fingers to carefully open the uterine walls to release 
embryos. Do not cut the umbilical cords too close to the body to prevent extensive blood loss. 
If embryos are to be used for analysis, proceed to step 3.9. If pups are to be fostered, proceed 
to step 2.8. 
2.8. If fostering is required, clean the pups before transferring them to the foster mother. 
While cleaning the pups, gently press the chest from time to time to initiate breathing. Place 
back on a second glove filled with warm water to improve survival rate. 
NOTE: It is important to gently remove any remaining amnion and/or placenta with a paper 
towel. 
2.9. Before transferring pups to the foster mother, remove the foster mother from her cage, 
remove the original pups, and replace with the experimental pups. Return the foster mother 
to her cage. 
NOTE: See discussion for additional suggestions to improve fostering acceptance rates. 
2.10. If genotyping is required, collect toe or tail biopsies between P6−P8. 
NOTE: Perform this step only if animal experimental licenses approve this practice. 
 
3. Tissue preparation for MADM clones in the brain 
NOTE: For experiments that include postnatal tissue (≥P4), proceed to step 3.1. For embryonic 




3.1. Anesthetize the experimental MADM animal with an IP injection of a 
ketamine/xylazine/acepromazine solution (65 mg, 13 mg, and 2 mg/kg body weight, 
respectively) and confirm that the mouse is unresponsive by pinching the paw. 
NOTE: Both male and female MADM mice (CD-1 background) are used for analysis. If 
genotyping is required, collect ear biopsies at this point. 
3.2. Place the anesthetized animal in the supine position on the perfusion surgery tray and 
disinfect fur with 70% ethanol. To begin surgery, carefully make an incision with scissors and 
surgical forceps through the outer layer of the skin and then a second incision through the 
muscle layer. Lift the tip of the sternum and cut connective tissue on the sides, taking extra 
caution to avoid cutting the liver. The thoracic cavity will be visible. 
3.3. Snip the diaphragm and lift to reveal the heart. Carefully trim the rib cage and pin to the 
surgical tray to expose the heart. For pups, remove the rib cage completely. 
3.4. Insert a needle with phosphate buffered saline (PBS) into the lower left ventricle (paler 
tissue). Using small iris scissors make an incision to the posterior end of the right atrium (dark 
red tissue) for the blood to drain. 
3.5. Perform perfusion with PBS followed immediately by freshly made, ice-cold 4% 
paraformaldehyde (PFA) prepared in PBS. For pups (P4−P10) use syringes to perform 
perfusion. Fill one syringe with 10 mL of PBS and another with 10 mL of 4% PFA. Ensure all air 
bubbles in the syringes have been removed. For older animals, use a peristaltic pump. 
3.6. Begin perfusing with PBS (10 mL at 2−4 mL/min in pups; 20 mL at 4−6 mL/min for adults 
using a peristaltic pump). The liver will become clear and pale yellow if the needle is 
positioned correctly. 
3.7. Once complete, remove the needle from pups and insert the needle containing PFA into 
the same hole. For adults, stop the peristaltic pump before exchanging the PBS solution with 
ice-cold PFA, making sure to avoid bubbles in the uptake tubing. Resume perfusing with PFA 
(10 mL at 2−4 mL/min in pups; 30 mL at 4−6 mL/min for adults using a peristaltic pump). 
3.8. When perfusion is complete, decapitate the mouse and remove the brain through careful 
dissection. Transfer brain to 4% PFA. Use at least 5x the brain volumes (i.e., ~5−10 mL of PFA 
in a 15 mL conical centrifuge tube) and incubate overnight at 4 °C for postperfusion fixation 




3.9. For embryonic tissue and early postnatal tissue (i.e., P0−P3), after performing a Caesarian 
section, decapitate the embryos with scissors. If genotyping is required, collect the tail of the 
embryo at this point. Immediately dissect out the brain and transfer to a 12 well plate 
containing 2−3 mL of 4% PFA/well. Incubate overnight at 4 °C for postfixation. 
3.10. Next morning exchange PFA with 10 mL (adult) or 2−3 mL (embryo) of PBS and repeat 
wash 3x for 15 min at RT. Transfer tissue to 30% sucrose solution in phosphate buffer (PB) 
and store at 4 °C on a rocking platform until the tissue sinks in the solution.  
3.11. Embed the brain in optimal cutting temperature (OCT) compound in an embedding 
mold, taking care to orient the brain for either coronal or sagittal sectioning. Freeze by placing 
the embedding mold on dry ice until OCT becomes completely opaque (~10−15 min). Store 
tissue at -80 °C until further use. 
 
4. Preparation of MADM tissue for immunohistochemistry 
4.1. Attach the tissue block to the specimen disk in the cryostat by applying a ring of OCT to 
the disk and placing the block directly into the OCT when it begins to freeze. Ensure the block 
is correctly oriented for the desired cutting plane. 
NOTE: Here, coronal sectioning to investigate cortical MADM clones is described in detail. 
4.2. Set the block temperature in the cryostat to -20 °C and the blade temperature to -21 °C. 
4.3. Allow the tissue block to adjust to the chamber temperature by mounting the specimen 
disk to the specimen holder and leave in cryostat for ~5 min before beginning sectioning. 
4.4. Trim block in thick sections (45−60 μm) until the tissue region of interest is reached.  
4.5. Once the edge of the cortex is clearly visible, stop sectioning and lock the blade. Ensure 
the blade is shielded before trimming the block. 
4.6. Trim excess OCT surrounding the tissue with a blade, leaving ~1−2 mm of OCT on all sides 
of the brain. 
4.7. Next orient the block so that one of the lateral edges of the cortex is oriented downward 
and the other upwards (i.e., the most rostral edge of the cortex is pointed right). 
4.8. Begin sectioning with a thickness of 45 μm for adult clones and 30 μm for embryonic 
clones. Perform each section individually and use a small brush to keep the area below the 




NOTE: If this is not done and a section falls, it may be difficult to determine the correct order 
of the slices.  
4.9. If sections begin to curl, trim the edges of the block and/or carefully adjust the glass 
antiroll plate. 
4.10. For embryonic clone analysis, mount sections directly to a frosted slide. Dry on a heating 
plate at 37 °C before proceeding directly to step 5.6.  
NOTE: Several sections can be added to one slide, but ensure the sequential order is 
maintained. 
4.11. To collect adult clones, prepare 24 well plates containing 1 mL of PBS/well (typically, 
5−6 plates per brain). Starting from the first well, with cold forceps collect individual serial 
sections in PBS in the order of sectioning.  
NOTE: The floating section method is adopted for adult tissue to ensure that no sections are 
missed and that mounted sections contain no wrinkles.  
4.12. Stop sectioning once the end of the neocortex is reached. 
4.13. For adult clones, proceed to mounting floating sections. 
NOTE: Sections can be kept in PBS at 4 °C for up to 24 h. 
 
5. Mounting adult tissue for imaging 
NOTE: The following tools are required: small paint brush, Petri dish, PBS with 0.5% Tween 
(PBS-T), adhesion slides, mounting medium, coverslips, and forceps. 
5.1. Fill a Petri dish with PBS-T. 
NOTE: Detergent is used to aid in the mounting process. If staining for additional antigens that 
are sensitive to detergents (i.e., glycoproteins) is necessary, it is best to skip the addition of 
Tween. 
5.2. Place an adhesion slide into the PBS-T so that it is nearly covered up to the label. 
5.3. Transfer the first section into the PBS-T. 
5.4. Using a small paint brush, maneuver the section onto the slide and arrange it to preserve 
the order of cutting. Proceed in the same way with all further sections. 
5.5. Once all sections are in position, place the slide (~12−16 sections/slide) in a dark slide 
chamber. Slightly lift the lid to allow the sections to dry completely (~10−20 min), ensuring 




5.6. If performing immunohistochemistry for additional antigens, proceed directly to section 
6 or 7. 
NOTE: For embryonic timepoints, it is necessary to perform immunostaining steps for at least 
GFP and tdT (section 6). For adult clones, this is only required if staining for additional antigens 
in parallel (sections 6 and 7). 
5.7. Rehydrate and wash sections 1x with 1x PBS for 5 min to remove residual PBS-T. Apply 
~1 mL of 4′,6-diamidino-2-phenylindole (DAPI) diluted in 1x PBS (1:5,000) to the slide, 
ensuring all sections are covered and incubate for 15 min. 
5.8. Carefully remove the DAPI and wash 1x with 1x PBS for 5 min. Remove excess PBS and 
dry for ~1−2 min before embedding in 110 µL of mounting medium. Seal with a 24 x 60 mm 
coverslip and let dry for at least 3 h before imaging. 
 
6. Immunostaining for GFP and tdT only 
NOTE: This section is necessary for embryonic clones. 
6.1. Place slides horizontally in a humidified slide incubation chamber. Mark slide boundaries 
with a wax marker to minimize the amount of buffer required. 
6.2. Rehydrate sections with 1x PBS. To improve staining quality, work with freshly sectioned 
tissue. 
6.3. Add 250−400 µL of blocking buffer (0.5% Triton X-100, 2−3% normal donkey serum in 1x 
PBS) per slide, ensuring all sections are covered. Incubate for 1 h. 
NOTE: The concentration of detergent (Triton X-100 or Tween-20) will vary depending on the 
additional primary antibodies used because some antigens are more sensitive to detergents 
than others.  
6.4. Remove blocking buffer and add primary antibodies in blocking buffer to the slide 
(300−400 µL/slide).  
NOTE: An example of a standard primary antibody reaction for anti-GFP/anti-tdT (MADM) 
could use chicken anti-GFP (1:500) and rabbit anti-RFP (1:500). 
6.5. Incubate with primary antibodies overnight at 4 °C. 
NOTE: The slides must be incubated perfectly horizontally with buffer covering all sections. 




6.6. Confirm the next morning that the blocking buffer with primary antibodies still covers all 
sections on the slide. If not, repeat the incubation step for 3−4 h at RT. 
6.7. Remove primary antibodies and wash 4x with 1x PBS for 10 min at RT. 
6.8. Add secondary antibodies diluted in blocking buffer to slide (300−400 µL/slide): Alexa 
Fluor 488 anti-chicken IgG (1:500) and Cy3 anti-rabbit IgG (1:500). 
6.9. Incubate at RT for 2 h. Keep slides covered from light to prevent bleaching of 
fluorophores. 
6.10. Remove secondary antibodies and wash 2x with 1x PBS for 10 min. 
6.11. Incubate with DAPI diluted in PBS (1:5,000) for 15 min. 
6.12. Wash sections 1x with 1x PBS for 10 min. 
6.13. Remove excess PBS and dry for ~1−2 min before embedding in 110 µL of mounting 
medium. 
6.14. Seal with 24 x 60 mm coverslip and let dry for at least 3 h before imaging. Image slides 
within 1−2 weeks after performing immunohistochemistry to ensure optimal signal. 
 
7. Immunostaining for GFP, tdT, and additional antigens 
7.1. Perform steps 6.1−6.3. 
7.2. Remove blocking buffer and add primary antibodies in blocking buffer to the slide 
(300−400 µL/slide). 
NOTE: When staining for three or more antigens (i.e., GFP, tdT, and a protein of interest) and 
the antibody for the protein of interest was raised in rabbit, it is recommended to use the 
anti-tdT (goat) primary antibody at a dilution of 1:500. An example of a primary antibody 
reaction for three antigens with alternative tdT staining could use chicken anti-GFP (1:500), 
goat anti-tdT (1:500), and antibody against the protein of interest (i.e., rabbit). 
7.3. Perform steps 6.5−6.7. 
7.4. Add a secondary antibody mix diluted in blocking buffer to slide (300−400 µL/slide): Alexa 
Fluor 488 anti-chicken IgG (1:500), Cy3 anti-goat IgG (1:500), and Alexa Fluor 647 anti-rabbit 
IgG (1:500). 






8. Confocal image acquisition and quantification of MADM clones 
8.1. Identify and document brain sections containing clones and their locations in the cortex. 
NOTE: The number of sections a clone spans will vary depending on when the clone was 
induced, the CreERT2 driver, and the time of analysis. This step can be performed on either a 
confocal microscope or an epifluorescence microscope. 
8.2. Using an inverted confocal microscope, begin by selecting and configuring the correct 
laser lines and filters. For MADM brains, select DAPI, GFP, and tdT (excitation: 358 nm, 488 
nm, and 554 nm, respectively; peak emission: 461 nm, 507 nm, and 581 nm, respectively). 
Ensure the pinhole is set to 1 airy unit for optimal imaging quality. 
8.3. For confocal specific settings, image clones with a 20x objective and 1x zoom. For images 
that will be used in quantifications, use a scanning speed pixel dwell value of 1.52−2.06 μs 
(values 7−8 in the image acquisition software) with no averaging. Adjust laser intensity and 
gain settings for each channel as appropriate. 
NOTE: Depending on the required image quality, settings for scanning speed and averaging 
may vary. 
8.4. Once the clone is clearly identified, arrange imaging tiles to cover all relevant sections in 
the clone. Adjust the z-stack so that all MADM labeled cells in the clone are captured with an 
interval of 1.5 μm/z-stack slice. Adjust the tiled region so that the entire width of the cortex 
is captured when imaging the clone (i.e., from pial surface to the corpus callosum). 
8.5. Image individual clones spanning multiple sections consecutively, ensuring that any 
sections without cells within a clone are still imaged for the purpose of 3D reconstruction and 
correct interpretation of cell spatial information. 
8.6. Analyze each section containing cells of a MADM clone sequentially from the rostral to 
the caudal end of the cortex. Distinguish individual neurons and glia based on their 
morphology and/or marker staining. Record positional information in parallel based on 
respective layer boundaries defined by nuclear staining (DAPI). 
NOTE: See Figure 22 for representative results for embryonic analysis and Figure 23 for 







9. Serial 3D reconstruction of clones 
NOTE: The 3D reconstruction of individual clones imaged over serial brain sections is useful 
for visual display as well as the analysis of 3D clonal architectures and can be performed 
according to the following steps. 
9.1. Stitch and fuse confocal tiled images based on acquisition parameters using image 
acquisition software. Open .czi file and then run the “Stitching” method under the “Processing 
“tab. 
9.2. Export stitched image stacks as individual z-planes in TIFF format. Open stitched .czi file 
and then run the “Image Export” method under the “Processing” tab. For multichannel 
images, export as Red/Green/Blue images for subsequent image processing. 
9.3. Repeat steps 9.1 and 9.2 for each serial brain section of a clone. 
NOTE: For accurate 3D reconstruction, all brain sections within a clone, including the ones 
without labeled cells, must also be processed. 
9.4. Concatenate individual images into a single stack in order beginning from the most rostral 
to the most caudal z-plane using open source image processing software such as ImageJ/Fiji. 
NOTE: Any blank images at the edges of each brain section should be removed at this point. 
9.5. If required, correct the image stack obtained from step 9.4 for misalignment using an 
ImageJ plugin called “MultiStackReg” by following steps 9.5.1−9.5.5. If image alignment is not 
required, proceed to step 9.6. 
NOTE: This plugin performs image alignment of the channel with highest contrast (usually 
DAPI) and then applies the recorded transformation to the other channels, thus allowing 
reliable image alignment of multichannel stacks. An auxiliary plugin called “TurboReg” must 
be preinstalled. 
9.5.1. In ImageJ, install the “MultiStackReg” and “TurboReg” plugins. 
9.5.2. Open the image stack of clone images obtained from step 9.4 to be aligned. Split 
channels into DAPI (blue), GFP (green), and tdT (red) within Color option under Image tab. 
9.5.3. Run “MultiStackReg” plugin to align DAPI channel by “Rigid Body” transformation and 
save the transformation file. 
9.5.4. Apply the saved transformation file to the other two channels using “MultiStackReg”. 
9.5.5. Merge all three aligned channels and save aligned stack. 




9.5.5 after alignment) in a vertical orientation with the pial surface on top and the corpus 
callosum at the bottom. Crop in the xy plane if necessary. 
9.7. For both qualitative presentation and quantitative analysis, generate a maximum z-
projection image (step 9.8) or perform 3D rendering (step 9.9) of the clone. 
9.8. In ImageJ, open the image stack from step 9.6 and select “Z-projection” option with 
projection type “Max intensity”. This will generate an image of the entire clone projected on 
the same plane. 
9.9. In ImageJ, open the image stack from step 9.6 and select “3D Project” z-function to 
generate a 3D visualization of the clone that can be rotated. 
NOTE: It is important in this step to input the correct slice interval equivalent to the thickness 
of individual z-stacks during image acquisition. The interpolation tool should be used to 
remove gaps between slices. 
 
 Representative Results 
MADM results in reconstitution of functional green and red fluorescent proteins with two 
daughter cells each expressing one of the two fluorescent proteins upon G2-X chromosome 
segregation events (Figure 19A). Since MADM events result in permanent and distinct 
labeling of the two descendent lineages, quantifiable assessment of green and red daughter 
cell lineages (subclones) can be performed. Variables including division pattern (symmetric 
versus asymmetric) and potential (the number of progeny) of the original progenitor can be 
determined. One daughter cell may exit cell cycle, thus only producing 1 daughter cell, or 
continue dividing to produce larger numbers of neurons. Quantifying each fluorescently 
labelled subclone is informative when retroactively determining if the original progenitor 
cell was undergoing symmetric proliferative divisions, or asymmetric, neurogenic divisions 
at the time of TM induction. Previous studies grouped Emx1-CreERT2 or Nestin-CreERT2 
derived excitatory projection clones in the cortex into two broad classes (Beattie et al., 2017; 
Gao et al., 2014; Hippenmeyer et al., 2010). The first, termed “symmetric proliferative 
clones”, on average are composed of a considerable number of neurons, with both green 
and red subclones containing 4 or more neurons each. The second group, “asymmetric 
clones” defines a class of clones where the “minority” subclone contains fewer than 3 




specific to cortical RGPs and may need to be revisited for other brain regions and tissues. 
For both classes of cortical clones, progeny will be distributed throughout superficial and 
deep layers. 
 
When designing MADM clonal studies there are a number of aspects that must be taken 
into consideration. The time when MADM events are induced by administration of TM is a 
key consideration (Figures 21 and 22). For cortical excitatory projection neuron MADM 
clones (i.e., using Emx1-CreERT2 or Nestin-CreERT2) at E10, nearly all RGPs are still undergoing 
symmetric divisions (Gao et al., 2014). Therefore, induction at E10 with TM will capture 
multiple rounds of proliferative RGP amplification and result in clones with high neuron 
numbers. However, the number of RGPs at E10 is generally low and thus TM administration 
will generate very few MADM events (sometimes less than 1/brain). The majority of RGP 
switch from symmetric to asymmetric neurogenic divisions at around E12. To target strictly 
asymmetric neurogenic clones, it is recommended to induce at E12 or later (Figure 21). In 
our experience, the time between TM induction and observing MADM recombination 
events in the cortex is less than 24 h. IP injections are our preferred method for 
administering TM at embryonic stages since in our hands this has led to greater 
reproducibility in clonal induction. It is also important to keep the TM dose to a minimum 
for two reasons. Firstly, if the MADM recombination rate increases, the probability of 
inducing multiple (perhaps overlapping) clones is higher. Secondly, if too much TM is 
delivered, an increased rate of abortion, embryo reabsorption and smaller litter sizes may 
be observed. We have observed abortions in approximately half of all pregnant dams when 
TM injection is delivered at E10. This frequency improves from E11 onwards and reduces to 
approximately 1/3 of pregnant dams aborting. For a summary of TM doses, induction times 
and CreERT2 drivers used in previous MADM studies, refer to Table 1. Reporter activity in the 
absence of TM has been reported with some TM-inducible CreERT2 drivers (Liu et al., 2010). 
In our experience, ectopic expression or MADM recombination events in the absence of TM 
have not been observed with the Emx1-CreERT2 of Nestin-CreERT2 drivers. This may be 
partially due to the fact that TM mediated chromosomal trans-recombinations occur at 
approximately 1:1,000 to 1:10,000 lower frequency than cis-recombinations, reducing the 




Another factor to consider when planning a MADM clonal analysis experiment is the 
duration of the study. Varying the length of the time between TM induction and when the 
experiment is analyzed (A) (time window) provides insight of stem cell dynamics over time 
(Picco et al., 2019). Short embryonic time windows (i.e., TM/E11−A/E13; TM/E11−A/E16) 
will capture the dynamics of embryonic neurogenesis (Figure 22). Comparing clones from 
two or more time windows provides quantitative insight into the number of cells produced 
and how neuron distribution varies at different stages of lineage progression (Picco et al., 
2019). To capture the entire potential of individual clones, it is necessary to extend the time 
window analyzed into postnatal or adult time points (Beattie et al., 2017; Gao et al., 2014; 
Llorca et al., 2019). Examples of neocortical clones induced in the embryo and analyzed in 
the adult are shown in Figure 23. It is of note that by E17, cortical neurogenesis has mostly 
completed, and gliogenesis increases. Approximately 1/6 neurogenic RGP will also proceed 
to generate astrocytes and/or oligodendrocytes (Gao et al., 2014). 
 
Symmetric clones occur when RGP have undergone one or more rounds of proliferative 
division (Gao et al., 2014). RGP clones induced between E10−E12 are on average larger in 
size and provide more spatial features of the final neuron distribution (Figure 22A-C). Clones 
with neurons relatively equally distributed throughout deep and superficial layers take on a 
“cylinder” shape while clones with neurons more dispersed in superficial layers than deeper 
layers develop a “cone” shape (Gao et al., 2014). To fully capture the spatial and 
morphological information of a clone, it is necessary to computationally reconstruct each 
clone using sequential images. To measure clonal dispersion, the maximal lateral dispersion 
(measured in all dimensions) in superficial layers (LII−VI) of a clone is compared to neuron 
dispersion in deep layers (LV/LIV). This ratio (distribution upper/distribution lower) provides 
a quantifiable readout of the overall clone shape. 
 
Asymmetric clones, where the minority subclone is 3 or less, provide insight into the 
neuronal output of single RGP (Figure 22D-F and Figure 23A-F) (Beattie et al., 2017; Gao et 
al., 2014; Llorca et al., 2019). The majority population (large subclone) can be labeled either 
in red or green, with an average of approximately 7 excitatory projection neurons per clone 




Gao et al., 2014; Llorca et al., 2019). The total number of cells in a MADM clone can be 
further dissected by analyzing the distribution of neurons in the large subclone across 
superficial and deep layers. The minority population (small subclone) is labelled by the 
reciprocal color and is on average 1−2 cells per clone (Figure 23H). The total “unit size” can 
be calculated by summing the small and large subclones together, which is on average 8−9 
neurons (Figure 23I) (Beattie et al., 2017; Gao et al., 2014; Llorca et al., 2019). It is important 
to note that while the neuronal output of RGPs is highly predictable, there is a degree of 
clonal heterogeneity (Klingler and Jabaudon, 2020; Llorca et al., 2019). 
 
Introduction of a mutation distal to the MADM cassette enables the generation of genetic 
mosaics providing a unique method to dissect the molecular regulators of stem cell lineage 
progression. As such, MADM provides an unparalleled experimental platform to study the 
cell-autonomous function of a gene, e.g., associated with microcephaly or macrocephaly. By 
comparing clones induced in a MADM genetic mosaic to clones induced in a control MADM, 
a highly quantitative readout of changes in neuron numbers and distribution can be 
generated. Previous MADM-based studies quantified the cell-autonomous function of Otx1 
in microcephaly formation at the clonal level (Figure 24A-E for representative example) (Gao 
et al., 2014). In another study, MADM clonal analysis demonstrated that Ndel1 does not cell-
autonomously regulate projection neuron number, but instead the ability of newborn 
neurons to enter or migrate within the cortical plate, which later forms the adult cortex 
(Hippenmeyer et al., 2010). These studies demonstrated the highly quantitative nature of 
MADM clonal analysis in studying the cell-autonomous functions of genes regulating cortical 
development. There are currently no examples in the literature where MADM has been used 
to study genes implicated in macrocephaly at the clonal level. However, in future studies 
analysis of genes relevant to the control of cortical size in general can provide highly 





 (A) To perform lineage tracing and clonal analysis with MADM, two components must be 
present. Firstly, MADM cassettes must be targeted to identical loci on homologous 
chromosomes. Cassettes consist of two chimeric fluorescent reporter genes, eGFP (green, [G]) 
and tandem dimer Tomato (red, tdT[T]). The GT cassette contains the N-terminus of eGFP and 
the C-terminus of tdT, separated by an intron containing a loxP site. The TG cassette is 
constructed inversely, with the N-terminus of tdT and the C-terminus of eGFP. Secondly, the 
expression of Cre recombinase must occur in the same cell containing the targeted MADM 
cassettes. The loxP sites serve as a target for Cre-mediated interchromosomal recombination, 
resulting in the reconstitution of both expression cassettes simultaneously. If recombination 
occurs during the G2 phase of cell cycle followed by X segregation (G2-X), two daughter cells 
will each express one of the two fluorescent proteins. (B) MADM principle for genetic mosaic 
analysis at single clone level. Mutant alleles (point mutations, deletions, insertions, loxP-
flanked conditional alleles as depicted in Figure 19B, etc.) can be introduced distal to the TG-





MADM cassette via meiotic recombination (see Figure 20 and (Hippenmeyer et al., 2010) for 
details of how to introduce mutant alleles into the MADM system). If a G2-X Cre recombinase-
mediated interchromosomal trans-recombination occurs between MADM cassettes it results 
in one GFP+ homozygous mutant cell (GeneX-/-) for the gene of interest and one tdT+ 
homozygous wild-type cell (GeneX+/+) in an unlabeled heterozygous environment 
(Hippenmeyer, 2013; Hippenmeyer et al., 2010; Zong et al., 2005). Alternate labeling 
outcomes that are not used in the clonal analysis (i.e., yellow cells) have been previously 
described in detail (Gao et al., 2014; Hippenmeyer, 2013; Zong et al., 2005). 
 
Breeding scheme for the generation of control-MADM (A) and Gene X-MADM (B) 
experimental MADM mice for clonal analysis. For more information regarding MADM 
breeding paradigms see Beattie et al.7 and (Beattie et al., 2017; Hippenmeyer et al., 2010). 
 
 Schematic of the experimental design time windows. For longitudinal sampling paradigms, 
the time point of clone induction remains constant with the length of time before analysis 
varying. In progressive interval sampling, the time point of analysis remains constant, but the 
time of induction varies. A combination of one or both approaches may be used depending 
on the questions to address. 
 
Figure 20. Breeding Schemes for Generation of Experimental MADM Mice for Lineage 
Tracing. 




TM-mediated MADM clone induction in symmetrically proliferative (TM at E10) (A−C) and 
asymmetrically neurogenic (TM at E12) (D−F) dividing RGPs. Depicted are individual MADM 
clones in vivo in the developing (TM/E10−A/E16 and TM/E12−A/E16) (B,E) and adult 
(TM/E10−A/P21 and TM/E12−A/P21) (C,F) in MADM-11GT/TG; Nestin-CreERT2+/- (B,E) and 
MADM-11GT/TG; Emx1-CreERT2+/- (C,F). Neuron output is independent of subclone color and 
green majority/minority subclones can be compared to red majority/minority subclones 
under control conditions (Beattie et al., 2017; Gao et al., 2014). Approximately 1/6 adult 
clones also contain astrocytes and/or oligodendrocytes, indicated by white asterisks. Panels 
B and F adapted and/or reproduced with permission from (Hippenmeyer et al., 2010) and 
Rulands and Simons (Rulands and Simons, 2016) respectively. CP: Cortical plate. 
 
  




Analysis of excitatory neuron (unit) production by individual neurogenic RGPs at the clonal 
level using MADM (Beattie et al., 2017; Gao et al., 2014). (A) Experimental paradigm for 
inducing mostly asymmetric MADM clones in the developing cortex. (B) Possible asymmetric 
clone outcomes with the majority subclone being labelled in either green or red (C) 
Representative consecutive sections spanning a single neurogenic asymmetric clone (D,E) 3D 
reconstruction images of representative asymmetric G2-X MADM clones with majority 
population in red (D) or green (E) in MADM-11GT/TG; Emx1-CreERT2+/- with TM induction at E12 
and analysis at P21. Note both green and red labelled cells are wt. (F) Schematic indicating 
the two possible experimental MADM clone outcomes. (G) Quantification of the size of the 
majority population arising from renewing RGPs in MADM-11 clones. (H) Quantification of the 
size of the minority population arising from renewing RGPs in MADM-11 clones. (I) 
Quantification of the unitary size of asymmetric neurogenic MADM-11 clones. Hypothetical 
values could represent mean ± SEM. Scale bar = 100 µm (D and E). TM: Tamoxifen. 




Hypothetical MADM clonal analysis results when performing functional genetic dissection of 
candidate genes that lead to microcephaly or macrocephaly. To dissect the cell-autonomous 
functions of a gene of interest (Gene X) on neuron output, MADM requires mutant alleles to 
be introduced distal to the MADM cassettes via meiotic recombination (for details how to 
introduce mutant alleles into the MADM system see also Figure 20, (Hippenmeyer et al., 2010) 
and (Laukoter et al., 2020). (A,B) Schematic indicating experimental MADM paradigm for 
functional analysis of clonal RGP units. The mutant subclone can either form the minority (A) 
or majority (B) population. (C−E) Hypothetical MADM clonal analysis results when quantifying 
control-MADM (white bars), Gene-X-MADM microcephaly (gray bars) and Gene-X-MADM 
macrocephaly black bars) asymmetric clones. (C) Quantification of the size of the majority 
population. (D) Quantification of the size of the minority population. (E) Quantification of the 
unitary size of asymmetric neurogenic clones. Hypothetical values could represent mean ± 
SEM. S: Hypothetical scenario where difference in subclone cell number could reach 
significance, relative to control. 
  








Table 2. MADM Clonal Studies in the Literature. 
 Summary of studies in the literature containing MADM clonal lineage experiments, including 






We describe here the details of a powerful methodology that utilizes MADM technology to 
track cell lineage of individual RGPs in vivo in the developing neocortex. When combined with 
TM inducible CreERT2, MADM events can be precisely birth dated, providing a highly 
qualitative and quantitative visual readout of stem cell division patterns at the single cell level. 
By titrating the dose of TM delivered, in an ideal situation an average of less than 1 clone per 
cortical hemisphere can be obtained, providing adequate spatial separation to unambiguously 
distinguish individual clones. By maintaining tissue integrity, this method also captures 
essential information regarding position, morphology and absolute cell numbers. MADM 
cassettes on Chr. 11 (Beattie et al., 2017; Gao et al., 2014; Hippenmeyer et al., 2010; Llorca et 
al., 2019; Shi et al., 2017; Wong et al., 2018), on Chr. 7 (Hippenmeyer et al., 2013) and the 
original MADM at Rosa26  (Bonaguidi et al., 2011; Brennand et al., 2007; Zong et al., 2005) 
have been used in MADM clonal analysis studies. The high resolution of individual cells 
provides unprecedented insight into both morphology and the clonal relationship of daughter 
cells, and permits the live-imaging of proliferating stem cells and emerging clones 
(Hippenmeyer et al., 2010; Riccio et al., 2016). 
 
Caesarean section and fostering of pups for analysis of clones at postnatal time points is a 
necessary and critical step in the protocol. Depending on the health status of the TM-treated 
pregnant dam, it may not be necessary to perform a caesarean section, but it is still required 
to raise pups with a foster mother since the TM-treated mother may have trouble lactating. 
Both MADM lines and foster mothers are all maintained on an outbred CD-1 background and 
we have not observed differences in the necessity for fostering with different CreERT2 drivers. 
If caesarean section was not necessary, TM-treated pregnant dam used to generate 
experimental pups may be reused for additional experimental breedings in accordance to 
principles of 3R (note that this is only if animal experimental licenses approve of this practice). 
Foster mothers can be used for fostering pups within 2 days after they give birth, but higher 
success rates have been observed when foster mothers give birth on the same day that 
experimental mice are to be fostered. Therefore, it is important to setup timed matings for 
foster mothers in parallel to setting up experimental matings in step 1.1. In our experience, 




survival rate of fostered pups, and therefore removal of some to all of the original litter may 
be necessary. Additional steps that may improve fostering includes rubbing the experimenters 
gloves with litter and food (to remove scent of the gloves); rubbing the pups gently after the 
caesarean section with fragments of foster mothers soiled litter and nest; and subsequent 
placement of these pups in close contact with some foster mothers pups prior to their 
placement in the foster mouse cage.  
 
Similar to other reporter-based lineage tracing methods, careful consideration must be taken 
when choosing the optimal CreERT2 driver for MADM clonal experiments. Firstly, the promoter 
must express the recombinase both temporally and spatially in the progenitor population of 
interest. This can be challenging since some promoters may change expression patterns or 
become silenced at different stages of development. One attempt to improve cell type 
specificity has been to use multiple site-specific recombinases, each driven by separate 
promoters. When one or both recombinases are expressed in the same cell, this labels the cell 
and its progeny with a fluorescent reporter (Daigle et al., 2018; He et al., 2016; Plummer et al., 
2015; Yamamoto et al., 2009). In summary, it is important to choose a CreERT2 driver that is 
specific to the population of progenitors being analyzed. 
 
The single most critical step in this method is the identification of a clone since all cells must 
be derived unambiguously from a single recombination event (step 8.1). Titration of TM 
concentration ensures less than 1 cluster of red/green cells per brain hemisphere and 
maximizes the probability of analyzing a single clone (step 2.2) (Beattie et al., 2017; Gao et al., 
2014). Clones should be discarded if neighboring clusters of cells occur within 500 µm of your 
clone of interest. Due to this, it is important to look several sections before and after the 
appearance of a clone to ensure that there are no additional recombination events in the 
vicinity. Due to weaker signal of the fluorophores, it is necessary to perform 
immunohistochemistry for eGFP and tdT in embryonic clones (see section 6), but only 
recommended in adult clones if additional antigens will be co-labelled. When imaging clones, 
it is important to capture the entire width of the cortex where the clone is located (step 8.4, 
i.e., from pial surface to the corpus callosum) to not miss any cells. This will also facilitate 




an inverted confocal microscope but can be adapted depending on the microscope setup 
available. Epifluorescence microscopy can be used but confocal microscopy is recommended 
since this leads to a decrease in light contamination from outside the focus plane. It is also 
important that the laser intensity and gain is adjusted so that green red and yellow cells can 
be unambiguously identified. Regardless of the setup, it is recommended to use an objective 
of at least 20x to ensure full spatial separation of closely positioned cells. In addition to 
recording cortical depth of all cells (step 8.6), identify cortical regions where the clones are 
located using a brain atlas such as the Allen Brain atlas or other stereotaxic coordinate maps. 
It is also recommended that a file naming paradigm is adopted so clone images are easily 
identifiable. For example, consider including the following information: unique image ID, date 
image was taken, genotype of animal, age of induction, age of analysis, image number in 
relation to the rest of the images from the same clone.  
 
Introduction of a mutation distal to one MADM cassette uniquely allows the generation of 
genetic mosaics (Hippenmeyer, 2013) and permits the dissection of molecular regulators of 
lineage and cell type diversity at the clonal level (Beattie et al., 2017; Gao et al., 2014; 
Hippenmeyer et al., 2010; Lv et al., 2019). To generate a genetic mosaic with MADM, the 
MADM cassettes must be meiotically linked to the same chromosome as your gene of interest 
(see Figure 20 for breeding scheme). This limits current clonal analysis with MADM to genes 
located on Chr. 7 (Hippenmeyer et al., 2013), Chr. 11 (Hippenmeyer et al., 2010), Chr. 12 
(Hippenmeyer et al., 2013) and Chr. 6 distal to the Rosa26 locus (Zong et al., 2005). In future 
studies it will be exciting to have MADM cassettes targeted to all chromosomes, permitting 
the mosaic analysis of virtually all genes of the mouse genome at the clonal level. 
 
Finally, MADM is not limited to the analysis of progenitor cells in the developing neocortex. 
Many stem cell niches could benefit from the ability to resolve spatiotemporal arrangements 
of clonally related cells. By applying MADM to other regions of the brain, in disease conditions 
such as cancer, or other tissues (Ali et al., 2014; Bonaguidi et al., 2011; Brennand et al., 2007; 
Hippenmeyer et al., 2013; Mayer et al., 2015; Muzumdar et al., 2016; Riccio et al., 2016; Shi 
et al., 2017; Wong et al., 2018; Xu et al., 2014; Zong et al., 2005) a number of studies have 




cells in general (see Table 1 for current list of MADM clonal studies). Another exciting future 
application of MADM technology would be to combine MADM with additional functional or 
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Generation of Neuronal Diversity from Common Progenitors via Notch 
Signaling in the Cerebellum 
 
 Summary 
The brain contains a bewildering diversity of neurons arising from relatively few pluripotent 
progenitors. In the vinegar fly Drosophila melanogaster, individual progenitors generate 
diverse neuronal subtypes in part through a mechanisms of binary cell fate choice via the 
conserved Notch signaling pathway. However, there is no evidence for a similar mechanism 
in the vertebrate brain. Using mouse and human cerebellar development as a model, we 
discover pluripotent embryonic cerebellar progenitors (ECPs) that give rise to most, if not all, 
types of cerebellar neurons. We find that the decision of excitatory versus inhibitory fate is 
regulated by Notch signaling, whereby the cell with lower Notch activity adopts the excitatory 
fate, while the cell with higher Notch activity adopts the inhibitory fate. Thus, Notch-mediated 




The cerebellum is composed of well characterized neuronal types making it an attractive 
model to investigate mechanisms of neuronal diversification (Volpe et al., 2017; Wang and 
Zoghbi, 2001). The cerebellar anlage arises from two distinct neuroepithelial zones (Fig.S1A): 
the dorsally located rhombic lip (RL) and the ventrally located ventricular zone (VZ) marked 
by the expression of two the basic helix-loop-helix (bHLH) transcription factors called Atonal 
homologue 1 (Atoh1; RL) and Pancreas transcription factor 1 alpha (Ptf1a; VZ), respectively. 
Atoh1+ RL precursors give rise to glutamatergic neurons, while Ptf1a+ VZ precursors give rise 
to GABAergic neurons (Leto et al., 2016), suggesting that these distinct neurons have 
independent origins. However, a number of observations suggest that these precursors share 
common features. First, cell fate in the two germinal niches can be switched when Atoh1 and 
Ptf1a are ectopically expressed in the VZ and RL, respectively (Wang et al., 2005; Yamada et 
al., 2014). Second, while the classic neural stem marker Sox2 is known as an early VZ marker, 




cerebellar organoids (Muguruma et al., 2015). Third, analysis of recent single cell RNA 
sequencing (scRNAseq) data form the developing mouse cerebellum suggest that cerebellar 
progenitors can adopt either a glutamatergic fate or a GABAergic fate (Vladoiu et al., 2019). 
Whether this means that common progenitors give rise to both types of neurons, and if so 
how this may be regulated is unknown. 
In Drosophila, neural progenitors give rise to daughter cells that adopt alternative fates via 
the Notch pathway, thus generating neuronal diversity. The conserved Notch receptor and its 
ligand Delta act in two successive steps. First, the progenitor and its daughters use Notch 
signaling to distinguish their fates with the progenitor retaining high levels of Notch activity 
(Notch-High), and the daughter lower levels (Notch-Low). Next, two different daughter cells 
adopt alterative fates – the so called Notch-ON and Notch-OFF fates – thus generating 
neuronal diversity from a common progenitor (Bertet et al., 2014). In mammals, Notch activity 
is crucial for maintaining neural progenitor state and inhibiting neurogenesis (Chambers et 
al., 2001) but there is no evidence that Notch is used to generate neuronal diversity from 
common progenitors. 
We sought to understand how neuronal diversity is generated using cerebellum development 
as a model. Gene expression data from the Allen Brain Atlas (not shown) suggested that the 
Sox2 transcription factor, a common marker of neural progenitors, is expressed throughout 
both the VZ and RL. Antibody staining confirms that Sox2 protein is broadly expressed 
throughout the cerebellar anlagen (E9.5 – E16; Figure 29B-F). Furthermore, some Sox2+ cells 
express Atoh1 (Figure 29B’-F’) while others express Ptf1a. This suggests that Sox2+ progenitor 
cells may represent a pool of ECPs generating both excitatory and inhibitory cell lineages. To 
test this, we performed lineage tracing using Sox2CreERT2/Gt(ROSA)26SortdTomato/Atoh1GFP mice 
using low doses of Tamoxifen (TM: 0.1mg, 0.03mg). Under both conditions in all mice 
examined Sox2+ cells and their progeny efficiently labelled with tdTomato (Tom+). We 
observed Ptf1a+/Tom+ and Atoh1+/Tom+ cells at E12.5 in the VZ and RL, respectively (Figure 
25A-F’’). At postnatal day 21 (P21) we found Tom+ Purkinje cells (PCs, Calbindin+), granule 
cells (GCs, Pax6+), glutamatergic deep cerebellar nuclei (glu-DCN, Olig2+, Pax6+ and Tbr1+) and 





To test whether single Sox2+ ECPs are likely to generate diverse cell types, we employed the 
sparse clonal Mosaic Analysis with Double Markers (MADM) technology (Hippenmeyer et al., 
2010; Zong et al., 2005) (see supplemental methods). Briefly, depending on how the red and 
green markers segregate after recombination and division, the two hemi-lineages of a 
common progenitor would label either in red versus green or in yellow versus no-label (Figure 
26A). Thus, the presence of rare clones containing either different cell types in two different 
colors, or only one cell type in yellow indicates recombination in a common progenitor. 
Failure to find such clones indicates lack of common progenitors. Consistent with sparsity of 
MADM clones (Beattie et al., 2017; Gao et al., 2014), we obtained 9 clusters in 27 brains. In 
2/9 clusters we observed two distinctly labelled GABAergic and glutamatergic cell lineages, 
containing GCs, PCs and cerebellar INs (Figure 26B-G and 31C-F). In 5/9 clusters we detected 
either GABAergic lineages (PCs or INs) or Glutamatergic lineage (GCs) in yellow (Figure 26H-I 
and 31G-G’’), but not both. Therefore, in these 7 clusters, common ECPs gave rise to both 
excitatory and inhibitory neurons. In the remaining 2 clusters sparse green or red PCs were 
observed (Figure 31A-B), indicating the recombination occurred in fate-restricted precursors. 
Consistent with the fact that GC precursors undergo several rounds of transient amplification 
before neurogenesis, while PC precursors do not, all our MADM clones contained much larger 
numbers of GCs than PCs. 
We asked if a common origin of GCs and PCs is conserved in human. We sparsely labelled 
Sox2+ ECPs by electroporating Sox2Cre/Venus vectors into human-iPS-derived cerebellar 
organoids and traced their fate after 16 days in culture. We observed both PCs 
(Venus+/Calbindin+) and GCs (Venus+/Pax6+) (Figure 26J-O’’’). Altogether, the lineage tracing 
data support a model whereby Sox2+ ECPs give rise to fate-restricted precursors that generate 
multiple, if not all, cerebellar cell-types, most prominently GCs and PCs. 
To identify the molecular underpinnings of the diversification of cerebellar neurons from 
common progenitors, we analyzed an available single-cell RNA sequencing (scRNAseq) 
dataset (ENA: PRJEB23051 (Carter et al., 2018)) to define the molecular features of different 
cerebellar cell types during early stages. We retrieved the original date from E10-E13, and 
used the Chromium system (10x Genomics) to profile the populations at different time points 
(Figure 32A). We identified individual clusters and mapped pseudo-time trajectory for 




two major lineages: glutamatergic cells from RL and GABAergic cells from VZ, in agreement 
with lineage tracing (Figure 27A). Analysis of Notch signaling related genes in these three 
populations revealed that Sox2+ progenitors have the highest level of Notch activity (high 
Hes1/Hes5, low Dll1/Dll3), followed by Ptf1a+ VZ precursors, while Atoh1+ RL precursors have 
the lowest levels of Notch activity, but the highest levels of Notch ligands Dll1 and Dll3 (Figure 
27A, 32E-F, 32I-J, 32N-O, 32K-M, 32P-R). 
These observations suggest that Notch activity may be required to segregate the three 
populations form each other: first the ECPs from their Ptf1a+ and Atoh1+ daughters and then 
Ptf1a+ PC precursors from Atoh1+ GC precursors. To test this idea, we created Notch gain of 
function (GOF) ECP clones using Sox2CreERT2/+/ Gt(ROSA)26SortdTomato/R26Rstop-NICD-nGFP mice, 
While both Ptf1a+ and Atoh1+ precursors were significantly reduced, the effect was much 
stronger on Atoh1+ cells than on Ptf1a+ cells (Figure 27B-E’’, 27F, 33A-B’’ and 33G) than 
Atoh1+/NICD-GFP+ cells (Figure 27G-L’’, 33C-D’’ and 33G). Conversely, Notch GOF in 
progenitor cells significantly increased Sox2+ cells both in the RL and VZ (Figure 27M-Q, 33E-
F’’ and 33H), at the expense of Ptf1a+ and Atoh1+ cells. Thus, constitutive strong activation of 
Notch in ECPs inhibits differentiation into both excitatory and inhibitory fates and retains cells 
in a Sox2+/NotchHIGH progenitor state. 
Next, we asked whether the choice of cell fate between Ptf1a+ and Atoh1+ cells in the 
cerebellar anlage is controlled by Notch signaling, by examining the consequences of Notch 
loss of function (LOF) either in clones using Sox2CreERT2/Notch1flox/Atoh1GFP conditional 
knockout (KO) mice, or in Presenilin1 KO (Psn1) mice, which have a near complete loss of 
Notch activity. Notch1 ablation in Sox2+ ECPs clones dramatically increased the number of 
Sox2+/Atoh1-GFP+ double positive cells and Atoh1+ cells could be found in the VZ (Figure 28A-
D), indicating Notch LOF induces Sox2+ cells to differentiate into Atoh1+ GC precursors. The 
increase in Atoh1+ cells came at the expense of Ptf1a+ cells which were significantly decreased 
in Notch1 LOF ECP clones (Figure 28E-G) as well as Psn1 KO mice (Figure 28H-J, 35A-B). 
Importantly, the ratio of the increase in Atoh1+ cell number was nearly identical to the ratio 
of the decrease Ptf1a+ cells number (0.672 vs 0.673, Figure 28G, J). Furthermore, whereas 
wild type cerebellar precursors rarely co-express Atoh1 and Ptf1a (Yamada et al., 2014), there 
was a dramatic increase in Ptf1a+/Atoh1+ double positive cells at the RL/VZ boundary in 




other types of GABAergic VZ precursors also derive from Sox2+ ECPs. We therefore examined 
the expression of other VZ precursor markers, namely Olig2, which maintains the identity of 
PC progenitors (Ju et al., 2016), and Lhx1/5, a marker for early GABAergic cells, in Psn KO mice 
and found that both were decreased, concomitantly with the increase in the number of 
Atoh1+ cells (Figure 35C and 35D-H). Therefore, Notch activity regulates the choice of ECP 
progeny between excitatory and inhibitory fate. 
In contrast to text book models, we show that mouse and human cerebellar GABAergic and 
glutamatergic neurons derive form common progenitors, which we term Embryonic 
Cerebellar Progenitors. Although we mainly focused on PCs and GCs, lineage tracing showed 
that ECPs likely give rise to most cerebellar cells. ECPs span the RL and the VZ and are 
characterized by the expression of Sox2+ and high levels of Notch activity. In silico analysis and 
in vivo manipulation of Notch showed that cerebellar cellular diversity is regulated by a binary 
choice mechanism. This is surprising because Notch activity was thought to only distinguish 
progenitors from committed daughters with no evidence for a role for Notch in neuronal cell 
fate diversification during mammalian neurogenesis. 
In Drosophila, generation of cells with different Notch-dependent fates relies partly on the 
biased segregation of Notch inhibitors  between two daughters of the same progenitor 
(Artavanis-Tsakonas et al., 1999; Bhat, 2014; Pinto-Teixeira and Desplan, 2014). Whether the 
production of Atoh1+ vs Ptf1a+ daughters is modulated by asymmetric division of ECPs needs 
further investigation. Single cell analysis in the neocortex is beginning to reveal significant 
diversity of neuronal fates in the same cortical layers (Pfeffer and Beltramo, 2017). It would 
be interesting to test whether Notch signaling also regulates the fate of sister cortical 
neurons, where paucity of markers likely precluded such findings. 
Finally, it is noteworthy that while postmitotic PCs and GCs are generated on different 
temporal scales, with PCs born earlier than GCs, their precursors are specified at the same 
time. GC neurogenesis is late because GC precursors undergo transient amplification first, 
thus creating heterochrony. The transient amplification of GC precursors is driven by Atoh1 
which requires low Notch activity to be expressed. Our work provides framework for how 
common progenitors create neuronal diversity across different time scales through a highly-






(A-B) Co-localization of Ptf1a (green) and Tom (red) in the VZ at E12.5. 
(C-C’’) High magnification of the rectangular region in (B). (D-E) Co-
localization of Atoh1 (green) and Tom (red) in RL at E12.5. (F-F’’) High 
magnification of the rectangular region in (E). (G-N) Co-localization of 
Tom (red) with Calbindin+ (green, G,H,K,L) or Pax6+ (green, I,J,M,N) at 
E16 and P21. (H,J,L,N) High magnification of the rectangular regions. 
Nuclei marked with DAPI (blue). Yellow arrows indicate double-positive 
cells of Tom with Ptf1a or Atoh1-GFP, white arrows indicate Tom-only 
cells. Scalebars=100μm and 25μm. 
 







(A) Schematic illustration of MADM-clones at E11 in MADM-11GT/TG/Sox2CreER mice. (B-E) 
Sparse G2-X MADM clones at P21. Two PCs (red and green) and tens of GCs (green) were found 
in the same cerebellum. Scalebars=500μm. (C-G) High magnification of the rectangular region 
in (B-E). Scalebars=25μm. (H-I) Sparse G2-Z MADM clones at P21 cerebellum. One PC (H, 
yellow) and tens of GCs (I, yellow) were found in two cerebella. Scalebar=25μm. (J) Expression 
of Venus (green) and Sox2 (red) in cerebellar organoids 1 day after electroporation. (K-K’’’) 
Higher magnification of the rectangular region in (J). Arrows indicate Sox2+/Venus+ cells. (L-N) 
Expression of Venus (green) and PC marker (Calbindin, red) or GC marker (Pax6, red) in 
cerebellar organoids 16 days after electroporation. (M-M’’’, O-O’’’) Higher magnification of 
the rectangular region in (L,N). Scalebars=100μm and 25μm. Nuclei marked with DAPI (blue). 
Figure 26. Sparse Lineage Tracing of ECPs in the Mouse and in Human Cerebellar Organoids. 
 
 





(A) Pseudo-time trajectory of cell lineages using scRNAseq data in the E10-E13 cerebellum: 
ECPs (blue dots), VZ GABAergic lineages (green dots) and RL glutamatergic lineages (red dots). 
(B) Immunostaining for Ptf1a+ (red) in Tom+ wildtype clones (grey) at E12. (C-C’’) Higher 
magnification of the rectangular region in (B). (D) Immunostaining for Ptf1a+ (red) in NICD-
GFP+ clones (green) at E12. (E-E’’) Higher magnification of the rectangular region in (D). Arrows 
indicate NICD-GFP+/Ptf1a+ double-positive cells. (F) Percentage of Ptf1a+ cells in control (Tom+) 
versus NICD-GFP+ VZ clones. (G) Immunostaining for Atoh1+ (red) in Tom+ wildtype clones 
(grey) at E12. (H-H’’) Higher magnification of the rectangular region in (G). (I) Immunostaining 
for Atoh1+ (red) in NICD-GFP+ clones (green) at E12. (J-J’’) Higher magnification of the 
rectangular region in (I). (K) Percentage of Atoh1+ cells in control (Tom+) versus NICD-GFP+ RL 
clones. (L) Comparison of the ratios of Ptf1a+ cells and Atoh1+ cells in NICD-GFP+ clones. (M) 
Immunostaining for Sox2+ (red) in Tom+ wildtype clones (grey) at E12. (N-N’’) Higher 
magnification of the rectangular region in (M). (O) Immunostaining for Sox2+ (red) in NICD-
GFP+ clones at E12. (P-P’’) Higher magnification of the rectangular region in (O). (Q) Percentage 
of Sox2+ cells in in control (Tom+) versus NICD-GFP+ RL and VZ clones. Nuclei marked with DAPI 
(blue). Scalebars=100 μm and 25 μm. Data distribution is mean ± SD. *p < 0.05; **p < 0.01; 
****p < 0.0001. 





(A-C’’) Immunostaining for Sox2+ (red) and Atoh1-GFP+ (green) at E11.5 in Cre-
/Notchfl/fl, Cre+/Notchfl/+ and Cre+/Notchfl/fl mice. (D) Percentage of Atoh1-
GFP+/Sox2+ double-positive cells within all Atoh1-GFP+ cells in the three 
genotypes. (E-F’’) Immunostaining for Ptf1a+ (red) and Atoh1-GFP+ (green) at E12 
in control cerebella (E-E’’) and in Notch1 conditional KO (cKO) cerebellum (F-F’’). 
(G) Percentage of Ptf1a+ cells or Atoh1-GFP+ cells within all cells (DAPI, blue) in 
control and Notch1 cKO cerebellum. (H-I’’) Immunostaining for Ptf1a+ (red) and 
Atoh1-GFP+ cells (green) at E11.5 in Control (H-H’’) and Presenilin1 (Psn) KO 
cerebellum (I-I’’). (J) Percentage of Ptf1a+ cells or Atoh1-GFP+ cells within all cells 
(DAPI) in control and Psn KO cerebellum. Scalebars=100 μm and 25 μm. Data 
distribution is mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. 
 










(A) Cerebellar morphology at different stages during development from E9.5 to P21. R1, 
rhombomere1; RL, rhombic lip; VZ, ventricular zone; NTZ, nuclear transitory zone; EGL, 
external granule layer; IGL, internal granule layer; PCL, Purkinje cell layer; ML, molecular 
layer; WM, white matter. (B-F’) Immunostaining for Sox2 (magenta) expression in a time 
series of mouse cerebellum during development. (G-H) Immunostaining for Calbindin and 
Pax6 (magenta) expression in the cerebellum at P21. Nuclei were stained with DAPI (blue). 
Scalebars=100 μm. 
 










(A) Scheme of the experiments. Pregnant females were injected Tamoxifen at E9.5 or E10.5 
through intraperitoneal (i.p.), and the samples were collected at E15 or P21, followed by 
immunostaining. (B-C) Co-localization of Pax2+ (green) and Tom+ (red) in cerebellar 
primordium at E15. (D-D’’) Higher magnification of the rectangular region in (C). (E-F) Co-
localization of Pax2+ (green) and Tom+ (red) at P21. (G-G’’) Higher magnification of the 
rectangular region in (F). (H-I) Co-localization of Olig2+ (green) and Tom+ (red) at E15. (J-J’’) 
Higher magnification of the rectangular region in (I). (K-L) Triple immunolabeling with Tom 
(red), Pax6 (grey) and Tbr1 (green) at E15. (M-N) Higher magnification of the rectangular 
region in (L). Nuclei were stained with DAPI (blue). Arrows indicate double positive cells of 
Tom+ with Pax2+ or Olig2+ or Pax6+ or Tbr1+. Scalebars=100 μm and 25 μm. 





(A-F) Sparse G2-X MADM labeling cells in P21 cerebellum. Two PCs (red and 
green), several Interneurons (Ins, green and red) and Bergmann glia were 
found in different mouse cerebella. (G- G’’) Sparse G2-Z MADM labeling cells 
in P21 cerebellum. Several yellow INs and Bergmann glia were found in 
mouse cerebella. (H-I) Immunostaining for Pax6, a marker for GCs, at P21. 
(J- J’’’) Higher magnification of the rectangular region in (E). Nuclei were 
stained with DAPI (blue). Scalebars=100 μm and 25 μm.  





(A) t-distributed stochastic neighbor embedding (t-SNE) visualizations of cerebellar 
derived cell clusters (right) and developmental time points (left) at E10-E13. Each point 
represents one cell. (B-D) t-SNE shows cell type specific markers expression: Sox2, 
Atoh1 and Ptf1a. eCSC, embryonic cerebellar stem cells; RLP, rhombic lip progenitors; 
VZP, ventricular zone progenitors. Cells are color-coded according to genes expression. 
(E-H) t-SNE shows Notch signaling related genes expression: Hes5, Hes1, Dll1 and Dll3. 
Cells are color-coded according to genes expression. (I-R) Expression of Hes5, Hes1, 
Dll1, Dll3 and Notch1 in three different groups: Ptf1a only, Sox2 only and Atoh1 only 
both at E12 (I-M) and E13 (N-R). Box plot center lines are median. ***p < 0.001, ****p 
< 0.0001.  
  
Figure 32. Analysis of Notch Signaling Gene Expression in scRNAseq Data from 









(A) Immunostaining for Ptf1a+ cells (red) in GFP+ Notch GOF clones (green) at E12. (B-B’’) 
Higher magnification of the rectangular region in (A). Arrows indicate double positive cells 
of NICD-GFP+ / Ptf1a+. (C) Immunostaining for Atoh1+ cells (red) in GFP+ Notch GOF clones 
(green) at E12. (D-D’’) Higher magnification of the rectangular region in (C). (E) 
Immunostaining for Sox2+ cells (red) in GFP+ Notch GOF clones (green) at E12. (F-F’’) Higher 
magnification of the rectangular region in (A). (G) The ratio of Ptf1a+ cells or Atoh1+ cells 
among total cells in GFP+ Notch GOF clones (Ptf1a+ or Atoh1+/ GFP+) compared with the 
ratio of Ptf1a+ cells or Atoh1+ cells among adjacent WT cells which the cell numbers are 
equivalent to the GFP clones (Ptf1a+ or Atoh1+/ DAPI+) in the VZ or RL, respectively. (H) The 
ratio of Sox2+ cells among total cells in GFP+ Notch GOF clones (Sox2+ / GFP+) compared 
with the ratio of Sox2+ cells among adjacent WT cells which the cell numbers are equivalent 
to the GFP clones (Sox2+ / DAPI+) both in the RL and VZ. Nuclei were stained with DAPI 
(blue). Scalebars=100 μm and 25 μm. Data presented as mean± SD. *p < 0.05; **p < 0.01; 
****p < 0.0001. 
 
Figure 33. Effects of Notch Gain of Function on Cerebellar Progenitor Fate Decisions 





 (A-B) Immunostaining for Ptf1a+ (red) and Atoh1-GFP+ (green) double positive cells at E11.5 in 
Control cerebellum. (C-C’’) Higher magnification of the rectangular region in (B). (D-E) 
Immunostaining for Ptf1a+ (red) and Atoh1-GFP+ (green) double positive cells at E11.5 in Notch1 
dKO cerebellum. (F-F’’) Higher magnification of the rectangular region in (E). Arrows indicate 
Ptf1a+ and Atoh1-GFP+ double positive cells. (G) Percentage of Ptf1a+ and Atoh1-GFP+ double 
positive cells in Control and Notch1 dKO cerebellum. (H-I) Immunostaining for Ptf1a+ (red) and 
Atoh1-GFP+ (green) double positive cells at E11.5 in Control cerebellum. (J-J’’) Higher 
magnification of the rectangular region in (I). (K-L) Immunostaining for Ptf1a+ (red) and Atoh1-
GFP+ (green) double positive cells at E11.5 in Psn KO cerebellum. (M-M’’) Higher magnification 
of the rectangular region in (L). Arrows indicate Ptf1a+ and Atoh1-GFP+ double positive cells. (N) 
Percentage of Ptf1a+ and Atoh1-GFP+ double positive cells in Control and Psn KO cerebellum. 
Nuclei were stained with DAPI (blue). Scalebars=100 μm and 25 μm. Data presented as mean ± 
SD. **p < 0.01, ****p < 0.0001. 








 (A-C) Comparison of Atoh1, Ptf1a and Olig2 mRNA levels in Control and Psn KO 
cerebellum by using RT-PCR at E13. (D) Immunostaining for Atoh1-GFP+ cells (green) at 
E13 in wild-type cerebellum. (E-E’’) Immunostaining for Lhx1/5+ cells (red) and Olig2+ 
(grey) at E13 in Control cerebellum. (F) Immunostaining for Atoh1-GFP+ cells (green) at 
E13 in Psn KO cerebellum. (G-G’’) Immunostaining for Lhx1/5+ cells (red) and Olig2+ (grey) 
at E13 in Psn KO cerebellum. (H) Percentage of Atoh1-GFP+ cells or Lhx1/5+ cells or Olig2+ 
cells compared with DAPI in Control and Psn KO cerebellum. Nuclei were stained with 
DAPI (blue). Scalebars=100 μm. Data presented as mean ± SD. *p < 0.05; **p < 0.01; ***p 
< 0.001. 
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All animal experiments in this study were carried out in accordance with animal welfare 
regulations and have been approved by Ethic Committee and French regulatory authorities of 
the respective institutes. The Sox2CreERT2 mice were crossed with Gt(ROSA)26SortdTom reporter 
mice, and then crossed with Atoh1GFP mice to generate the lineage tracing line. Notch gain-
of-function mice were generated by breeding Sox2CreERT2 with R26Rstop-NICD-nGFP (JAX, stock 
#008159, borrowed from Shahragim TAJBAKHSH lab)(Murtaugh et al., 2003). Presenilin1 
deficient (Psn-/-) mice (borrowed from Bart De Strooper) crossed with Atoh1GFP mice to get 
Atoh1GFP/Psn-/- mice. And Notch conditional knock out mice was generated by crossing 
Notch1flox (purchased from JAX, stock #007181) with Sox2CreERT2 mice. Mice were genotyped 






Table 2. Primers for mouse genotyping 
Gene Name Forward Reverse 















Notchflox TGC CCT TTC CTT AAA AGT GG GCC TAC TCC GAC ACC CAA TA  
NICD-nGFP 
WT-AAG GGA GCT GCA GTG GAG TA   
Mut-TGG TAT GCC TGA CAC TCA CC 
WT-CAG GAC AAC GCC CAC ACA 
Mut-ACA CCG GCC TTA TTC CAA 
 
Tamoxifen Administration 
Tamoxifen (TM, Sigma) or 4-Hydroxytamoxifen (4-OH, Sigma) was dissolved to a final 
concentration of 1mg/ml or 3mg/ml in 90% corn oil (Sigma) with 10% ethonal (Sigma). For 
Sox2CreERT2/ Gt(ROSA)26SortdTom / Atoh1GFP mice, if collected the samples at embryonic stages, 
0.1mg TM was intraperitoneal (i.p.) injected into per pregnant female at E9.5 or E10.5. If 
collected the samples at postnatal stages, each pregnant female was injected 0.03mg TM (i.p.) 
at E10.5. For Sox2CreERT2/Gt(ROSA)26SortdTom/R26Rstop-NICD-nGFP mice and Sox2CreERT2/ Notch1flox 
mice, 0.1ml 4-OH TM or TM (3mg/ml) was injected into the pregnant females (i.p.) at E8.5, 
respectively. 
 
RNA extraction and Real time PCR (RT-PCR) 
Total RNA was isolated from whole cerebellar tissue samples at E13 using Trizol Reagent 
(Invitrogen). The RNA concentration was measured by a spectrophotometer (NanDrop1000; 
Thermo) followed by a reverse transcription process using PrimeScript RT reagent kit (Roche). 
Real time PCR analysis was performed using SYBR green mix (Roche) and the values were 
normalized to β-actin values. The primer pairs for different genes are as follows: Atoh1, sense 
5'-CCCAATGTCGGAGAGCAACC-3' and anti-sense 5'-TCCTCGAAGGCTGGGA 




ACA-3' and anti-sense 5'-ACAAAGACGCGG CCAACCCGATGTGAG-3'; Olig2, sense 5'- 
CGCAAGCTCTCCAAGATCG-3' and anti-sense 5'- CTCACCAGTCGCT 
TCATCTC-3'. β-actin, sense 5'- TCCATCATGAAGTGTGACGT-3' and anti-sense 5'- 
GAGCAATGATCTTGATCTTCAT -3'. PCR conditions used here were denaturing at 95 °C for 10 
s, followed by 40 cycles of 95 °C for 5 s and 60 °C for 30 s. Data were analyzed using the 
comparative threshold cycle (Ct) method, and results were expressed as fold difference 
normalized to β-actin.  
 
Immunohistochemistry and antibodies 
For the samples collection, embryos before E13.5 were fixed in 2% paraformaldehyde (PFA) 
in PBS at 4 °C for 2-3 hours, and embryos after E13.5 but before born first were perfused with 
2% PFA, then post-fixed for 24 hours. Whereas, samples which were collected at postnatal 
stages, perfused the mice with 1 X PBS, followed by 4% PFA perfusion, and then post-fixed in 
4% PFA for another 24 hours. Dehydrated embryos or the whole head in 30% sucrose in 1 X 
PBS overnight (o/n). After all the samples sank into the bottom of the tube, embedded them 
in OCT compound (TissueTek) and frozen at -20 °C. Sagittal sections were made by cryostat 
(Leica) at 20 μm and then stored slices at -80 °C. For the immunostaining, sections were fixed 
with 4% PFA for 10 minutes at room temperature (RT), then blocked with 10% normal donkey 
or goat serum in 1 X PBS with 0.1% Triton (PBT) for 1 hour at RT followed by 3 times washing 
in 1 XPBT. Thereafter, these sections were incubated with primary antibodies diluted in 0.1% 
1 X PBT containing 1% normal donkey or goat serum o/n at 4 °C or 3-4 hours at RT. After 3 
times washing with 1 X PBT, incubated with appropriate secondary antibodies conjugated 
with Alexa Fluor 488, Alexa Fluor 555, or Alexa Fluor 647 (1:500, Invitrogen) in 0.1% 1 X PBT 
containing 1% normal donkey or goat serum for 1-2 hours at RT. Washed with 1 X PBT for 3 
times, then counterstained the slides with DAPI (1:2000, Sigma) and mounted by using 
Vectashield (Vector) after rinsing. Antigen retrieval was performed by using 10 mM sodium 
citrate buffer, pH 6.0, boiled 5 minutes in microwave, and cooled down in RT for about 20 
minutes for Lhx1/5 and Olig2 staining. Primary antibodies used in this study were rabbit anti-
Sox2 (1:500, Millipore, AB5603), rabbit anti-Ptf1a and Rabbit anti-Atoh1 (1:200, a kind gift 
from Dr. Mikio Hoshino, National Center of Neurology and Psychiatry · Department of 




rabbit anti-Pax6 (1:300, Biolegend: PRB-278P), rabbit anti-Pax2 (1:200, Thermo, QE215176), 
mouse anti-Lhx1/5 (1:100, DSHB, AB_531784), goat anti-Olig2 (1:500, R&D systems, AF2418) 
and Guinea pig anti-Tbr1 (1:500, Synaptic Systems, 328 005). After staining, images were 
obtained by using confocal microscope (Olympus FV-1200 or Leica SP8). 
 
Cell counts 
Confocal images for single layer scanning of sagittal cerebellar sections were calculated for 
each developmental stages (E11.5, E12 and E13) after DAPI staining. Each section took the 
average of the four values that obtained from 4 single layer calculating, which could form a Z 
stack. And each cerebellar samples counted 6-8 sections that took from the beginning to the 
end of the cerebellum. All quantifications were done blinded to the genotyping. For each 
stage littermates were analyzed and all groups of quantifications were carried out from at 
least 3 individuals.  
 
scRNAseq quantification and statistical analyses 
Aligned 10X data were retrieved from ENA: PRJEB23051 data set for the following samples: 
E10, E11, E12 and E13. Umitools has been used to generate gene-cell matrices with the 
following parameters: --extract-umi-method=tag, --umi-tag UB, --cell-tag CB, --per-gene, --
gene-tag GX, --per-cell. Genes not expressed in any cells were removed from considerations, 
as were all mitochondrial and ribosomal protein genes. To remove likely dead or multiplet 
cells from downstream analyses, cells were discarded if they had less than 3500 UMIs, greater 
than 15000 UMIs, or were composed of over 10% mitochondrial UMIs. The final dataset was 
composed of 14637 cells and 18937 genes. Then Seurat bioconductor package v2.3.4 (Butler 
et al., 2018) has been used to do cell-cell comparison and identify cell types. First, we 
performed a t-SNE (t-distributed stochastic neighbor embedding) with the first 20 principal 
components after application of PCA reduction. This allowed us to visualize the grouping of 
cells and the expression of genes of interest. Expression of cells in 3 populations has been 
represented with boxplot and differential expression between the 3 populations has been 
calculated with a Welch two sample t-test procedure. 
Monocle 2.6.4 (Qiu et al., 2017) was used to infer the pseudotime trajectory. As we worked 




distribution with fixed variance. The genes that "define progress" were selected using the 
unserpervised procedure "dpFeature": we first selected genes expressed in at least 5% of all 
the cells. We then run reduceDimension with tSNE as the reduction method, num_dim=10", 
norm_method="log" and max_components = 2. Finally cells were clustered with the density 
peak clustering algorithm by setting P to 2 and Δ to 5 (and skip_rho_sigma = T to facilitate the 
computation). The top 1000 significantly differentially expressed genes between clusters 
were selected as the ordering genes. The state 3 where Sox2 is expressed and Atoh1 not 
expressed was defined as the start of the pseudotime. The seurat FindMarkers function was 
used to identify the top 10 genetic markers of each lineage state's.  
 
MADM Mouse Lines and Maintenance 
MADM employs Cre recombinase/loxP-dependent interchromosomal recombination 
highlighting two scenarios: (i) Recombination occurs in G2 phase of the cell cycle will exhibit 
X segregation (G2-X MADM clone) which can create two distinctly labelled daughter cell 
lineages from their common mother progenitor cell; (ii) Recombination occurs in G1 phase or 
in G2 phase followed by Z segregation (G1/G2-Z MADM clone), one or both daughter cell 
lineages will be labelled in yellow. Mouse protocols were reviewed by institutional ethics 
committee and preclinical core facility (PCF) at IST Austria and all breeding and 
experimentation was performed under a license approved by the Austrian Federal Ministry 
of Science and Research in accordance with the Austrian and EU animal laws. Mice were 
maintained and housed in animal facilities with a 12-hour day/night cycle and adequate 
food/water conditions according to IST Austria institutional regulations. Mouse lines with Chr. 
11 MADM cassettes (MADM-11TG JAX stock #013751, and MADM-11GT JAX stock #013749), 
and Sox2-CreER (JAX stock #017593) have been described previously (Arnold et al., 2011; 
Hippenmeyer et al., 2010). All MADM-based analyses were carried out in a mixed C57BL/6J, 
CD1 genetic background. 
 
Generation of MADM Clones in Cerebellum and Tissue Collection 
To induce MADM labeling, MADM-11GT/GT/Sox2CreER were crossed with MADM-11TG/TG in order 
to generate experimental mice MADM-11GT/TG/Sox2CreER. The day of observed vaginal plug was 




mg/pregnant female) (Sigma) dissolved in corn oil (Sigma) at E11 to induce MADM clones. 
Live embryos were recovered at E18–E19 through cesarean section, fostered, and raised until 
further analysis. At P21 experimental MADM mice were deeply anesthetized through 
injection of a ketamine/xylazine/acepromazine solution (65 mg, 13 mg and 2 mg/kg body 
weight, respectively), and confirmed to be unresponsive through pinching the paw. Mice 
were perfused transcardially with 4% PFA in phosphate-buffered saline (PBS, pH 7.4). Brains 
were removed and postfixed o/n at 4°C to ensure complete fixation. Brains were washed with 
PBS, and cryopreserved with 30% sucrose solution in PBS for approximately 48 hr. Brains were 
then embedded in Tissue-Tek O.C.T. (Sakura). For the analysis of MADM labeling, 30-45µm 
sagittal sections were directly and consecutively collected and fixed to superfrost glass slides 
(Thermo Fisher Scientific). Sections were washed 3 times for 5 min with PBS, followed by 
staining with the nuclear stain DAPI (Invitrogen). After this step the slides were again washed 
3 times with PBS and embedded in mounting medium containing 1,4-diazabicyclooctane 
(DABCO; Roth) and Mowiol 4-88 (Roth). 
 
Imaging and analysis of MADM-labeled brains 
Sections were imaged using an inverted LSM800 confocal microscope (Zeiss) and processed 
using Zeiss Zen Blue software. Confocal images were analyzed in Photoshop software (Adobe) 
by manually counting MADM-labeled cells. Cerebellar areas were identified by using the Allen 
Brain Atlas (http://mouse.brain-map.org/static/atlas). 
 
Cerebellar Organoids labeling and staining 
Human iPS cells (iPSCs, ATCC-DYS0100) were maintained in self renewal on a layer of geltrex 
(Gibco, A14133-01), in E8 Basal Medium (Gibco, A15169-01) supplemented with E8 
Supplement (50X). iPSC were dissociated with EDTA (Invitrogen) 0.5mM, pH 8.0, for 3 minutes 
incubation, to maintain cell clusters. Cerebellar organoids were culture as described by 
Muguruma et al and Ishida et al (Ishida et al., 2016; Muguruma et al., 2015), and were 
electroporated at 25 days of differentiation protocol with 33,3 ug of pGL3_Sox2_Cre and 66,6 
ug of pCAG_LSL_Venus_NLS (the 24h experiment) or with 20 ug of pGL3_Sox2_Cre, 20 ug 
pPBase, 80 ug pCAG_LSL_Venus_NLS (the 16d experiment). Organoids were transferred 




(under patent) and electroporation was performed with the Gene Pulser XcellTM. Organoids 
were fixed at 26d or 41d of differentiation with 4% PFA, cryoprotected in 20% sucrose and 
embedded in Frozen Section Compound (Leica, 3801480). Organoids were cryosectioned at 
40 μm with Leica CM 1850 UV Cryostat. Immunofluorescence staining were performed on 
glass slides. Blocking and antibody solutions consisted of PBS supplemented with 3% goat 
serum, 0.3% Triton X-100 (Sigma). Primary antibodies were incubated overnight at 4°C and 
secondary antibodies for 1 hour at RT. Primary antibodies used were Chicken anti-GFP 
(1:2000, abcam, ab13970), Rabbit anti-Sox2 (1:500, abcam, ab97959), Mouse anti-Pax6 
(1:100, SantaCruz, sc-53108)and Rabbit anti-Calbindin (1:500, Sigma, c2724-2). Nuclei were 
stained with 1 μg/ml DAPI (Sigma). Sections and coverslips were mounted with Permanent 
Mounting Medium.  
 
Statistical analysis 
Statistical analyses were performed using GraphPad Prism software (GraphPad Software Inc., 
La Jolla, CA, USA). N values refers to independent animals and are detailed in the figure 
legends. All data are presented as mean ± SEM. Statistical testing was based on t-tests or one-








4 Chapter 4 – Genetic Dissection of Neural Stem Cell Lineage Progression 
using Mosaic Analysis with Double Markers 
 
4.1 Summary  
The cerebral cortex represents the largest brain area and consists of an extraordinary number 
and diversity of neurons. Yet, how the cortical entity, with all its functional neuronal circuits, 
arises from the neural stem cells (NSCs) in the developing neuroepithelium is a major 
unsolved question in Neuroscience. Radial glia progenitors (RGPs) are responsible for 
producing all neocortical projection neurons, certain glia, and establish the adult stem cell 
niche in the lateral ventricle. Recent efforts have demonstrated a highly deterministic nature 
of RGP behavior in the mammalian neocortex. RGPs transit through distinct proliferation and 
cell states across different time windows. However, the cellular and molecular mechanisms 
controlling RGP lineage progression through proliferation, neurogenesis and gliogenesis are 
unknown. In a pursuit to obtain definitive insights into these fundamental questions I 
employed functional genetic analysis to probe molecular mechanisms, namely the role of 
Pten function, in RGP lineage progression at single-cell and temporal resolution, using the 
unique MADM technology which offers a genetic approach to visualize and genetically 
manipulate small subsets neurons. I focused on the functional genetic analysis of the Pten 
signaling pathway since it is predicted to play a fundamental role in temporal RGP lineage 
progression. Furthermore, PTEN mutations in human result in cortical malformations 
including macrocephaly. In this project, I established a MADM-based experimental paradigm 
that enabled the analysis of corticogenesis upon sparse and complete deletion of Pten in 
RGPs. Next, I determined that Pten plays a critical role in temporal stem cell lineage 
progression. In particular, I demonstrated that Pten cell-autonomously controls RGP-
mediated neurogenesis and astrocyte generation. Interestingly, the function of Pten in 
astrocyte generation is independent of Egfr signaling. Furthermore, I showed that Pten cell-
autonomously controls the generation and/or migration of neurons in areas beyond the 
cortex, such as in the CA1 area and the dentate gyrus in the hippocampus. Finally, I dissected 
the relative contribution of cell-non-autonomous niche-derived cues and cell-autonomous 






The cerebral cortex in mice develops from the early neuroepithelium, composed by a 
common progenitor cell type known as neuroepithelial stem cell (NESC), that gives rise to all 
subsequent neural progenitor cells and to different neuronal lineages. Initially, NESCs amplify 
their own pool and around embryonic day (E) 9 begin to transform into radial glial progenitor 
(RGP) cells (Howard et al., 2008). RGPs are the major neural progenitors in the developing 
cortex and their division dynamics along a precise temporal lineage progression determine 
the final number of neurons in the mature cortex (Beattie and Hippenmeyer, 2017; Lodato 
and Arlotta, 2015; Taverna et al., 2014). Neurogenesis finishes at around E17 and is generally 
known to be followed by gliogenesis (Costa et al., 2009; Magavi et al., 2012; Schmechel and 
Rakic, 1979; Voigt, 1989), where RGPs may also produce glia intermediate progenitors that 
give rise to glia cells, including astrocytes and oligodendrocytes, which are important for the 
development, maintenance and overall function of neuronal assemblies (Chung et al., 2015; 
Freeman and Rowitch, 2013). Finally, shortly after birth the neuroepithelium transforms and 
establishes the adult stem cell niche within the lateral ventricle (Doetsch et al., 1999; 
Kriegstein and Alvarez-Buylla, 2009; Lim and Alvarez-Buylla, 2016). Importantly, the 
developmental programs that regulate the different steps of RGP lineage progression must 
be implemented with precision to ensure proper cortical development. Nonetheless, the 
underlying principles that regulate glia production at the individual RGP level are not yet clear 
(Bayraktar et al., 2014; Molofsky and Deneen, 2015).  
MADM-based lineage tracing has led to an inaugural quantitative framework characterized 
by highly deterministic RGP proliferation behavior in distinct temporal windows, from which 
a number of outstanding mechanistic questions emerge. Most importantly, which signaling 
pathways control RGP proliferation behavior determining the unit size and therefore also the 
global brain size. To this end, is important to investigate the functional requirement of 
candidate genes, at sequential stages during RGP lineage progression, which when mutated 
in human lead to cortical abnormalities such as microcephaly or macrocephaly. Here, I focus 






 PTEN in human disease 
In the 1980s partial or complete loss of chromosome 10 was identified in cancers (Bigner et 
al., 1984). Then in 1997, PTEN was first identified as a frequently mutated gene at 
chromosome 10q23 in various human cancers (melanoma, glioma, prostate and breast 
cancer) and in patients with cancer predisposition (Li et al., 1997; Song et al., 2012; Steck et 
al., 1997). For instance, PTEN  heterozygous and homozygous mutations are frequently found 
in glioma, which is one of the most commonly occurring malignant brain tumors with high 
incidence of therapeutic resistance (Duerr et al., 1998; Wang et al., 1997; Yang et al., 2010; 
Zhou et al., 1999). Germline heterozygous mutations in PTEN have been identified in 60-80% 
of individuals presenting PTEN hamartoma tumor syndromes (PHTSs) (Hollander et al., 2011). 
Hamartomas are benign noncancerous tumorlike malformations made from an abnormal 
mixture of tissues and cells from the area in which it grows. PHTSs are clinically distinct allelic 
disorders (Cowden, Bannanyan-Riley-Ruvacalba and Proteus-syndrome) associated with 
unregulated cellular proliferation leading to the formation of hamartomas (Hobert and Eng, 
2009). The typical PTEN-associated neurological deficits frequently observed in PHTSs are 
macrocephaly, developmental delay and mental retardation (Kreis et al., 2014; Mester and 
Eng, 2013; Mester et al., 2011). Furthermore, 10-20% of individuals with ASD with 
macrocephaly present a variety of heterozygous mutations in PTEN (Butler et al., 2005; 
Buxbaum et al., 2007; Chen et al., 2015; McBride et al., 2010; Varga et al., 2009). In general, 
mutations, insertions and deletions are not limited to the catalytic domain of PTEN only and 
are located throughout the whole gene including promoter, splice donor and acceptor sites 
(Eng, 2003; Trotman et al., 2007; Zhou et al., 2003). 
 
 PTEN functions 
The PTEN gene encodes the phosphatase and tensin homolog protein which among various 
other functions is a protein and lipid phosphatase. It consists of 403 amino acids and contains 
a PIP2 binding motif, a phosphatase catalytic domain, a lipid-binding C-terminal domain, and 
a PDZ-binding motif. One of the most studied and predominant functions of PTEN at the 
plasma membrane is to directly antagonize the activity of phosphoinositide 3-kinases (PI3K), 




prevalent signal transduction events associated to activation of cell-surface receptors by 
extracellular signals in mammalian cells (Hawkins et al., 2006). PI3K synthesizes 
phosphatidylinositol-3,4,5-triphosphate (PIP3) from phosphatidylinositol-4,5-biphosphate 
(PIP2) which is a phosphoinositide particularly enriched at the plasma membrane. In contrast, 
PTEN dephosphorylates PIP3 into PIP2. Because PIP3 is a potent activator of PDK1 (3-
phosphoinositide-dependent kinase 1) and AKT (protein kinase B) isoforms, PTEN acts as a 
canonical negative regulator of the PI3K-Akt-mTOR pathway which promotes cell growth and 
survival (Figure 37). Canonically, loss of PTEN function leads to increased levels of PIP3 at the 
plasma membrane and thus to the recruitment of the tyrosine kinases such as PDK1 and 
different isoforms of AKT (Manning and Cantley, 2007).   Once translocated from the cytosol 
to the plasma membrane, AKT binds PIP3 and is activated by PDK1-mediated phosphorylation 
and mTORC2 (mammalian target of rapamycin complex 2)-mediated phosphorylation (Zoncu 
et al., 2011). AKT in turn drives cell survival, proliferation, angiogenesis and cellular 
metabolism by inhibiting phosphorylation of a set of downstream signaling proteins (GSK3, 
FOXO, PGC1, p27) and activating phosphorylation of a different set of downstream signaling 
proteins (ENTPD5, SREBP1, AS160, SKP2) (Manning and Cantley, 2007). AKT may also activate 
mTORC1 (mammalian target of rapamycin complex 1) by inducing the inhibitory 
phosphorylation of TSC2 (tuberous sclerosis protein 2) and of PRAS40 (40 kDa Pro-rich AKT1 
substrate 1), a component and negative regulator of mTORC1 (Haar et al., 2007; Zoncu et al., 
2011). Additionally, TSC2 may be inhibited by ERK (extracellular signal-regulated kinase) or 
activated by LKB1 (liver kinase B1) via AMPK (AMP-activated protein kinase). Active TSC2 in 
complex with TSC1 normally functions as a GAP (GTPase-activating protein) to RHEB (RAS 
homolog enriched in brain).  Hence, the inhibition of TSC2 relieves the inhibition of RHEB, 
which in its active form can stimulate the phosphotransferase activity of mTORC1 (Guertin 
and Sabatini, 2007). mTORC1 may then activate protein translation of specific mRNAs that are 
crucial for cell growth and proliferation through phosphorylation of S6K (p70 ribosomal 
protein S6 kinase) and 4EBP1 (eukaryotic translation-initiation factor 4E(eIF4E)-binding 
protein 1) (Ma XM and Blenis J, 2009).  
Interestingly, there is evidence of several different negative feedback mechanisms regulating 
the mTORC1 pathway. For instance, p90 ribosomal protein S6K may directly inhibit mTORC1 




Zoncu et al., 2011). Activated TSC1-TSC2-RHEB-mTORC1 signaling may trigger a negative 
feedback loop inhibiting the PI3K-AKT pathway. For example, homozygous loss of Tsc1 or Tsc2 
results in activation of mTORC1 and a strong inhibition of growth factor-stimulated PI3K 
signaling (Radimerski et al., 2002; Zhang et al., 2003). In addition, the mTORC1-S6K1 signaling 
triggers a negative feedback loop that inhibits the insulin-PI3K-AKT pathway through 
phosphorylation and degradation of IRS1 (insulin receptor substrate 1), critical for insulin 
signaling. For example, inhibition of mTORC1 results in a hyperactive IRS1-PI3K-AKT pathway 
and increased RAS-MAPK signaling (Carracedo et al., 2008; Kinkade et al., 2008). Furthermore, 
activated mTORC1 may phosphorylate and activate GRB10 to perform negative feedback 
inhibition of both PI3K-AKT and RAS-MAPK pathways (Hsu et al., 2014a; Yu et al., 2011). These 
mechanisms may limit tumorigenesis triggered by PI3K-independent mTORC1 activation due 
to loss of function of TSC1-TSC2 complex, loss of function of the LKB1-AMPK pathway or gain 
of function of RHEB. Strikingly, inactivation of PTEN is able to override the mTORC1-mediated 
negative feedback of the PI3K pathway and effectively dysregulate both upstream and 
downstream branches of the PI3K pathway (Manning and Cantley, 2007; Nardella et al., 
2008). The impairment of feedback regulation may explain why despite several tumor 
suppressors converging on the mTOR signaling pathway, PTEN is one of the most frequently 
mutated genes in sporadic cancers.  
PTEN expression and activity have been shown to be rightly regulated at many different levels 
- transcriptionally, translationally and post translationally. However, it seems that the most 
important mode of regulation is through posttranslational modifications. PTEN can be 
modified by phosphorylation, acetylation, oxidations, S-nitrosylation, uniquitination and 
sumoylation. Such modifications may influence different aspects of PTEN function including 
its phosphatase activity, membrane-binding, localization to subcellular compartments and 
interaction with binding partners, all important features that must be finely tuned temporally 











The most studied catalytic function of PTEN is to dephosphorylate phosphatidylinositol-
3,4,5-triphosphate (PIP3) into phosphatidylinositol-4,5-biphosphate (PIP2) antagonizing 
the function of PI3K. Therefore, PTEN overall acts as a negative regulator of the PI3K-Akt-
mTOR pathway which promotes cell growth and survival.   
Loss of PTEN function leads to increased levels of PIP3 and to the activation AKT by PDK1 
and mTORC2. AKT promotes cell survival, proliferation and cellular metabolism. Active 
AKT can also inhibit TSC2 and of PRAS40 and thus activate RHEB and mTORC1. Active 
mTORC1 promotes protein translation of specific mRNAs that are crucial for cell growth 
and proliferation through phosphorylation of S6K and 4EBP1. 
 




 Mouse models of PTEN 
 
The generation of Pten mouse models has enabled the study of Pten and its tumor suppressor 
functions in several tissues (Di Cristofano et al., 1998; Podsypanina et al., 1999; Stambolic et 
al., 1998; Suzuki et al., 1998). Pten is widely expressed throughout embryogenesis and 
adulthood. Consequently, global Pten homozygous knockout mice are embryonically lethal 
and do not survive beyond E9.5. In contrast, global Pten heterozygous knockout mice are 
viable, have a very mild increase in brain size and an increased incidence of tumors (Chen et 
al., 2015; Di Cristofano et al., 1998; Suzuki et al., 1998). Importantly, conditional knockout 
mice have enabled the study of Pten in brain development. For instance, brain specific KO 
mice using the Nestin-Cre driver established that Pten depletion in all neuronal progenitors 
results in macrocephaly, early postnatal death and hyperactivation of Akt and S6k in vivo 
(Groszer et al., 2001). Conditional KO mice with Pten depletion in postmitotic forebrain 
excitatory neurons, using the NEX-Cre driver, revealed that homozygous mutant neurons are 
hypertrophic (increased cell size) and have a dramatic activation of Akt (mediated by mTORC2 
and PDK) and mTORC1-S6 while heterozygous mutant cells have only a very mild effect 
(Kazdoba et al., 2012). Mice with Pten depletion in all forebrain excitatory neurons using 
Emx1-Cre driver are not viable after postnatal day (P) 10 and demonstrated that the cortex 
size does not linearly increase with the decrease of Pten dosage since heterozygous cKO mice 
display a very mild increase in brain size compared to the dramatic macrocephaly in the 
homozygous cKO mice (Chen et al., 2015). Furthermore, the same mice also showed that the 
effects on mTOR-S6 signaling and cellular growth depend on Pten dosage. Notably, 
homozygous loss of Pten results in robust Akt, mTor-S6k and Akt-βcatenin hyperactivation, 
whereas heterozygous loss of Pten results in only a moderate effect on Akt and βcatenin  
activation and no mTOR-S6K hyperactivation (Chen et al., 2015). Mice with Pten deletion in 
radial glia-derived neurons and astroglia using the hGFAP-Cre driver also display 
macrocephaly and overall cellular disorganization and lamination in different brain regions 
such as the hippocampus, cerebral cortex and cerebellum (Fraser et al., 2004; Wen et al., 
2013).  
Collectively, substantial contributions in the past two decades have advanced our knowledge 




understanding the cellular and molecular mechanisms underlying such alterations. In all Pten 
KO models the major biochemical result of Pten deletion invariably observed is an 
enhancement in Akt-mTORC1 signaling pathway activity. However, understanding the 
functions and regulation of Pten in different subcellular compartments and in specialized cell-
types, the mechanisms of association and recruitment of Pten to membranes, and PI3K-
independent functions of Pten in the context of neurological disease will become increasingly 
important. Nonetheless, most work on neural stem cells and their proliferation behavior has 
been limited to in vitro experiments of rather late developmental stages with low temporal 
and spatial resolution. Thus, although it is clear that Pten loss of function results in 
macrocephaly, hypertrophy and hyperplasia, the precise role of Pten in cortical neural stem 
cell lineage progression in vivo is not yet fully understood. Likewise, it is also unclear whether 
the underlying mechanisms are shared among different cell-types or specific to certain 
lineages.  
The increased brain size with more numerous cortical cells in human patients with PTEN 
mutations implies a defect in RGP lineage progression, such that RGPs may acquire aberrant 
proliferation properties as a result of false cell states in the wrong temporal stages during 
development. For instance, the number of rounds of symmetric amplification divisions could 
be increased which would translate into more numerous units of projection neurons. 
However, it is likewise possible that the total output of individual neurogenic RGPs could be 
increased. To tackle such questions, I established genetic paradigms to ablate Pten either in 
very sparse mosaic or neuroepithelium-wide in all RGPs, both coupled with single-cell labeling 






 MADM-Based Experimental Paradigm for Sparse and Complete Pten 
Ablation 
To determine the cell-autonomous function of Pten in RGP lineage progression I used a 
quantitative MADM-based genetic strategy, consisting of phenotypic analysis at single cell 
resolution of 1) control-MADM (MADM-19GT/TG; Emx1Cre/+)  with sparse MADM labeling where 
all cells are Pten+/+ (Figure 38A), 2) genetic mosaic Pten-MADM (MADM-19GT/TG;Pten-flox; 
Emx1Cre/+)  with only sparse Pten deletion in just a few RGPs in a genetic background of 
heterozygous and wild-type (WT) cells (Figure 38B), and 3) conditional knockout cKO-Pten-
MADM (MADM-19GT;Pten-flox/TG;Pten-flox; Emx1Cre/+) with global Pten deletion in cortical RGPs in a 
Pten-/- mutant background (Figure 38C). Hence, individual Pten-/- RGP cells are surrounded 
either by a local microenvironment with rather normal cells in the Pten-MADM animals, or 
mainly mutant cells in the cKO-Pten-MADM. I used Cre recombinase expressed from the Emx1 
locus (Gorski et al., 2002) to induce sparse MADM labeling and/or genetic manipulation in 
NSCs from the dorsal telencephalon in control-MADM,  Pten-MADM and cKO-Pten-MADM 
mice (Figure 38A-C). In order to generate Pten-MADM animals, I genetically linked the Pten-
flox allele (Groszer et al., 2001) via meiotic recombination to the MADM-TG cassette on the 
novel  MADM chromosome 19 (MADM-19) (Figure 38E-F). Emx1-Cre mediates 
interchromosomal trans-recombination between the MADM cassettes, as well as cis-
recombination between the LoxP sites of the Pten-flox allele, essentially converting the Pten-
flox allele into a Pten-delta allele. Consequently, in the Pten-MADM brains, MADM-labeled 
green cells are homozygous Pten-/- and red cells are homozygous Pten+/+. Yellow cells may also 
be generated by certain MADM events and are heterozygous Pten+/-. The majority of 
unlabeled cells generated from the Emx1+ lineage are also Pten+/-, whereas unlabeled cells 
from other lineages (eg. Cortical interneurons) are Pten+/+ . In order to generate cKO-Pten-
MADM animals, I genetically linked the Pten-flox allele to both TG and GT MADM cassettes 
on MADM-19, separately (Figure 38E-F). In experimental cKO-Pten-MADM brains, Emx1-Cre-
mediated cis-recombination converts both Pten-flox alleles into Pten-delta alleles globally in 
all Emx1 expressing RGPs in the dorsal telencephalon (i.e., conditional Pten KO). Additionally, 




yellow and unlabeled cells in the background. Importantly, all these cells carry the Pten-/- 






For the 3 different genetic paradigms I employed constitutive Emx1-Cre, which results in  
MADM events occurring stochastically at any given time in a random subset of dividing Emx1+ 
RGP. In MADM-control if RGP divisions are symmetric, the number of red and green cells 
within an individual clone are nearly the same (Gao et al., 2014; Hippenmeyer et al., 2010).If 
a large number of RGP divisions are instead asymmetric, such that the red and green progeny 
numbers are different in individual clones, the overall number of red and green daughter cells 
would still be close to identical because the distribution of colors in asymmetric clones is 
random. Hence, a combination of both scenarios would result in a ratio of green/red cells of 
approximately 1. 
  
(A) Control-MADM (MADM-19GT/TG; Emx1Cre/+) with sparse MADM labeling in forebrain 
excitatory neurons. All labeled and unlabeled cells are Pten+/+. 
(B) Pten-MADM (MADM-19GT/TG;Pten-flox; Emx1Cre/+)  genetic mosaic with sparse Pten deletion 
in a background of heterozygous and WT cells. Green cells are Pten-/-, red cells are Pten+/+ and 
yellow cells are Pten+/-. Unlabeled cells from the Emx1 lineage are Pten+/- and all cells from 
other lineages are Pten+/+. 
(C) cKO-Pten-MADM (MADM-19GT;Pten-flox/TG;Pten-flox; Emx1Cre/+)conditional Pten knockout with 
Pten deletion in all forebrain excitatory neurons. All labeled and unlabeled forebrain 
excitatory neurons are Pten-/-. All other cell-types are Pten+/+. 
(D) Generation of recombinant allele for Pten-MADM mice. Here, only the TG-MADM allele 
in chromosome 19 is genetically linked to the Pten-flox allele via meiotic recombination. 
(E) Generation of recombinant alleles for cKO-Pten-MADM mice. Here, both TG-MADM and 
GT-MADM alleles in chromosome 19 are separately genetically linked to the Pten-flox allele 
via meiotic recombination. 
(F) Breeding schemes for the generation of experimental control- Pten- and cko-Pten-MADM 
mice. 




 Pten is Cell-Autonomously Required to Control the RGP Pool 
The increased brain size with more numerous cortical cells in human patients with PTEN 
mutations and in brain specific knockout and genetic mosaic mice suggests a defect in RGP 
lineage progression. In other words, the RGPs may acquire aberrant proliferation properties 
as a result of false cell states in the wrong temporal stages during development. For instance, 
the number of rounds of symmetric amplification divisions could be increased which would 
translate into more numerous RGP-derived units of projection neurons. In wild-type 
conditions, RGPs switch relatively sharply from symmetric to asymmetric division mode at 
E12/E13. In case of increased rounds of symmetric division, I would expect the embryonic 
brains to contain a higher number of progenitor cells and/or the switch from symmetric to 
asymmetric division to occur at later embryonic stages. To probe for this scenario, I carried 
out MADM-based gene functional analysis using Emx1-Cre and compared the numbers of 
neuronal progenitors in wild-type animals and genetic mosaics that lack Pten in a sparse 
population at 3 different embryonic stages; E12.5, E14.5 and E16.5 (Figure 39A-C). In order to 
identify neuronal progenitors, I used PAX6 immunolabeling, a known marker for neuronal 
progenitors (Ian Simpson and Price, 2002; Osumi, 2001; Osumi et al., 2008). 
I first quantified the g/r ratio of PAX6+ progenitors (Figure 39D left) and found significant 
differences depending on the genetic paradigm (two-way ANOVA, F(2,36)=25.90, p<0.0001) 
and on the timepoint (two-way ANOVA, F(2,36)=7.40, p=0.002). Furthermore, the effects of the 
genetic paradigm on the g/r ratio of PAX6+ progenitors depend on the timepoint (two-way 
ANOVA, F(4,36)=5.66, p=0.0012). In particular, the g/r ratio of Pten-MADM (0.96, SEM±0.34) 
does not differ significantly from control-MADM (0.75, SEM±0.51) or cKO-Pten-MADM (0.96, 
SEM±0.08) at E12.5 (Dunnet’s post hoc test, control-MADM p=0.88, cKO-Pten-MADM 
p=0.31). However both at E14.5 and E16.5 the g/r ratio of PAX6+ progenitors in Pten-MADM 
(E14.5: 1.23, SEM±0.06, E16.5: 1.42, SEM±0.13) is significantly higher than in both control-
MADM and cKO-Pten-MADM (E14.5: Control-MADM: 0.98, SEM±0.24; cKO-Pten-MADM: 
0.83, SEM±0.24; E16.5: Control-MADM: 0.93, SEM±0.3; cKO-Pten-MADM: 0.98, SEM±0.18) 
(Dunnet’s post hoc test, E14.5: control-MADM p=0.006, cKO-Pten-MADM p=0.002; E16.5: 
control-MADM p<0.0001, cKO-Pten-MADM p<0.0001). Additionally, the g/r ratio in Pten-
MADM significantly increased from E12.5 to E14.5 (Tukey’s post hoc test, p=0.01) and from 




I also quantified the green/red ratio of PAX6- cells, which is a mix of postmitotic neurons and 
intermediate progenitors (Figure 10 D right) and found significant differences in the g/r ratio 
of PAX6- cells depending on the genetic paradigm (two-way ANOVA, F(2,36)=4.98, p=0.01). 
Furthermore, the effects of the genetic paradigm on the g/r ratio of PAX6- cells depend on 
the timepoint (two-way ANOVA, F(4,36)=2.87, p=0.04). In particular, the g/r ratio of Pten-
MADM (1.01, SEM±0.11) does not differ significantly from control-MADM (1.08, SEM±0.10) 
or cKO-Pten-MADM (1.10, SEM±0.17) at E12.5 (Dunnet’s post hoc test, control-MADM 
p=0.70, cKO-Pten-MADM p=0.70). At E14.5 there are no significant differences either 
(Dunnet’s post hoc test, control-MADM p=0.06, cKO-Pten-MADM p=0.053) but a trend of a 
higher g/r ratio in Pten-MADM (1.37 SEM±0.07). Finally, at E16.5 the g/r ratio of PAX6- cells 
in Pten-MADM (1.53, SEM±0.06) differs significantly from control-MADM (1.05, SEM±0.02) 
and cKO-Pten-MADM (0.99, SEM±0.03) (Dunnet’s post hoc test, control-MADM p=0.01, cKO-
Pten-MADM p=0.01). The g/r ratio of PAX6- cells in Pten-MADM significantly increased from 
E12.5 to E14.5 (Tukey’s post hoc test, p=0.01) but not from E14.5 to E16.5 (Tukey’s post hoc 
test, p=0.66. 
Altogether, the cell-autonomous progressive increase, at a population level, of Pten-depleted 
PAX6+ RGPs in comparison to wild-type RGPs supports an increase in the number of symmetric 
proliferative rounds and likely explains the increase in postmitotic neurons observed in 
adulthood. These data highlights the cell-autonomous requirement of Pten in RGPs in order 
















(A) Confocal images 20 µm thick of control-MADM, Pten-MADM and cKO-Pten-MADM at 
embryonic day 12.5 (E12.5), (B) E14.5 and (C) E16.5, stained for PAX6, a marker for neuronal 
progenitors. In control-MADM animals both green and red cells are Pten+/+, and in cKO-Pten-
MADM both green and red cells are Pten-/-. In contrast, in Pten-MADM animals where green 
cells are Pten-/- and red cells are Pten+/+. VZ= Ventricular Zone. IZ= Intermediate Zone, CP= 
Cortical Plate. Scale bar=50 µm. 
(D) Left. Quantification of the g/r ratio of PAX6+ progenitors. There are significant differences 
in the g/r ratio of PAX6+ progenitors depending on the genetic paradigm (two-way ANOVA, 
F(2,36)=25.90, p<0.0001) and on the timepoint (two-way ANOVA, F(2,36)=7.40, p=0.002). 
Furthermore, the effects of genetic paradigm on the g/r ratio of PAX6+ progenitors depend 
on the timepoint (two-way ANOVA, F(4,36)=5.66, p=0.0012). In particular, the g/r ratio of Pten-
MADM (0.96, SEM±0.34) does not differ significantly from control-MADM (0.75, SEM±0.51) 
or cKO-Pten-MADM (0.96, SEM±0.08) at E12.5 (Dunnet’s post hoc test, control-MADM 
p=0.88, cKO-Pten-MADM p=0.31). However at both E14.5 and E16.5 the g/r ratio of PAX6+ 
progenitors in Pten-MADM (E14.5: 1.23, SEM±0.06, E16.5: 1.42, SEM±0.13) is significantly 
higher than in both control-MADM and cKO-Pten-MADM (E14.5: Control-MADM: 0.98, 
SEM±0.24; cKO-Pten-MADM: 0.83, SEM±0.24; E16.5: Control-MADM: 0.93, SEM±0.3; cKO-
Pten-MADM: 0.98, SEM±0.18) (Dunnet’s post hoc test, E14.5: control-MADM p=0.006, cKO-
Pten-MADM p=0.002; E16.5: control-MADM p<0.0001, cKO-Pten-MADM p<0.0001). The g/r 
ratio in Pten-MADM significantly increased from E12.5 to E14.5 (Tukey’s post hoc test, 
p=0.01) and from E14.5 to E16.5. 
Right. Quantification of the green/red ratio of PAX6- cells. There are significant differences in 
the g/r ratio of PAX6- cells depending on the genetic paradigm (two-way ANOVA, F(2,36)=4.98, 
p=0.01), but not on the timepoint (two-way ANOVA, F(2,36)=1.63, p=0.21). Furthermore, the 
effects of genetic paradigm on the g/r ratio of PAX6- cells depend on the timepoint (two-way 
ANOVA, F(4,36)=2.87, p=0.04). In particular, the g/r ratio of Pten-MADM (1.01, SEM±0.11) does 
not differ significantly from control-MADM (1.08, SEM±0.10) or cKO-Pten-MADM (1.10, 
SEM±0.17) at E12.5 (Dunnet’s post hoc test, control-MADM p=0.70, cKO-Pten-MADM 
p=0.70). However, at E16.5 the g/r ratio of PAX6- cells in Pten-MADM (1.53, SEM±0.06) differs 
significantly from control-MADM (1.05, SEM±0.02) and cKO-Pten-MADM (0.99, SEM±0.03) 
(Dunnet’s post hoc test, control-MADM p=0.01, cKO-Pten-MADM p=0.01). The g/r ratio of 
PAX6- cells in Pten-MADM significantly increased from E12.5 to E14.5 (Tukey’s post hoc test, 
p=0.01) but not from E14.5 to E16.5 (Tukey’s post hoc test, p=0.66. 
*p<0.05. **p<0.01. ***p<0.001. ****p<0.0001. Data are mean ± SEM. E12.5: n=7 control-
MADM, n=7 Pten-MADM n=4 cKO-Pten-MADM. E14.5: n=5 of each genotype.  E16.5 n=5 
control-MADM, n=4 Pten-MADM n=3 cKO-Pten-MADM. 
 




 Analysis of Corticogenesis upon Sparse and Complete Pten Deletion in 
RGPs 
I first analyzed corticogenesis and overall cortical morphogenesis in control-MADM, Pten-
MADM and cKO-Pten-MADM at postnatal day (P) 0 (Figure 40). As previously reported 
(Groszer et al., 2001) conditional deletion of Pten in forebrain excitatory neurons using the 
Emx1-Cre driver results in severe macrocephaly (Figure 40D top). The whole brain weight of 
cKO-Pten-MADM (145.4 mg, SEM±5.15) is >1.5 fold higher than the brain weight of control-
MADM (89.82 mg, SEM±1.61) and Pten-MADM (93.67 mg, SEM±1.99) animals. The effect of 
the genetic paradigm on brain weight is statistically significant (one-way ANOVA, F(2,22)=1.61, 
p<0.0001; Tukey’s post hoc test, control-MADM p<0.0001; cKO-Pten-MADM p<0.0001). At 
this timepoint there is only a very small (4%) increase in brain weight in Pten-MADM animals 
(heterozygous cKO Pten deletion) that is not statistically significant (Figure 40D bottom). 
I then quantified the green/red ratio of MADM-labeled cells in the somatosensory cortical 
area of the 3 MADM paradigms. At this timepoint MADM labeled cells may comprise mainly 
of post mitotic neurons, glia progenitors, and immature glia which are all hardly 
distinguishable solely on their morphology. The g/r cell ration in control-MADM (0.99, 
SEM±0.04) and cKO-Pten-MADM (1.06, SEM±0.06) animals is ~1, as expected since green and 
red cells have identical genotypes in each of those paradigms. In contrast, in Pten-MADM the 
g/r ratio (1.72, SEM±0.07) was significantly higher than in both control-MADM and cKO-Pten-
MADM (one-way ANOVA, F(2,8)=40.37, p<0.0001; Tukey’s post hoc test, control-MADM 
p=0.0001; cKO-Pten-MADM p=0.0002) indicating a cell-autonomous 70% increase of green 
Pten-deficient cells in comparison to red wild-type cells (Figure 40B).  
In this experiment, all green cells bear a paternal UPD (uniparental chromosome disnomy) of 
Chr19 with no copies from the father, and red cells a maternal UPD (double dose of maternal 
Chr 19) due to the chromosomal translocation upon MADM G2-X events. For this, control-
MADM (MADM-19GT/TG; Emx1Cre/+) Pten-MADM (MADM-19GT/TG;Pten-flox; Emx1Cre/+) and cKO-
MADM (MADM-19GT;Pten-flox/TG;Pten-flox; Emx1Cre/+) inherit the GT-MADM cassette from the 
mother and the TG-cassette from the father. Additionally, in Pten-MADM animals the Pten-
flox allele is inherited from the father. It has been previously assessed that UPDs in MADM 
chromosome 19 have no effect in cell numbers (see Chapter 2), however,  to rule out whether 




g/r cell ratio in a set of control-MADMUPD-swap (MADM-19GT/TG; Emx1Cre/+) and Pten-MADMUPD-
swap (MADM-19 GT/TG; Pten-flox; Emx1Cre/+) animals from parent swap matings where all green cells 
bear a maternal UPD and red cells a paternal UPD (GT-MADM cassette is inherited from the 
father and the GT-MADM cassette from the mother) and Pten-deficient cells inherit the flox 
allele from the mother (Figure 40C). As expected, Pten-MADMUPD-swap animals also show a 
comparable and significantly higher g/r cell ratio (1.64, SEM±0.08) than control-MADMUPD-swap 
(0.99, SEM±0.04) (two-tailed unpaired Student’s t-test t(4)=7.43 ,p=0.002). These results 
demonstrate that the state of the UPD and the parental origin of the Pten-flox allele do not 














(A) Confocal images 30 µm thick of control-MADM, Pten-MADM and cKO-Pten-MADM at 
postnatal day 0. Scale bar=500 µm, Ctx inset=50 µm. Ctx=cortex. 
(B) Quantification of g/r cell ratio. Here, all green cells bear a paternal UPD, red cells a 
maternal uniparental disomy, and the Pten-flox allele in Pten-MADM is inherited from the 
father. The g/r ratio of Pten-MADM (1.72, SEM±0.07) reflects a higher number of Pten-
deficient cells compared to WT cells and is significantly higher than the g/r ratio of control-
MADM (0.99, SEM±0.04) and cKO-Pten-MADM (1.06, SEM±0.06) where the g/r cell ratios are 
close to ~1 since both green and red cells in those paradigms have the same genotype (one-
way ANOVA, F(2,8)=40.37, p<0.0001; Tukey’s post hoc test, control-MADM, p=0.0001; cKO-
Pten-MADM, p=0.0002). Control-MADM, n=3; Pten-MADM, n=4; cKO-Pten-MADM, n=4. 
(C) Quantification of g/r ratio cell ratio. Here, all green cells bear a maternal UPD, red cells a 
paternal UPD and the Pten-flox allele in Pten-MADM is inherited from the mother. However, 
this does not alter the phenotype. Pten-MADM animals have a comparable and significantly 
higher g/r ratio (1.64, SEM±0.08) than control-MADM (0.99, SEM±0.04) (two-tailed unpaired 
Student’s t-test t(4)=7.43 ,p=0.002). N=3 per genotype 
(D) Brain specific Pten loss of function in excitatory forebrain results in macrocephaly. Brain 
weight of cKO-Pten-MADM (145.4 mg, SEM±5.15) is significantly higher than of control-
MADM (89.82 mg, SEM±1.61), and Pten-MADM (93.67 mg, SEM±1.99 (one-way ANOVA, 
F(2,22)=1.61 , p<0.0001; Tukey’s post hoc test, control-MADM, p<0.0001; cKO-Pten-MADM, 
p<0.0001). Scale bar=500 µm. Control-MADM, n=11; Pten-MADM, n=9; cKO-Pten-MADM, 
n=5. 
**p<0.01. ****p<0.0001. Data are mean ± SEM.  




 Pten Cell-Autonomously Controls Cortical Neuron and Astrocyte 
Generation 
Mice with brain specific deletion of Pten in forebrain excitatory neurons using the Emx1-Cre 
driver do not survive longer than P10 (Groszer et al., 2001). Accordingly, cKO-Pten-MADM 
animals usually die between P7-P10 and very often they are eaten by their mothers shortly 
after birth (data not shown). At P7 cKO-Pten-MADM animals are significantly smaller (2.68g, 
SEM±0.35) than both control-MADM (3.92, SEM±0.23) and Pten-MADM animals (4.24g, 
SEM±0.16) (one-way ANOVA, F(2,22)=3.72, p=0.04); Tukey’s post hoc test, control-MADM 
p=0.014; cKO-Pten-MADM p=0.003). However, control-MADM and Pten-MADM animals are 
undistinguishable by body weight (Tukey’s post hoc test, p=0.55) (Figure 41C).  
I also observed a significant difference in brain weight in the different genetic paradigms. In 
particular, the brain weight of cKO-Pten-MADM (380 mg, SEM±15.28) is significantly higher 
(> 50%) than of control-MADM (212 mg, SEM±3.74) and Pten-MADM (242 mg, SEM±7.18) 
(one-way ANOVA, F(2,10)=0.70 , p<0.0001; Tukey’s post hoc test, p<0.001). At this timepoint 
the weight of Pten-MADM brain is slightly (>10%) and significantly higher than of control-
MADM (Tukey’s post hoc test, p=0.04) (Figure 41 D).  
At postnatal day 7 is possible to unambiguously distinguish neurons and astrocytes solely by 
morphology. I thus first quantified the g/r neuron ratio at this timepoint (Figure 41A-B) and 
found a significant effect of the genetic paradigm on the g/r neuron ratio (one-way ANOVA, 
F(2,11)=47.10, p<0.0001) In particular, the g/r neuron ratio of Pten-MADM (1.65, SEM±0.04) is 
significantly higher than the g/r neuron ratio of control-MADM (1.04, SEM±0.03) and cKO-
Pten-MADM (1.01, SEM±0.06) (Tukey’s post hoc test, p<0.0001). 
I then quantified the green/red astrocyte ratio and also found a significant effect of the genetic 
paradigm on the g/r astrocyte ratio (one-way ANOVA, F(2,8)=8.03, p=0.007). The g/r astrocyte 
ratio of Pten-MADM (2.96, SEM±0.97) is significantly higher than the g/r astrocyte ratio of 
control-MADM (0.92, SEM±0.14) and cKO-Pten-MADM (1.15, SEM±0.12) (Tukey’s post hoc 
test, control-MADM, p=0.009; cKO-Pten-MADM, p=0.03). Notably, the almost 3-fold increase 
in Pten-depleted astrocytes compared to WT astrocytes is more pronounced than in neurons 
where the increase is ~ 1.5-fold.  
To dissect possible cell-non-autonomous phenotypes in the generation of astrocytes upon 




(neurons and astrocytes) for each color in the 3 genetic paradigms. Importantly, the 
proportion of astrocytes from both green and red astrocytes in cKO-Pten-MADM (Green: 0.30, 
SEM±0.02, Red: 0.28, SEM±0.01) is significantly higher than in control-MADM (Green: 0.09, 
SEM±0.01, Red: 0.11, SEM±0.009) and Pten-MADM (Green: 0.12, SEM±0.03, Red: 0.08, 
SEM±0.02) (one-way ANOVA, F(2,22)=44.53, p<0.0001; Tukey’s post hoc test, Green astrocytes: 
control-MADM p<0.0001, Pten-MADM p=0.0001; Red astrocytes: control-MADM p<0.0002, 
Pten-MADM p<0.0001). Notably, in Pten-MADM the astrocyte proportion of Pten-depleted 
cells is not significantly different that the astrocyte proportion of WT cells (one-way ANOVA, 
F(2,22)=44.53, p<0.0001; Sidak’s post hoc test p=0.16) at this timepoint. This data demonstrates 
that at P7 in a rather normal environment Pten-depletion does not yet significantly alter the 
proportion of astrocytes compared to neurons, although both two cell-types are found in 
excess numbers at this timepoint. In contrast, at P7 in a mutant environment the proportion 
of mutant astrocytes is already increased 3-fold compared to WT and mosaic deletion of Pten 
scenarios. Notably, later on at P21 Pten-MADM do display a significantly higher proportion of 
green mutant astrocytes than of red WT astrocytes (Green: 0.23, SEM±0.03, Red: 0.10, 
SEM±0.009) (two-tailed paired Students’ t-test, t(3)=6.92, p=0.006) suggesting that the mutant 
environment speeds or exacerbates the phenotype. 
These results suggest that Pten is required cell-autonomously for both correct cortical 
neurogenesis and astrogenesis, and that additional cell-non-autonomous (community) effects 










(A) Confocal images 30 µm thick of control-MADM, Pten-MADM and cKO-Pten-MADM at 
postnatal day 7. Control-MADM cell inset shows magnification of pyramidal neurons (Py) and 
astrocytes (As). Scale bar=500 µm, Ctx inset=50 µm, cell inset= 20 µm. Ctx=cortex. 
(B) Left. Quantification of g/r neuron ratio in the 3 genetic paradigms. The g/r neuron ratio of 
Pten-MADM (1.65, SEM±0.04) is significantly higher than the g/r neuron ratio of control-
MADM (1.04, SEM±0.03) and cKO-Pten-MADM (1.01, SEM±0.06) similarly to P0 data (one-
way ANOVA, F(2,11)=47.10, p<0.0001; Tukey’s post hoc test, p<0.0001). 
Center. Quantification of g/r astrocyte ratio in the 3 genetic paradigms. More pronounced 
than in neurons, the g/r astrocyte ratio of Pten-MADM (2.96, SEM±0.97) is also significantly 
higher than the g/r astrocyte ratio of control-MADM (0.92, SEM±0.14) and cKO-Pten-MADM 
(1.15, SEM±0.12) (one-way ANOVA, F(2,8)=8.03, p=0.007; Tukey’s post hoc test, control-
MADM, p=0.009; cKO-Pten-MADM, p=0.03). 
Right. Quantification of the astrocyte proportion per color in the 3 genetic paradigms. The 
proportion of astrocytes in cKO-Pten-MADM (G: 0.30, SEM±0.02, R: 0.28, SEM±0.01) is 
significantly higher than in control-MADM (G: 0.09, SEM±0.01, R: 0.11, SEM±0.009)  and Pten-
MADM (G: 0.12, SEM±0.03, R: 0.08, SEM±0.02)  (one-way ANOVA, F(2,22)=44.53, p<0.0001; 
Tukey’s post hoc test, Green astrocytes: control-MADM p<0.0001, Pten-MADM p=0.0001; 
Red astrocytes: control-MADM p<0.0002, Pten-MADM p<0.0001 ). Control-MADM, n=4; Pten-
MADM, n=5; cKO-Pten-MADM, n=5. 
(C) Body weight of cKO-Pten-MADM (2.68g, SEM±0.35) is significantly lower than of control-
MADM (3.92, SEM±0.23) and Pten-MADM (4.24g, SEM±0.16) (one-way ANOVA, F(2,22)=3.72, 
p=0.04); Tukey’s post hoc test, control-MADM p=0.014; cKO-Pten-MADM p=0.003).  
(D) Brain weight of cKO-Pten-MADM (380 mg, SEM±15.28) is significantly higher than of 
control-MADM (212 mg, SEM±3.74), and Pten-MADM (242 mg, SEM±7.18) (one-way ANOVA, 
F(2,10)=0.70 , p<0.0001; Tukey’s post hoc test, p<0.001). The weight of Pten-MADM brain is 
slightly but significantly higher than of control-MADM (Tukey’s post hoc test, p=0.04). Scale 
bar=500 µm. Control-MADM, n=5; Pten-MADM, n=5; cKO-Pten-MADM, n=3. 
*p<0.05. **p<0.01. ***p<0.001.  ****p<0.0001. Data are mean ± SEM. 
 




 Pten Neuronal and Astrocytic Phenotypes Persist Through Adulthood 
Pten-MADM mosaic mice survive well beyond 6 months of age and display no signs of 
astrocytoma, which enables the analysis of Pten-deficient cells at adult stages (Figure 42A-C). 
At postnatal day 21 the brain weight of Pten-MADM (435.7 mg, SEM±8.88) is slightly (>10%) 
but significantly higher (two-tailed unpaired Student’s t-test t(25)= 3.43,p=0.002) than of 
control-MADM (389.2 mg, SEM±10.34) similar to the difference at P7 (Figure 42E). 
I quantified the green/red neuron ratio at three adult timepoints (21 days, 3 months and 6 
months of age) in control-MADM and Pten-MADM (Figure 42D left). I found that the g/r 
neuron ratio is significantly different between the two genetic paradigms (two-way ANOVA 
genotype, F(1,18)=122.6, p<0.0001). In particular, the g/r neuron ratio in Pten-MADM (P21: 
1.99, SEM±0.19; 3mo: 1.48, SEM±0.11; 6mo: 1.54, SEM±0.05) is significantly higher than in 
control-MADM (P21: 1.01, SEM±0.02; 3mo: 1.0 SEM±0.03; 6mo: 0.98 SEM±0.05) at all 
timepoints (Sidak’s post hoc test, P21 p<0.0001; 3mo p=0.003; 6mo p<0.0001).  I also found 
that the g/r neuron ratio is significantly different among timepoints (two-way ANOVA, 
F(2,18)=4.44, p=0.03). This does not apply to control-MADM (Tukey’s post hoc test, P21-3mo 
p=0.98; P21-6mo p=0.91; 3-6mo p=0.96). However, in Pten-MADM the g/r ratio decreases 
slightly between P21 and 3 months but it then stays constant (Tukey’s post hoc test, P21-3mo 
p=0.005; P21-6mo p=0.02; 3-6mo p=0.83). Importantly, I found no significant interaction 
between genetic paradigm and timepoint on the g/r neuron ratio (two-way ANOVA, 
F(2,18)=3.34, p=0.06). These data indicate that the overall phenotype of neurons in distinct 
genetic paradigms does not depend on the timepoint.  
I also quantified the green/red astrocyte ratio at the same 3 time points in the same animals 
(Figure 42D right) and found that the g/r astrocyte ratio is significantly different between 
control-MADM and Pten-MADM (two-way ANOVA, F(1,18)=101.3, p<0.0001). Similarly, but 
more pronounced than in neurons, the g/r astrocyte ratio in Pten-MADM (P21: 5.16, 
SEM±0.39; 3mo: 5.84, SEM±1.69; 6mo: 3.54, SEM±0.58) is significantly higher than in control-
MADM (P21: 0.97, SEM±0.06; 3mo: 1.22 SEM±0.13; 6mo: 1.24 SEM±0.15) at all timepoints 
(Sidak’s post hoc test, P21 p<0.0001; 3mo p<0.0001; 6mo p=1.0). I found that the g/r astrocyte 
ratio in a genetic paradigm does not differ significantly among timepoints (two-way ANOVA, 
F(2,18)=0.70, p=0.51 ) and that there is no significant interaction between the effects of genetic 




demonstrating that the overall phenotype of astrocytes does not depend on the timepoint 
either. As previously reported in earlier developmental stages (Kazdoba et al., 2012), Pten-
deficient neurons and astrocytes display hyperthrophy and thicker processes at the 
timepoints analyzed (data not shown). In summary, the increase in the number of Pten-
deficient cortical neurons and astrocytes compared to wild-type counterparts persists 
through adulthood in the genetic mosaic mice and it demonstrates that hyperthropic Pten-
deficient neurons and astrocytes are able to survive for several months surrounded by a 
rather normal (mix of wild-type cell-types and heterozygous neurons) environment 
potentially exerting a positive effect on them. Altogether, this data indicates an important 
cell-autonomous function of Pten, likely different for neurogenesis in comparison to astrocyte 










(A) Confocal images 30 µm thick of control-MADM and Pten-MADM at postnatal day 21 
(P21), (B) 3 months old and (C) 6 months old. Scale bar=500 µm, Ctx inset=50 µm. 
Ctx=cortex. 
(D) Left. Quantification of the g/r neuron ratio at 3 time points. The g/r neuron ratio in 
Pten-MADM (P21: 1.99, SEM±0.19; 3mo: 1.48, SEM±0.11; 6mo: 1.54, SEM±0.05) is 
significantly higher than in control-MADM (P21: 1.01, SEM±0.02; 3mo: 1.0 SEM±0.03; 
6mo: 0.98 SEM±0.05) at all timepoints (two-way ANOVA, F(1,18)=122.6, p<0.0001; Sidak’s 
post hoc test, P21 p<0.0001; 3mo p=0.003; 6mo p<0.0001).  In Pten-MADM the g/r neuron 
ratio decreases slightly between P21 and 3 months and then stays constant (two-way 
ANOVA, F(2,18)=4.44, p=0.03; Tukey’s post hoc test, P21-3mo p=0.005; P21-6mo p=0.02; 3-
6mo p=0.83). This did not apply to control-MADM. There is no significant interaction 
between the genetic paradigm and timepoint on the g/r neuron ratio (two-way ANOVA, 
F(2,18)=3.34, p=0.06). 
Right. Quantification of the g/r astrocyte ratio at 3 time points in control-MADM and Pten-
MADM. Similarly, but more pronounced than in neurons, the g/r astrocyte ratio in Pten-
MADM (P21: 5.16, SEM±0.39; 3mo: 5.84, SEM±1.69; 6mo: 3.54, SEM±0.58) is significantly 
higher than in control-MADM (P21: 0.97, SEM±0.06; 3mo: 1.22 SEM±0.13; 6mo: 1.24 
SEM±0.15) at all timepoints (two-way ANOVA, F(1,18)=101.3, p<0.0001; Sidak’s post hoc 
test, P21 p<0.0001; 3mo p<0.0001; 6mo p=1.0).The g/r astrocyte ratio in a genetic 
paradigm does not differ significantly at the different timepoints (two-way ANOVA, 
F(2,18)=0.70, p=0.51). There is no significant interaction between the effects of genetic 
paradigm and age on the g/r astrocyte ratio (two-way ANOVA, F(2,18)=1.90, p=0.18). N=4 
for each genotype and timepoint. 
(E) Brain weight of Pten-MADM (435.7 mg, SEM±8.88) is slightly but significantly higher 
than control-MADM (389.2 mg, SEM±10.34) at P21 (two-tailed unpaired Student’s t-test 
t(25= 3.43,p=0.002). Scale bar=500 µm. Control-MADM, n=13; Pten-MADM, n=14. 
*p<0.05. **p<0.01. ***p<0.001. ****p<0.0001. Data are mean ± SEM. 
 





 Genetic Epistasis Experiments Suggest an Egfr-independent Role of Pten 
in Cortical Astrocyte Generation 
On the cellular level, loss of Pten function leads to an exuberant number of cortical astrocytes. 
To obtain potential mechanistic insights at the molecular level, I pursued a candidate gene 
approach with a genetic epistasis experiment in the MADM context. I focused of Egfr because 
previous studies suggested a crucial and dose-dependent regulatory function of Egfr signaling 
in gliogenesis (Burrows, et al. 1997, Sibilia 1998) and in vitro interactions between PTEN and 
EGFR (Shinde and Maddika, 2016; Vivanco et al., 2010). I thus tested the hypothesis that the 
exuberant generation of astrocytes upon loss of Pten could be dependent on functional Egfr 
by conditionally ablating Egfr from all forebrain excitatory neurons on top of the Pten-MADM 
mosaic (Pten-MADM-cKO-Egfr: MADM-19GT;Pten-flox/TG;Pten-flox; Egfrflox/flox; Emx1Cre/+) where red 
cells are Pten+/+; Egfr-/- and green cells are Pten-/-; Egfr-/-( Figure 43).  
As a control, I first quantified the g/r neuron ratio at P21 (Figure 43E left). The g/r neuron ratio 
of Pten-MADM-cKO-Egfr (1.75, SEM±0.01), where green cells are Pten-/-; Egfr-/- and red cells 
Pten+/+; Egfr-/-, is higher than in control-MADM-cKO-Egfr (MADM-19GT/TG; Egfrflox/flox; 
Emx1Cre/+)(0.96, SEM±0.06), where both green and red cells are Pten+/+; Egfr-/- (one-way 
ANOVA, F(3,9)=88.24, p<0.0001; Tukey’s post hoc test, p<0.0001). As in previous data sets, the 
g/r neuron ratio of Pten-MADM (MADM-19GT/TG;Pten-flox; Emx1Cre/+)(1.75, SEM±0.01) is 
significantly higher than of control-MADM (MADM-19GT/TG; Emx1Cre/+)(1.09, SEM±0.05) 
(Tukey’s post hoc test, p<0.0001).  Importantly, the g/r neuron ratio of control-MADM and 
control-MADM-cKO-Egfr do not differ from each other (Tukey’s post hoc test, p=0.13) and 
neither does the g/r neuron ratio of Pten-MADM-cKO-Egfr from Pten-MADM (Tukey’s post 
hoc test, p=1.00). This supports that Egfr deletion has no effect on g/r neuron ratio. 
I then evaluated the astrocyte density (astrocytes/mm2) in the epistasis experiment (Figure 
43E right). As in previous results, the density of Pten-deficient astrocytes in Pten-MADM (9.07, 
SEM±0.67) is significantly higher than of WT astrocytes in control-MADM (4.54, SEM±0.32) 
(one-way ANOVA, F(3,9)=17.42, p<0.0004; Tukey’s post hoc test, p<0.01). Likewise, as 
previously reported (Beattie et al., 2017), the density of only Egfr-deficient astrocytes in 
control-MADM-cKO-Egfr (0.33, SEM±0.13) is drastically reduced to almost zero and thus 
significantly lower than the density of both WT astrocytes in control-MADM and Pten-




epistasis experiment, I detected a large number of green astrocytes (Pten-/-; Egfr-/-) despite 
detecting almost no red astrocytes (Pten+/+; Egfr-/-) in the same mice. The density of astrocytes 
with depletion of both Pten and Egfr in Pten-MADM-cKO-Egfr (12.20, SEM±1.52) does not 
differ significantly from the density of only Pten-depleted green astrocytes in Pten-MADM 
(Tukey’s post hoc test, p=1.0) and is therefore higher than the density of Egfr-deficient 
astrocytes in control-MADM-cKO-Egfr and WT astrocytes in control-MADM (Tukey’s post hoc 
test, p<0.0001, p=0.0007). Additionally, I found that in 5 out of 6 analyzed mice, loss of both 
Pten and Egfr results in the formation of cellular aggregates in the dentate gyrus, but not in 
the cortex, composed of what appears to be astrocytes. 
Altogether, this demonstrates that depletion of Egfr is not sufficient nor necessary to rescue 
or dampenthe increase in astrocyte generation caused by Pten deletion. The role of Pten in 
astrocyte generation therefore appears not to depend on Egfr function. These data show that 
the cell-autonomous Pten loss of function phenotype (i.e., excessive astrocyte production) is 
not dependent on functional Egfr. Altogether the Pten/Egfr genetic interaction experiment 











 (A) Confocal images 30 µm thick of control-MADM (green and red cells are Pten+/+; Egfr+/+), (B) 
Pten-MADM (green cells are Pten-/-; Egfr+/+ and red cells are Pten+/+; Egfr+/+), (C) Control-MADM-
Egfr-cKO (green and red cells are Pten+/+; Egfr-/-) and (D) Pten-MADM-Egfr-cKO (green cells are 
Pten-/-; Egfr-/- and red cells Pten+/+; Egfr-/- at P21. Scale bar=500 µm, Ctx inset=50 µm. Ctx=cortex. 
(E) Representative example of the dentate gyrus disorganization and mass aggregates in the 
hippocampus composed of what appears to be astrocytes. Mass aggregates of different sizes 
were found in 5 out of 6 mice. Scale bar = 200 µm 
(F) Left. Quantification of g/r neuron ratio. As in previous results, the g/r neuron ratio of Pten-
MADM (1.75, SEM±0.01) is higher than of control-MADM (1.09, SEM±0.05) reflecting a higher 
number of Pten-deficient neurons than WT neurons (one-way ANOVA, F(3,9)=88.24, p<0.0001; 
Tukey’s post hoc test, p<0.0001). Similarly, the g/r neuron ratio of Pten-MADM-cKO-Egfr (1.75, 
SEM±0.01) is higher than in control-MADM-cKO-Egfr (0.96, SEM±0.06) (Tukey’s post hoc test, 
p<0.0001). The g/r neuron ratio of control-MADM and control-MADM-cKO-Egfr do not differ 
from each other (Tukey’s post hoc test, p=0.13) and neither does the g/r neuron ratio of Pten-
MADM-cKO-Egfr from Pten-MADM (Tukey’s post hoc test, p=1.00). This supports that Egfr 
deletion has no effect on g/r neuron ratio. 
Right. Quantification of astrocyte density (astrocytes/mm2). As in previous results, the density 
of Pten-deficient astrocytes in Pten-MADM (9.07, SEM±0.67) is higher than of WT astrocytes in 
control-MADM (4.54, SEM±0.32) (one-way ANOVA, F(3,9)=17.42, p<0.0004; Tukey’s post hoc 
test, p<0.01).  As previously reported, the density of Egfr-deficient green astrocytes in control-
MADM-cKO-Egfr (0.33, SEM±0.13) is drastically reduced to almost none and thus significantly 
lower than the density of both WT astrocytes in control-MADM and Pten-deficient astrocytes in 
Pten-MADM (Tukey’s post hoc test, p=0.03, p=0.0001). Surprisingly, the density of astrocytes 
with depletion of both Pten and Egfr in Pten-MADM-cKO-Egfr (12.20, SEM±1.52) does not differ 
significantly from the density of only Pten-depleted astrocytes in Pten-MADM (Tukey’s post hoc 
test, p=1.0) and is therefore higher than the density of Egfr-deficient astrocytes in control-
MADM-cKO-Egfr and WT astrocytes in control-MADM (Tukey’s post hoc test, p<0.0001, 
p=0.0007). This demonstrates that depletion of Egfr is not sufficient or necessary to rescue the 
increase in astrocyte generation caused by Pten deletion, and that the role of Pten in astrocyte 
generation does not depend solely on Egfr function.  
Control-MADM, n=3; Pten-MADM, n=4; Control-MADM-cKO-Egfr n=3; Pten-MADM-cKO-Egfr 
n=3.*p<0.05. ***p<0.001. ****p<0.0001. Data are mean ± SEM.  
Figure 43. Genetic Interaction of Pten with Egfr Suggests an Egfr-independent Role of Pten 




 Pten Cell-Autonomously Controls Neuron Generation and Migration in 
the Hippocampus 
I quantified the green/red neuron ratio two different hippocampal areas in control-MADM 
and Pten-MADM animals at P21 (Figure 44A). I observed a dramatic increase in the g/r ratio 
of granule cells in the dentate gyrus of Pten-MADM (8.59) compared to WT (0.79) (Figure 44B, 
D). Likewise, I observed a more moderate increase in g/r ratio of CA1 pyramidal neurons in 
Pten-MADM (1.61) compared to WT (1.02). Furthermore, I found a high proportion of ectopic 
Pten-depleted CA1 pyramidal neurons (86.96%) suggesting defects in migration from the 
stratum oriens into the stratum pyramidale, where in WT conditions CA1 pyramidal neurons 
reside and form a compact layer, (Figure 44C, E). Collectively, these results highlight crucial 
cell-autonomous function of Pten in the generation of major cell types in the cortex and 
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(A) Confocal images 30 µm thick of control-MADM and Pten-MADM hippocampus at P21. 
Scale bar=250 µm.( B) Magnification of the dentate gyrus. GG=dentate gyrus, ML=molecular 
layer, GCL= granule cell layer. Scale bar=50 µm. (C) Magnification of the CA1 area. SO=stratum 
oriens, SP=stratum pyramidale, SR=stratum radiale. Scale bar=50 µm. (D) Quantification of g/r 
ratio of granule cells in the dentate gyrus in control-MADM (0.79) and Pten-MADM (8.59). 
N=1. (E) Left) Quantification of pyramidal neurons in the CA1 hippocampal formation. Control-
MADM (1.02), Pten-MADM (1.61) 
Right) Quantification of ectopic CA1 neurons in control-MADM (5%) and Pten-MADM (86.96 
%). N=1 




4.4 Discussion  
In the developing cerebral cortex, NSCs generate cell-type diversity. However, the underlying 
cellular and molecular mechanisms controlling NSC proliferation behavior and lineage 
progression are poorly defined. MADM is a powerful approach to study cell-autonomous gene 
function at high spatiotemporal resolution (Beattie et al., 2017; Hippenmeyer et al., 2010; Joo 
et al., 2014). In this work, quantitative MADM-based experimental paradigms at single cell 
resolution revealed that loss of Pten function results in a cell-autonomous overproduction of 
Pten-deficient neurons and specifically, that at embryonic stages Pten cell-autonomously 
controls NSC proliferation behavior. In particular I found that Pten is cell-autonomously 
required in RGPs in order to regulate the expansion of the RGP pool. In WT conditions it is 
known that at around E12 RGPs transition into a neurogenic state and begin to divide mainly 
asymmetrically to generate intermediate progenitors and neurons (Alvarez-Buylla et al., 
1998; Gao et al., 2014; García-Verdugo et al., 2002). Until this stage I found no obvious 
differences upon sparse ablation of Pten in terms of the proportion of the RGP population 
(roughly 80%), characterized by PAX6 expression, or in the ratio of mutant/WT RGPs (~1). 
However, along the next days of embryonic development, the sparse ablation of Pten results 
in a 50% increase of the RGP population and an accompanying 50% increase of postmitotic 
neurons and/or IPs (both PAX6 negative) at E16.5 (Englund et al., 2005). Notably, this 
experiment monitors the result of Pten-depletion in a sparse population of NSCs, thus in order 
to confirm these results at the single progenitor level, a future independent analysis of clonal 
data induced at E11 (when NSCs divide mainly symmetrically) and analyzed at E13 and 16 will 
be required.  
It has been previously proposed that depletion of Pten in neural stem cells increased 
proliferation. For instance, 1 hr BrdU pulse in Pten cKO using Emx1-Cre driver at E14.5 showed 
a 30% increase in BrdU+  cells, and 24 hr BrdU pulse in E14.5 cortex cultures showed more 
than double Brdu+ cells in neurospheres (Groszer et al., 2001). To confirm and clarify such 
phenotype in vivo, I used MADM analysis. I confirmed an increase of Pten-depleted Pax6+ 
RGPs as well as of neurons and/or IPs and determined that the phenotype has a very strong 
cell-autonomous component that emerges after E12.5 and is evident at E14.5. 
Previous studies in Pten cKO mice using Emx1-Cre driver (Groszer et al., 2001) and hGFAP-Cre 




using Nse-Cre driver (Pten deletion in upper-layer differentiated neurons, CA3 and dentate 
gyrus) show disorganization and increased postnatal proliferation in the dentate gyrus (24 hr 
and 4-week BrdU pulses at P14) (Kwon et al., 2006). A different group has reported that 
granule cells from the dentate gyrus of Pten cKO mice using Nse-Cre driver display a loss of 
polarity. In particular, ectopic mossy fibers (axons of granule cells) are found in the molecular 
layer (where usually only dendrites reside) instead of projecting to the CA3 area (Zhou et al., 
2009). In addition, yet another group has reported that in Pten cKO mice using Nse-Cre driver  
the CA1 hippocampal area forms a less compact layer (Takeuchi et al., 2013). In this regard, 
MADM analysis has contributed to clarify the previously reported abnormalities in the 
hippocampus as well as to identify the cell-autonomous requirement of Pten for proliferation 
and migration of different cell-types in areas beyond the cortex. In particular, I identified a 
cell-autonomous increase in numbers of both Pten-depleted pyramidal neurons in the CA1 
area and in granule cells of the dentate gyrus. In addition, I observed a cell-autonomous 
migration deficit of CA1 neurons from the stratum oriens into the stratum pyramidale, thus 
likely explaining the origin of the previously observed disorganization of this region.  
Once RGPs complete the production of projection neurons, they may undergo a switch to 
activate their gliogenic potential (Bayraktar et al., 2014; Kriegstein and Alvarez-Buylla, 2009). 
Nevertheless, the cellular and molecular mechanisms controlling glia production and 
quantitative output are not well understood. It has been previously shown that germline 
heterozygous Pten mice display a very subtle 10% increase in glia (microglia, oligodendrocytes 
and astrocytes) by using immunolabeling to identify different glia cell-types in combination 
with isotrophic fractionator measurements (Chen et al., 2015). It has also been reported that 
Pten cKO using hGFAP-Cre driver display a 4-fold increase in GFAP levels in Western blot (Wen 
et al., 2013). However, this assay cannot differ between an increase in astrocyte numbers or 
an increased protein expression without cell number alterations, or a combination of both. 
In this regard, MADM analysis has demonstrated conclusively that upon loss of Pten, the 
production of astrocytes is gradually highly increased. This phenotype has a very strong cell-
autonomous component evident at P7 that plateaus after P21. Importantly, the comparison 
between Pten-MADM and cKO-Pten-MADM at P7 revealed that in cKO-Pten-MADM the 




autonomous (community) effects in the mutant environment play an important role in 
exacerbating the cell-autonomous phenotype upon loss of Pten. 
It has been proposed that RGPs give rise to astrocytic intermediate precursor cells (aIPCs) that 
locally amplify astrocyte production in a tightly controlled manner (Farhy-Tselnicker and 
Allen, 2018; Ge et al., 2012). Currently it is not clear whether astrocyte production follows a 
strictly deterministic program similar to neurogenic RGPs (Gao et al., 2014) or whether it 
follows a rather stochastic behavior. However, it is clear that clonally related astrocytes do 
not disperse very broadly (Gao et al., 2014; Molofsky et al., 2014) and that astrocytes exhibit 
precise tiling (i.e., do not overlap their fine projections). Consequently, it has been suggested 
that astrocyte production may be controlled by homeostatic cues to ensure the complete 
coverage of the local neuropil (Molofsky and Deneen, 2015).  
Loss of Pten function results in a cell-autonomous overproduction of Pten-deficient astrocytes 
more dramatic than the overproduction of Pten-deficient neurons.  Importantly, it is unclear 
what precise Pten-dependent signaling cascades are misregulated specifically in aIPCs and 
whether they are a global feature of neural stem cells or a specific feature of aIPCs. Given that 
astrocytes tile the neuropil, is possible that Pten-deficient aIPCs have an advantage over WT 
aIPCs and neurogenic RGP. Astrocyte overproduction in Pten-MADM could reflect a 
combination of increased survival combined with a dominant increased proliferative potential 
that could be attributed to enhanced sensitivity to astrocyte proliferating signals in aIPCs.  
Mechanistically, Pten could have additional roles in regulating cell-surface abundance of 
growth factor receptors and thus provide differential cellular responsiveness to growth 
factors (Laketa et al., 2014) in aIPCs. Potentially, PIP3 and environment sensing mechanisms 
could play a major role in aIPCs and astrocytes to maximize the interplay with their 
environment to ensure full tiling and to avoid overlap of processes. Possibly even more so 
than in neurogenic RGPs that are anchored apically and basally and form gap junctions with 
the neighboring RGPs, or than early neurons that make use of RGP processes for their directed 
migration to the CP.  
In this regard, it has been shown that EGFR signaling has a crucial dose-dependent regulatory 
function in gliogenesis and that germline Egfr depletion results in cortical astrocyte apoptosis 
(Burrows et al., 1997; Wagner et al., 2006), and conditional deletion of Egfr using the Emx1-




that Pten depletion results in the overproduction of astrocytes it was intriguing to ask whether 
Pten depletion could rescue the lack of astrocytes due to Egfr depletion. My prediction was 
that it was highly likely taking into account that Egfr KO results in lack of EGFR signaling, low 
Akt activation and increased apoptosis astrocytes (Wagner et al., 2006) whereas Pten KO 
leads to strong activation of Akt (Chen et al., 2015; Groszer et al., 2001) and Akt has been 
shown to oppose apoptosis in different cell lines (Grant et al., 2002; Leverrier et al., 1999; 
Panka et al., 2001). On the other hand, it was also intriguing to interrogate whether Egfr 
depletion could attenuate the overproduction of astrocytes due to Pten depletion. This 
seemed less likely, considering the breast cancer scenario where tumor cells with loss of Pten 
proliferate in an Egfr-independent manner but upon induction of Pten become sensitized to 
EGFR inhibitors (EGFR-dependent). 
In fact, I could observe that loss of both Pten and Egfr together does not overcome the 
exhuberant number of cortical astrocytes and results in the formation of cellular aggregates 
composed of what appears to be astrocytes in the hippocampus dentate gyrus. The genetic 
interaction between Pten and Egfr in aIPC/astrocytes, may suggest a functional relationship 
in vivo where Pten is the dominant party. Although the precise nature of Pten-Egfr interaction 
remains to be determined, it seems highly specific for cortical and hippocampal astrocyte 
generation, but not for pyramidal neuron generation. It will be revealing to probe whether 
PTEN and EGFR interact at the protein level in vivo and to assay EGFR cell surface levels and/or 
turnover in a Pten loss of function context during astrocyte generation. 
For instance, PTEN has been shown in vitro to promote degradation of ligand-bound receptors 
such as EGFR by stabilizing ubiquitin ligase complexes (Vivanco et al., 2010) and to promote 
maturation of endosomes which is necessary to degrade ligand-bound receptors upon 
endocytosis (Shinde and Maddika, 2016). In contrast, high levels of PIP3 in combination with 
polarity complex proteins such as PARD3 (partitioning defective 3) have been shown to 
increase RTK trafficking and recycling which may enhance cellular responsiveness to growth 
factors (Laketa et al., 2014).  
It is thus tempting to speculate that in the context of aIPC in Pten WT conditions EGFR could 
be the main regulator of astrogenesis, but that upon Pten loss of function, cells are able to 
escape from the EGFR-dependency as a result of increased levels of PIP3 and PI3K-Akt 




responsiveness to growth factors. In such scenario, the loss of EGFR signaling could easily be 
compensated and the phenotype of Pten loss of function would remain dominant. This would 
imply that cell-non-autonomous effects would also play an important role since growth 
factors are secreted by neighboring cells. 
It is intriguing to note that endocytosis and downstream intracellular trafficking events could 
actually represent differential functions of Pten in the control of proliferating RGP and aIPCs. 
Alternatively, but not mutually exclusive, Pten could regulate the number of symmetric 
amplification versus asymmetric differentiation divisions by regulating intracellular polarity 
and/or the symmetry of the division plane in aIPCs (Sun et al., 2005).  
While genetic depletion can reveal cell-autonomous gene functions, the contribution of non-
cell-autonomous gene functions and/or community effects often remain poorly defined. Non-
cell-autonomous gene functions may involve directed cell-to-cell communication either via 
contact-mediated or secreted signaling cues (Greenman et al., 2015; Hippenmeyer, 2014). For 
instance, excess activation of AKT3 in just a small population of cells is associated with human 
focal malformations in cortical development, which disrupts the architecture of the entire 
hemisphere (Baek et al., 2015). These findings suggest that alteration of the properties of 
individual neurons collectively may affect the entire community. Such a phenomenon is also 
observed in distinct cellular contexts including collective cell migration and tissue 
morphogenesis (Beattie et al., 2017; Heisenberg and Bellaïche, 2013). The cellular and 
molecular mechanisms orchestrating community effects during brain development are 
mostly unknown due to the lack of experimental assays enabling the visualization and 
quantitative assessment of the non-cell-autonomous elements in full or whole tissue 
conditional loss-of-function phenotypic analysis (Greenman et al., 2015). To this end, I have 
established a genetic strategy that relies on MADM-based single-cell phenotypic analysis of 
individual mutant cells in distinct cellular environments to visualize and dissect the non-cell-
autonomous influence (community effects) on the single-cell phenotype. The two different 
environments are either a rather normal environment (due to sparse mosaic ablation of Pten) 
or a homozygous mutant environment (due to global/whole tissue wide ablation of Pten). 
Single-cell phenotypes in the conditional full knockout reflect a combination of both cell-




or exacerbate the phenotypes observed in single-cells from genetic mosaics with sparse 
deletion of Pten.  
At P7 the relative proportion of astrocytes in WT conditions is roughly 10%. Although sparse 
ablation of Pten-MADM results in a cell-autonomous increase of Pten-depleted neurons and 
astrocytes, the relative proportion of astrocytes (~12% mutant, ~8% WT) is not significantly 
altered. Interestingly, the relative proportion of astrocytes in the cKO-Pten-MADM at P7 is 
significantly higher (30%), indicating a dominant cell-autonomous component but 
significantly influenced by non-cell-autonomous community effects. A study relying on 
quantifications from isotrophic fractionator suggested that in Pten cKO using Emx1-Cre driver 
cell numbers are similar to heterozygous Pten cKO and that the difference is only a decreased 
cell density attributed to the hyperthrophy of Pten-depleted cells (Chen et al., 2015). I, 
however find that although neuron numbers are indeed not very different between WT and 
Het, that both the relative and absolute number of astrocytes in Pten cKO is severely 
increased.  
Additionally, I found that layer stainings for upper- and lower-layer markers are comparable 
in WT and upon mosaic ablation of Pten and suggest proper neuronal migration in the cortex. 
However, global ablation of Pten results in dramatic migration phenotypes, indicating a cell-
non-autonomous effect of the Pten-depleted environment.  
Altogether, by using genetic MADM approaches to sparsely and globally ablate Pten gene 
function in RGPs, I demonstrate the cell-autonomous requirement at single cell level of Pten 
during cortical RGP lineage progression in neurogenesis and astrocyte production, as well as 
in proliferation and migration behavior of hippocampal neurons. I find that the local niche 
environment (non-cell-autonomous contributions) acts together with cell-autonomous gene 
function to control astrocyte production and neuronal migration in the cortex. Moreover, I 
find that the role of Pten in the exuberant production of astrocytes is independent of Egfr and 
propose that a candidate mechanism responsible of increasing the proliferative potential of 
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All experimental work involving transgenic MADM mice was performed in both female and 
male animals. Experiments were approved by the Austrian Federal Ministry of Science and 
Research (BMWFW-66.018/002-WF/V/36/2017) and in accordance with the Austrian and EU 
animal laws. The principles of the 3R (Replace, Reduce, Refine) were strictly applied and 
animal welfare was guaranteed by institutional guidelines. 
 
Generation of Recombinant MADM Mice 
In order to generate Pten-MADM and cKO-Pten-MADM animals, Pten-flox mice (Groszer et 
al., 2001) were bred to both the MADM-TG cassette and MADM-GT on chromosome 19 
(previously generated). Recombinant mice resulting from meiotic recombination events were 
recovered and subsequently bred to the mice bearing the complementary MADM cassette in 







Isolation of MADM-Labeled Tissue 
Mice at least 7 days old were deeply anesthetized through injection of a 
ketamine/xylazine/acepromazine solution (65 mg, 13 mg and 2 mg/kg body weight, 
respectively), and confirmed to be unresponsive through pinching the paw. Perfusion was 
performed with PBS followed by ice-cold 4% PFA.  Brains were surgically removed and fixed 
in 4% PFA overnight at 4°C.  For embryo collection, pregnant females previously plug-checked 
were sacrificed by cervical dislocation, embryos were collected, and the heads were dissected 
and fixed in 4% PFA at 4°C for 48 hrs. Tissue was fixed in 4% PFA overnight at 4°C. Next, tissue 
was cryopreserved in 30% sucrose for approximately 48 hr and then embedded in Tissue-Tek 
O.C.T. (Sakura). All samples were stored at -20°C or -80°C until further usage. Samples were 
sectioned in a cryo microtome 20 µm thick for embryonic stages and 30 µm thick for postnatal 
stages. Brain samples were collected either directly on Superfrost Glass Slides (Thermo Fisher 
Scientific) or in 24 multi-well dishes with PBS and then mounted onto Superfrost Glass Slides. 
 
Histology and Immunostaining of MADM-Labeled Tissue 
For immunofluorescence stainings, sections were thawed at room temperature for 15 min 
and encircled with DAKO hydrophobic pen. Then, they were washed 3x for 5 min with PBS. 
Antigen retrieval was performed by adding pre-warmed Citrate Buffer pH=6.0 to the samples 
and incubating them at 85°C for 30 min. Samples were washed 3x for 5 min with PBS. Samples 
were incubated in Blocking Solution (10% Horse Serum, 0.5% Triton X-100 in PBS) for 1h at 
room temperature. Primary antibodies were diluted in Staining Solution (5% Horse Serum, 
0.5% Triton X-100 in PBS) and added to the samples over night at 4°C. Next day, the samples 
were washed 3x for 5min with PBS and incubated with secondary antibodies in Staining 
Solution for 1h at room temperature. After washing 3x for 5min with PBS, samples were DAPI 
stained (1:20’000) for 15 min and then embedded in mounting medium containing 1,4-
diazabicyclooctane (DABCO; Roth) and Mowiol (Roth) and stored at 4°C until they were 
imaged at a Zeiss LSM800. Primary antibodies: rabbit anti-Pax6 (Cell Signaling) 1:500, chicken 
anti-GFP (Aves) 1:400, goat anti-Tdt (SICgen) 1:400, rabbit anti-RFP (MBL). Secondary 
antibodies: Alexa Fluor 647 anti-rabbit (Molecular Probes), Alexa Fluor FITC anti-chicken 
(Molecular Probes), Alexa Fluor 586 anti-goat (Cell Signaling), Alexa Fluor 568 anti-rabbit 





Analysis of MADM-Labeled Brains 
Images were acquired using either an inverted LSM800 confocal microscope (Zeiss) and 
processed using Zeiss Zen Blue software and Photoshop (Adobe), or acquired using a 
SlideScanner VS120 (Olympus) and processed via custom scripts in ImageJ. Tiled images, 
encompassing the entire region of interest, were taken for a minimum of 4 brain sections per 
animal. Images were imported into Photoshop software (Adobe) and the boundaries for the 
region of interest were traced. MADM-labeled cells were manually counted based on 
respective marker expression. 
 
Quantification and Statistical Analysis 
Statistical analysis was performed in the software Prism8 (GraphPad). Data expressed as ratio 
was log-transformed previously to statistical testing.  Evaluation of data was performed by 
two-tailed unpaired Student’s t-test for comparisons between two groups (Figure 40C, Figure 
42E), one-way ANOVA for comparisons between multiple groups (Figure 40 B and D, Figure 
41 C and D, Figure 43F) or two-way ANOVA for comparisons between groups split by other 
variable (Figure 41B, Figure 42D, Figure 39D). N was defined as the g/r ratio from one animal 
resulting from the quantification of at least 4 sections in adults and 7-10 sections in embryonic 
stages. For Figure 43, n was defined as the density of green cells per mm2 from one animal 









Mosaic genetic analysis has been widely used in different model organisms, mainly 
nematodes and arthropods, to study gene-function in a cell-autonomous or tissue-specific 
fashion. More recently, and less easily conducted, mosaic genetic analysis in mammals such 
as mice has been enabled in different modalities with the ambition to shed light on human 
gene function and disease. These genetic tools are of particular interest, but not restricted to, 
the study of the brain. Notably, the MADM technology for genetic mosaic analysis in mice at 
single cell resolution has already advanced the study of genetic mechanisms regulating brain 
development. Consequently, it is expected that MADM-based analysis of genetic alterations 
will continue to reveal important insights on the fundamental principles of development and 
disease to potentially assist in the development of new therapies or treatments. 
The MADM technology offers a genetic approach in mice to visualize and concomitantly 
manipulate small subsets of genetically defined cells at a clonal level and single cell resolution. 
Altogether, I have contributed to expanding the genome-wide MADM library genetic resource 
which required the generation of transgenic mice with MADM cassettes knocked in close to 
the centromeres of all 19 mouse autosomes. I have validated and analyzed the mitotic 
recombination efficiency in all MADM strains in the majority of the mouse organs with special 
focus on the brain. Remarkably, the completion of the genome-wide MADM library now 
enables the genetic dissection of the cell-autonomous function of the vast majority of mouse 
genes in virtually any cell-type. Next, capitalizing on the novel MADM resource and its 
property of mitotic recombination-based lineage tracing, I addressed the hypothesis of non-
random sister chromatid segregation for the first time comprehensively in an in vivo context. 
I found that chromatid sister segregation patterns are chromosome-specific and further 
affected by cell-type. In a broader context my results indicate that the selective sister 
chromatid segregation process may reflect a mechanism for stem cell lineage progression 
and/or cellular differentiation in the developing brain. 
Clonal analysis using MADM provides a quantitative framework to measure the proliferative 
behavior, cellular output, and lineage relationship of individual progenitors and their 
daughter cells. In the interest of making available not only the genetic tools but also the 
methods to exploit this resourceful asset, I have contributed to the generation of a protocol 




level using MADM. Furthermore, I have illustrated the applicability and power of MADM-
based clonal analysis by contributing to the MADM analysis of sparse clones in the cerebellum 
and revealed that SOX2+ embryonic cerebellar progenitors are capable of generating different 
cell-types from both GABAergic and glutamatergic lineages. These results support the findings 
of our collaborators that in the cerebellum common progenitors generate neuronal diversity 
and give rise to most, if not all, types of cerebellar neurons via a conserved Notch-mediated 
binary cell fate choice mechanism.  
PTEN mutations are responsible of neurological deficits and/or tumor susceptibility in 
humans. Thus, I have established a quantitative genetic strategy to enable the functional 
MADM analysis of Pten in the brain. I have demonstrated that Pten cell-autonomously 
controls cortical RGP-mediated neurogenesis and astrocyte generation in an Egfr-
independent manner. Next, I have shown that Pten cell-autonomously controls the 
generation of hippocampal neurons in the dentate gyrus, and the generation and migration 
of neurons in the CA1 area. Finally, I have dissected the relative contribution of cell-non-
autonomous (community) effects and cell-autonomous Pten function in RGP lineage 
progression. Altogether, I have determined that Pten plays a critical role in temporal RGP 
lineage progression during corticogenesis. 
In summary, this work generated and characterized the necessary genetic tools to perform 
MADM-based analysis at single cell level of virtually any gene in any cell type and provides a 
protocol to perform lineage tracing using the novel MADM resource. In addition, this work 
also shed light on biologically relevant events in an in vivo context such as chromosomal 
segregation upon mitosis and the generation of cell-type diversity in the cerebral cortex and 
cerebellum. This work provides a foundation and opens the door to further elucidating the 
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 Appendix - Key Reagents or Resources 
  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Keratin 8 #ab59400 Abcam RRID:AB_942041 
Keratin 14 #PRB-155P BioLegend(former Covance) RRID:AB_292096 
Beta-Catenin #8480 Cell Signaling RRID:AB_11127855 
CD3-HorizonV451 eBioscience RRID:AB_1272193 
CD19 APC eBioscience RRID:AB_469358 
Alexa Fluor 647 Anti-Rabbit 
IgG Molecular Probes RRID:AB_2762835 
Anti-DIG AP Merck RRID:AB_2313640 
Hoechst H33258 Sigma No identifier 
   
Chemicals, Peptides, and Recombinant Proteins 
Papain Vial Source Worthington Cat#PAP2 
DNase Vial Source Worthington Cat#D2 
ACK Lysis Buffer Gibco Cat#A1049201 
Fc Block CD16/32 BioLegend RRID:AB_469358 
DIG DNA Labelling Mix Merck 11277065910 
Blocking Reagent Merck Cat#11096176001 
Positively Charged Nylon 
Membrane Merck Cat#11209272001 
CDP-Star Merck Cat#11759051001 
   
Critical Commercial Assays 
N/A   
   
Deposited Data 
N/A   
   
Recombinant DNA 
MADM-1-GT targeting vector This study N/A 
MADM-1-GT targeting vector This study N/A 
MADM-2-GT targeting vector This study N/A 
MADM-2-TG targeting vector This study N/A 
MADM-3-GT targeting vector This study N/A 
MADM-3-TG targeting vector This study N/A 
MADM-4-GT targeting vector This study N/A 
MADM-4-TG targeting vector This study N/A 
MADM-5-GT targeting vector This study N/A 




MADM-6-GT targeting vector This study N/A 
MADM-6-TG targeting vector This study N/A 
MADM-8-GT targeting vector This study N/A 
MADM-8-TG targeting vector This study N/A 
MADM-9-GT targeting vector This study N/A 
MADM-9-TG targeting vector This study N/A 
MADM-10-GT targeting vector This study N/A 
MADM-10-TG targeting vector This study N/A 
MADM-13-GT targeting vector This study N/A 
MADM-13-TG targeting vector This study N/A 
MADM-14-GT targeting vector This study N/A 
MADM-14-TG targeting vector This study N/A 
MADM-15-GT targeting vector This study N/A 
MADM-15-TG targeting vector This study N/A 
MADM-16-GT targeting vector This study N/A 
MADM-16-TG targeting vector This study N/A 
MADM-17-GT targeting vector This study N/A 
MADM-17-TG targeting vector This study N/A 
MADM-18-GT targeting vector This study N/A 
MADM-18-TG targeting vector This study N/A 
MADM-19-GT targeting vector This study N/A 
MADM-19-TG targeting vector This study N/A 
   
Genotyping primers 
MADM line ID Sequence 
MADM-1 
Chr 1 primer 1 for CCTCTGGCCTGAGTACACTGC 
Chr 1 primer 1 rev TCATGTGTTTTGCAGCGATGG  
Chr 1 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-2 
Chr 2 primer 1 for GAGACCATGGGTAGGTAGTGTGG 
Chr 2 primer 1 rev AGAGACAGGCCATGGTCACA 
Chr 2 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-3 
Chr 3 primer 1 for  CACCAGCACTCGGATTTCAG 
Chr 3 primer 1 rev TGAATGCCCAGGTTCAGTTC 
Chr 3 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-4 
Chr 4 primer 1 for GTACTTGCTGTGTGTCCAGACC 
Chr 4 primer 1 rev ATTGAACCCAGGTCCTTTGC 
Chr 4 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-5 
Chr 5 primer 1 for AGAAATTCCCAGCAATGCAC 
Chr 5 primer 1rev CAACTCGTGGTCCCTATCATC 
 Chr 5 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-6 
Chr 6 primer 1 for ACTGGATGGCTTCCTTGCTC 
Chr 6 primer 1rev AAAACTCGTGGGTGATGCTG 





Chr 7 primer 1 for GGCTGAACTGGAGGATTGTCTAGTTTTCC 
Chr 7 primer 1 rev GCTCTTGCTCTCATTTCTCAGTTCAAACCGCGTATC  
Chr 7 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-8 
Chr 8 primer 1 for CCCCAGGTTGAGTCACACAC 
Chr 8 primer 1 rev GAGAGCAAGCAGGCAGAAAC 
Chr 8 primer 2  rev TCAATGGGCGGGGGTCGTT  
MADM-9 
Chr 9 primer 1 for GGCCAAACTAACCCAAGCAG 
Chr 9 primer 1 rev TAGAGCCTCCTCCCAACACC 
Chr 9 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-10 
Chr 10 primer 1 for CCGGCCTAGTCTCACAAGAG 
Chr 10 primer 1 rev AAGGGAGGAGCTGGAGAGTC 
Chr 10 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-11 
Chr 11 primer 1 for TGGAGGAGGACAAACTGGTCAC 
Chr 11 primer 1 rev TTCCCTTTCTGCTTCATCTTGC 
Chr 11 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-12 
Chr 12 primer 1 for CACTAAGCTCCACTCGCACC 
Chr 12 primer 1 rev TCCCTCATGATGTATCCCCT 
Chr 12 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-13 
Chr 13 primer 1 for TCCCCAACCAGCTCCTTAAC 
Chr 13 primer 1 rev TGGGTCACAGTCCAGTCTCC   
Chr 13 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-14 
Chr 14 primer 1 for CTGGGGCTAATTTGGGCTAC 
Chr 14 primer 1 rev ATGCCCCCACAGAAGGTAAC 
Chr 14 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-15 
Chr 15 primer 1 for CTCCTAATTTTTCCCCACCTTG 
Chr 15 primer 1 rev TACTTTGCTGTTAAGCCCTGGA 
Chr 15 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-16 
Chr 16 primer 1 for TCCCAACCCTGTGCTATCAG 
Chr 16 primer 1 rev CGAACCTAAAGGTGCCTTAA 
Chr 16 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-17 
Chr 17 primer 1 for AGCACCTGTGCCATCCTG 
Chr 17 primer 1 rev AGCCACACAATTATCGAAGAGC 
Chr 17 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-18 
Chr 18 primer 1 for CGTCTCAGAAGCCAAAGGTC 
Chr 18 primer 1 rev GGAATTGGTCCATTGGTGAA 
Chr 18 primer 2 rev TCAATGGGCGGGGGTCGTT  
MADM-19 
Chr 19 primer 1 for GGGGAAACCCCTATGCTGAG 
Chr 19 primer 1 rev GCCAGAAAGCCAAGAACAAG  





TG for GGACTGGGTGCTCAGGTAGTGGTTGTCG 
TG rev GGTACGTCCAGGAGCGCACC TCTTCTTCAAGG 
GT-cassette 
GT for CCAAGCTGAAGGTGACCAAG 
GT rev TCTTCTTCTGCATTACGGGG 
Y chromosome 
Ychrom for AGATGAAGATGCTGGTGGCACAGC 
Ychrom rev GACTAGACATGTCTTAACATCTGTCC 
Cre 
Cre for GTCCAATTTACTGACCGTACACC 
Cre rev GTTATTCGGATCATCAGCTACACC 
   
Experimental Models: Cell Lines 
Parental ES cell line C2, Stock 
Number: 011989-MU A. Nagy MMRRC_011989-MU 
   
Experimental Models: Organisms/Strains/Lines 
Mouse: MADM-1-GT This study N/A 
Mouse: MADM-1-TG This study N/A 
Mouse: MADM-2-GT This study N/A 
Mouse: MADM-2-TG This study N/A 
Mouse: MADM-3-GT This study N/A 
Mouse: MADM-3-TG This study N/A 
Mouse: MADM-4-GT This study N/A 
Mouse: MADM-4-TG This study N/A 
Mouse: MADM-5-GT This study N/A 
Mouse: MADM-5-TG This study N/A 
Mouse: MADM-6-GT This study N/A 
Mouse: MADM-6-TG This study N/A 
Mouse: MADM-7-GT The Jackson Laboratory RRID:IMSR_JAX:021457 
Mouse: MADM-7-TG The Jackson Laboratory RRID:IMSR_JAX:021458 
Mouse: MADM-8-GT This study N/A 
Mouse: MADM-8-TG This study N/A 
Mouse: MADM-9-GT This study N/A 
Mouse: MADM-9-TG This study N/A 
Mouse: MADM-10-GT This study N/A 
Mouse: MADM-10-TG This study N/A 
Mouse: MADM-11-GT The Jackson Laboratory RRID:IMSR_JAX:013749 
Mouse: MADM-11-TG The Jackson Laboratory RRID:IMSR_JAX:013751 
Mouse: MADM-12-GT The Jackson Laboratory RRID:IMSR_JAX:021460 
Mouse: MADM-12-TG The Jackson Laboratory RRID:IMSR_JAX:021461 




Mouse: MADM-13-TG This study N/A 
Mouse: MADM-14-GT This study N/A 
Mouse: MADM-14-TG This study N/A 
Mouse: MADM-15-GT This study N/A 
Mouse: MADM-15-TG This study N/A 
Mouse: MADM-16-GT This study N/A 
Mouse: MADM-16-TG This study N/A 
Mouse: MADM-17-GT This study N/A 
Mouse: MADM-17-TG This study N/A 
Mouse: MADM-18-GT This study N/A 
Mouse: MADM-18-TG This study N/A 
Mouse: MADM-19-GT This study N/A 
Mouse: MADM-19-TG This study N/A 
Mouse: Emx1-Cre The Jackson Laboratory RRID:IMSR_JAX:005628 
Mouse: Hprt-Cre The Jackson Laboratory RRID:IMSR_JAX:004302 
Mouse: Nestin-Cre Petersen et al. 2002 N/A 
   
Software and Algorithms 







FACS Diva  BD Biosciences  
Graphpad Prism 8.0 Graphpad https://www.graphpad.com/scientific-software/prism/ 
FlowJo Becton, Dickinson and Company; 2019 https://www.flowjo.com/ 
Photoshop Adobe adobe.com/products/photoshop 
ImageJ  https://imagej.nih.gov/ij/ 
   
Other 
FACS Aria III BD Biosciences N/A 
LSM 800 Confocal Zeiss N/A 
SlideScanner VS120 Olympus N/A 
Cryostat Cryostar NX70 Thermo Fisher Scientific N/A 
Peqlab FUSION SL Advance Peqlab N/A 
 
